data_2ke9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ke9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.446 HD11 ' N ' ' A' ' 285' ' ' LYS . 2.7 tm? -94.89 141.64 28.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.446 ' N ' HD11 ' A' ' 284' ' ' LEU . 0.0 OUTLIER -116.57 136.8 52.67 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.93 0.395 . . . . 0.0 110.964 -177.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.4 154.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.463 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -102.55 141.78 34.8 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.429 ' HA ' HG11 ' A' ' 342' ' ' VAL . . . -82.73 110.94 18.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.87 -32.23 31.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.34 164.96 16.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.768 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.11 157.52 18.82 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . 0.424 ' HB3' HG12 ' A' ' 303' ' ' VAL . 23.4 t80 -141.15 112.73 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -141.67 119.48 11.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.916 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -150.44 126.88 10.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.79 166.85 10.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 71.94 7.59 5.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.575 0.75 . . . . 0.0 111.042 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -127.71 114.98 20.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.82 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.89 -9.97 26.75 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.966 2.444 . . . . 0.0 113.624 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 22.0 p -107.16 8.04 29.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.179 0.514 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.32 150.09 27.41 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.158 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' A' ' 337' ' ' PHE . 20.7 tp -105.29 152.73 22.54 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.871 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -119.84 105.26 10.94 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 292' ' ' PHE . 8.2 p -148.78 144.39 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.041 0.448 . . . . 0.0 111.255 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -112.74 146.51 38.64 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.09 125.6 16.08 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.84 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.82 -22.76 20.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.225 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -76.85 165.23 24.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 13.6 m -116.36 137.86 48.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.313 0.578 . . . . 0.0 111.6 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 3.6 mp -116.7 132.95 64.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.831 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 6.5 m -98.32 107.25 19.67 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' A' ' 284' ' ' LEU . 35.9 m -93.5 142.81 12.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.475 0.655 . . . . 0.0 112.071 -176.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 60.1 tp -87.88 -14.67 38.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.024 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -91.31 164.7 13.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.149 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -155.3 121.92 5.33 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.5 m80 58.42 75.52 0.52 Allowed Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.408 0.443 . . . . 0.0 110.129 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -95.03 -170.26 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.115 2.543 . . . . 0.0 112.767 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.19 104.98 5.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 92.85 -69.03 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.24 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -148.85 158.19 43.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.652 0.263 . . . . 0.0 110.493 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -137.03 167.98 20.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.505 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -104.73 137.94 41.77 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.93 26.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.957 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -114.79 130.89 56.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 41.6 mm -72.78 135.45 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.877 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 120.621 0.248 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 47.6 mm -124.08 124.42 68.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.827 0.346 . . . . 0.0 110.815 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.1 21.05 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -102.27 136.83 41.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.863 0.363 . . . . 0.0 110.443 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.518 ' CD1' HD22 ' A' ' 301' ' ' LEU . 4.8 p90 -154.87 154.78 29.55 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.267 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.432 ' O ' HG12 ' A' ' 341' ' ' ILE . 73.8 Cg_endo -77.44 134.33 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.39 2.06 . . . . 0.0 112.176 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.85 -6.88 13.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.867 2.378 . . . . 0.0 112.311 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -74.52 -19.59 79.82 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.157 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 338' ' ' PRO . 39.0 pt -99.58 2.91 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 117.254 0.527 . . . . 0.0 111.733 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 288' ' ' ALA . 29.1 m -133.8 155.32 39.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -160.68 150.13 17.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.048 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.15 -28.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 20.4 m -77.05 168.41 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.853 0.359 . . . . 0.0 111.665 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 162.87 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.54 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -179.23 6.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? . . . . . 0 C--O 1.244 0.816 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.259 177.271 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 121.134 0.493 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.17 -176.88 3.06 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 7.4 ptpp? -143.7 134.22 24.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 111.36 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 31.3 m -118.55 156.67 20.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.112 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -102.74 134.87 45.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.6 115.52 18.36 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.169 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.401 ' HG ' ' OE2' ' A' ' 343' ' ' GLU . 4.2 mm? -87.77 -17.11 32.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.235 0.54 . . . . 0.0 110.137 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -140.75 147.26 38.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.42 134.44 39.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -78.74 112.58 16.01 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -71.35 -31.96 67.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.54 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -79.83 78.76 6.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.06 -9.85 10.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.13 68.75 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.258 0.551 . . . . 0.0 110.223 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -179.76 126.15 0.24 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.16 -27.69 81.15 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.449 . . . . 0.0 113.531 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.89 -1.79 57.62 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.191 0.52 . . . . 0.0 111.105 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -102.28 150.78 22.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 337' ' ' PHE . 3.9 tp -90.01 104.49 17.06 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.375 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -79.42 102.24 8.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.07 144.79 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.266 0.555 . . . . 0.0 111.592 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -104.4 147.29 27.72 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.279 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.51 124.44 20.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.385 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.03 40.89 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.928 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.54 158.07 19.61 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.22 139.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.171 0.51 . . . . 0.0 111.632 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 285' ' ' LYS . 20.5 mt -110.94 132.58 59.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.438 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 27.5 m -80.86 108.54 14.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.63 143.44 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 6.2 mp -81.89 -49.73 9.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.19 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -162.47 162.78 27.67 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.608 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.7 132.36 40.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -145.23 81.02 10.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.426 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.87 -0.8 10.91 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.897 2.398 . . . . 0.0 112.398 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -70.3 -21.97 62.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.225 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -180.0 -156.92 19.16 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -65.34 110.72 2.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.088 0.471 . . . . 0.0 110.773 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . 0.464 ' HD1' ' O ' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -85.13 175.5 8.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -119.03 142.1 48.13 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.107 0.48 . . . . 0.0 112.171 -175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -159.72 171.25 36.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.778 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -109.14 129.52 55.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.915 0.388 . . . . 0.0 110.141 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 325' ' ' HIS . 8.2 tp -119.61 149.42 22.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.355 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . 0.422 ' CE1' HG21 ' A' ' 324' ' ' ILE . 8.3 p-80 . . . . . 0 N--CA 1.486 1.339 0 C-N-CA 124.887 1.275 . . . . 0.0 114.144 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . 0.481 HD11 ' N ' ' A' ' 335' ' ' GLY . 0.0 OUTLIER -179.51 145.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.481 ' N ' HD11 ' A' ' 334' ' ' ILE . . . -138.21 175.79 21.15 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.634 -1.27 . . . . 0.0 113.197 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -111.07 146.12 37.32 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.523 ' CD1' HD22 ' A' ' 301' ' ' LEU . 4.4 p90 -154.01 151.07 23.87 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.003 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.437 ' O ' HG12 ' A' ' 341' ' ' ILE . 70.4 Cg_endo -77.32 127.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.49 2.127 . . . . 0.0 112.109 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.86 -13.28 29.89 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.996 2.464 . . . . 0.0 112.636 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -70.62 -18.9 76.06 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.324 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 338' ' ' PRO . 42.4 pt -103.13 4.3 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 117.4 0.6 . . . . 0.0 111.714 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 288' ' ' ALA . 35.3 m -131.2 150.86 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.87 0.367 . . . . 0.0 111.099 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.401 ' OE2' ' HG ' ' A' ' 289' ' ' LEU . 46.7 mt-10 -137.91 145.38 42.03 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.95 -30.47 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.7 p -83.37 143.31 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 63.7 m -76.94 146.43 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.643 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.68 129.28 34.65 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 . . . . . 0 C--N 1.315 -0.919 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.382 179.302 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 285' ' ' LYS . 2.2 tm? -124.14 141.12 52.32 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.698 -0.401 . . . . 0.0 109.98 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.468 ' N ' HD13 ' A' ' 284' ' ' LEU . 58.9 mtpt -124.69 134.4 52.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.53 142.3 29.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -103.8 132.9 49.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -84.87 125.7 32.85 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.806 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.0 -13.76 30.49 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.052 0.453 . . . . 0.0 110.836 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -132.55 146.47 51.94 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -73.74 120.55 19.49 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.379 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -103.06 113.89 27.74 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -141.53 149.64 41.11 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.511 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -139.62 147.07 40.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.602 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 37.7 tp -75.88 -44.65 39.56 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -161.37 90.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.614 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 15.3 t70 -138.46 126.68 13.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 297' ' ' ASP . 15.9 Cg_exo -68.08 -15.82 43.77 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.047 2.498 . . . . 0.0 114.234 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 20.9 p -113.81 -32.38 6.13 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.52 131.23 48.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.367 0.603 . . . . 0.0 112.53 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 24.0 tp -83.05 153.99 24.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.092 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -110.2 108.13 18.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.02 136.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 111.42 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -88.86 152.84 21.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.87 25.61 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.805 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 100.42 -9.17 58.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.023 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -84.46 164.0 19.1 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.684 0.278 . . . . 0.0 110.528 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 15.8 m -111.2 128.38 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.574 0.702 . . . . 0.0 112.301 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.416 HG23 ' CE1' ' A' ' 337' ' ' PHE . 49.0 mt -97.82 130.4 46.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 7.0 m -93.63 108.08 19.85 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 18.0 m -105.46 148.31 10.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 5.6 mp -64.35 -77.81 0.05 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 167.49 134.99 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.486 1.114 . . . . 0.0 108.321 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 178.79 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.771 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 16.3 m80 52.85 71.49 1.43 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.253 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.64 173.98 9.05 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.729 2.286 . . . . 0.0 111.316 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.57 125.14 45.1 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 100.69 -32.68 7.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.367 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -151.65 137.52 18.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.875 0.369 . . . . 0.0 111.073 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . 0.412 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 56.1 m95 -110.52 159.03 17.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.406 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -136.48 122.23 19.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.89 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -152.86 175.02 31.55 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.472 -1.346 . . . . 0.0 113.898 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 333' ' ' ARG . 53.5 m80 -107.12 128.27 54.25 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 10.2 tp -111.91 155.54 13.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.563 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 . . . . . 0 CA--C 1.533 0.312 0 O-C-N 123.455 0.472 . . . . 0.0 110.758 177.585 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 65.4 mtt180 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 120.775 0.321 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 31.3 mm -113.26 121.35 65.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.055 0.455 . . . . 0.0 110.772 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.89 149.69 20.77 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.551 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 67.5 m-85 -107.64 139.15 42.62 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 338' ' ' PRO . 17.0 p90 -140.93 147.19 47.02 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.632 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 4.8 Cg_exo -75.79 130.85 12.83 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.893 2.395 . . . . 0.0 111.979 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.59 -16.57 37.1 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.366 2.711 . . . . 0.0 112.921 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.57 76.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.541 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 41.2 pt -107.99 1.18 9.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 117.386 0.593 . . . . 0.0 112.048 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.409 HG13 ' CD2' ' A' ' 337' ' ' PHE . 35.4 m -124.11 150.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.421 . . . . 0.0 111.362 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -146.98 170.27 17.45 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.326 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.83 -167.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.22 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 37.2 t -67.78 -34.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 54.7 m -70.0 95.07 0.91 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 110.907 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -100.27 136.96 39.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.694 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--O 1.24 0.559 0 CA-C-O 118.651 -0.69 . . . . 0.0 109.801 177.827 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 120.914 0.388 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -122.71 175.4 6.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.651 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -144.36 133.81 23.29 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.81 168.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.531 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -124.34 134.48 53.15 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.436 ' HA ' HG13 ' A' ' 342' ' ' VAL . . . -78.05 137.04 38.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.242 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.06 -28.8 22.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.517 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -129.16 146.76 51.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.929 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.87 138.06 47.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.851 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -101.92 110.5 22.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -151.32 119.62 6.37 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -151.4 -43.57 0.11 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.325 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 14.6 mt -150.83 134.03 16.12 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.502 ' HA ' ' OD1' ' A' ' 302' ' ' ASN . 38.7 m80 -84.19 84.44 7.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.81 146.89 28.01 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.245 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.88 -8.32 4.4 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.073 2.515 . . . . 0.0 113.668 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 8.1 t -87.59 -11.82 47.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.013 0.435 . . . . 0.0 110.369 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -121.76 150.56 41.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.458 HD22 ' CD1' ' A' ' 337' ' ' PHE . 31.3 tp -88.51 104.03 16.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.576 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 296' ' ' HIS . 29.1 m-80 -84.05 94.09 8.24 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.303 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.46 146.1 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.753 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -108.73 161.29 15.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.77 128.03 34.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.675 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 98.28 -13.3 63.2 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.827 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -80.89 161.17 24.49 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 120.688 0.28 . . . . 0.0 110.659 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 26.5 m -98.03 144.71 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.202 0.525 . . . . 0.0 111.678 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 42.9 mt -128.99 129.49 68.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.752 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 23.5 m -86.69 108.82 18.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 10.6 t -90.79 148.15 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.92 -56.05 13.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.804 0.335 . . . . 0.0 110.222 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -176.68 144.63 0.5 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.431 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . 0.479 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 23.9 pt20 -92.29 79.27 5.05 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.743 0.782 . . . . 0.0 110.626 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . 0.464 ' HB3' ' HD3' ' A' ' 316' ' ' PRO . 1.4 t-80 -136.74 -53.73 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.217 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 315' ' ' HIS . 2.0 Cg_endo -83.48 101.03 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.18 1.92 . . . . 0.0 110.501 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.53 146.57 48.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.824 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 126.8 -158.65 20.88 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -80.65 98.62 7.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 0.0 109.575 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . 0.511 ' CZ2' ' HB3' ' A' ' 339' ' ' PRO . 0.2 OUTLIER -89.4 158.91 17.57 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.908 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -85.91 127.8 34.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.255 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -126.05 154.16 18.74 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.971 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -119.72 139.43 52.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 37.2 mt -106.94 139.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.155 0.502 . . . . 0.0 110.97 -177.858 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.211 0.529 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 19.5 mm -128.06 111.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.304 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -144.35 159.09 27.68 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.555 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 5.4 p90 -104.03 137.71 41.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.458 ' CD1' HD22 ' A' ' 301' ' ' LEU . 20.2 p90 -147.81 155.08 44.58 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.278 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.01 134.59 6.18 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.544 2.162 . . . . 0.0 111.379 176.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . 0.511 ' HB3' ' CZ2' ' A' ' 320' ' ' TRP . 11.1 Cg_endo -54.94 -19.96 21.32 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.2 2.6 . . . . 0.0 113.202 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -60.92 -20.27 57.3 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 114.258 0.463 . . . . 0.0 114.258 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 43.1 pt -100.55 4.84 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.605 0.703 . . . . 0.0 112.259 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 288' ' ' ALA . 31.9 m -132.77 164.19 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.096 0.474 . . . . 0.0 111.596 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.06 149.57 50.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.07 -33.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.1 p -158.25 -20.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 74.0 m -80.24 14.93 1.72 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.981 -0.449 . . . . 0.0 111.981 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -88.67 127.36 35.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.683 177.557 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.444 -0.742 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 60.0 tp -128.64 148.64 50.82 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -124.82 135.48 52.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.016 0.436 . . . . 0.0 111.266 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.456 HG13 ' CH2' ' A' ' 320' ' ' TRP . 16.0 m -125.11 146.68 30.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.898 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -103.07 139.5 38.52 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.86 119.67 23.06 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.076 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.93 -26.87 17.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.413 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -127.31 146.89 50.29 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.83 122.31 25.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -103.49 113.02 26.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -115.55 104.72 12.01 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.956 0.408 . . . . 0.0 111.469 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -130.69 106.25 8.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.1 pp -107.24 -1.01 22.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.178 0.513 . . . . 0.0 110.703 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.57 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.25 113.6 23.67 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.685 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.13 -0.48 9.17 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.621 2.214 . . . . 0.0 111.978 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 3.4 m -85.26 -16.84 38.83 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.48 0.657 . . . . 0.0 109.564 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -91.94 144.7 25.2 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.379 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.71 110.9 18.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.051 0.453 . . . . 0.0 111.166 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -101.06 121.62 42.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.96 152.34 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.939 0.4 . . . . 0.0 111.253 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -101.74 146.58 27.57 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.28 125.51 23.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.758 0.313 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.33 -16.06 29.79 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.699 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -84.29 156.55 21.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.53 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 8.9 t -112.14 135.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.353 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 20.8 mt -114.7 134.05 58.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.952 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 39.7 m -104.19 120.09 40.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.043 0.449 . . . . 0.0 110.711 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 31.3 m -105.24 146.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.133 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 80.0 mt -83.27 -60.12 2.25 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.312 0.577 . . . . 0.0 109.795 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -114.09 114.21 25.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.065 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 141.93 43.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 320' ' ' TRP . 66.8 m-70 -139.95 89.47 11.3 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.22 -9.21 25.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.874 2.382 . . . . 0.0 113.318 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -123.41 117.8 26.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.3 -102.41 1.82 Allowed Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.964 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -153.62 158.0 40.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . 0.456 ' CH2' HG13 ' A' ' 286' ' ' VAL . 0.1 OUTLIER -148.76 170.69 17.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 178.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -128.25 144.56 51.14 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.439 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.1 34.51 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.997 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' A' ' 333' ' ' ARG . 3.9 p-80 -114.26 133.83 55.36 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 47.2 mt -80.93 150.96 4.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.407 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 . . . . . 0 CA--C 1.508 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.44 177.628 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 30.3 tpt180 . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 14.1 mm -153.77 116.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.35 151.49 21.15 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.439 -1.363 . . . . 0.0 112.563 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -89.14 146.33 24.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -158.38 158.48 29.7 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.896 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.454 ' O ' HG12 ' A' ' 341' ' ' ILE . 78.2 Cg_endo -82.39 132.97 7.15 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.334 2.023 . . . . 0.0 111.942 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.8 -14.83 19.12 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.249 2.633 . . . . 0.0 113.116 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -67.9 -19.86 71.99 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.861 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 338' ' ' PRO . 39.5 pt -94.28 -8.15 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 117.599 0.699 . . . . 0.0 111.835 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.05 170.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.974 0.416 . . . . 0.0 111.083 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -157.12 151.19 24.8 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.3 -67.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 73.7 t -104.03 -41.19 6.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.2 m -60.05 133.96 56.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -99.15 158.23 15.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.794 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.908 179.308 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.433 0.635 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.59 173.09 7.39 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.147 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.31 143.16 28.95 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.266 0.555 . . . . 0.0 112.181 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.19 164.04 34.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.86 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -113.64 144.58 42.67 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.131 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.5 118.28 23.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.751 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 -5.96 48.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.29 0.567 . . . . 0.0 110.426 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -138.85 146.49 41.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -80.12 121.92 26.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.663 0.268 . . . . 0.0 110.634 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.83 53.69 1.76 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.511 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.54 ' HB2' ' CE1' ' A' ' 292' ' ' PHE . 50.4 t-20 -66.82 -61.35 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.497 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 13.9 tp -160.48 165.06 31.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -97.38 20.46 11.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.905 0.383 . . . . 0.0 111.936 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.47 153.54 41.36 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.017 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.86 -19.42 65.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.887 2.392 . . . . 0.0 112.829 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.4 m -81.25 -14.99 56.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 110.698 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -109.55 137.65 47.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.963 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.453 HD13 ' CG1' ' A' ' 324' ' ' ILE . 31.4 tp -86.59 111.24 20.44 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.082 0.467 . . . . 0.0 110.978 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.14 102.68 12.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.17 148.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.416 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -96.05 149.25 21.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.78 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.43 27.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.743 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.42 -19.36 26.75 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.382 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -76.98 155.88 32.31 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 116.904 0.352 . . . . 0.0 111.146 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.77 134.13 43.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.344 0.592 . . . . 0.0 111.429 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.44 HG12 ' CD1' ' A' ' 324' ' ' ILE . 56.3 mt -109.24 116.85 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 22.4 m -91.2 114.84 27.47 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.2 142.09 17.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.67 -66.73 0.57 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -178.71 113.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.439 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -158.64 132.49 7.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -64.0 116.94 31.2 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 97.32 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.537 2.158 . . . . 0.0 113.035 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -150.57 129.2 12.28 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.503 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.24 -87.5 0.49 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -151.03 132.03 14.27 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.59 166.3 16.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.663 -175.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -89.16 140.07 29.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 111.886 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.96 156.23 26.33 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.371 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -111.2 121.08 44.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.933 0.397 . . . . 0.0 110.148 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.453 ' CG1' HD13 ' A' ' 301' ' ' LEU . 35.3 mm -85.9 121.75 37.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.438 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 C--N 1.311 -1.086 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.457 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 . . . . . 0 C--O 1.224 -0.271 0 CA-C-O 120.543 0.211 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 15.8 tt -101.44 140.25 20.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.847 0.356 . . . . 0.0 110.337 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.05 179.26 35.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -110.9 143.98 40.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.693 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -149.14 156.51 40.17 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.115 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.418 ' O ' HG12 ' A' ' 341' ' ' ILE . 3.5 Cg_exo -81.72 131.04 7.03 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.822 2.348 . . . . 0.0 111.363 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.17 -15.79 36.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.862 2.375 . . . . 0.0 112.789 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.38 -19.55 74.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.594 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 338' ' ' PRO . 41.1 pt -100.25 1.7 10.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.539 0.669 . . . . 0.0 111.803 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 33.5 m -128.18 164.5 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.182 0.515 . . . . 0.0 111.581 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -160.35 151.83 19.59 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.4 HG11 HG12 ' A' ' 345' ' ' VAL . 7.2 p -66.54 -40.92 87.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.4 HG12 HG11 ' A' ' 344' ' ' VAL . 7.9 p -157.09 122.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.411 . . . . 0.0 110.752 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.6 m -163.96 -23.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.22 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -64.56 121.09 13.62 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.653 -0.689 . . . . 0.0 109.657 179.489 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 311' ' ' VAL . 30.5 p . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 120.886 0.374 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 311' ' ' VAL . 24.6 tp -144.39 157.48 44.23 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.24 133.44 56.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.789 0.328 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.98 152.08 36.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -105.41 137.43 43.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.696 0.284 . . . . 0.0 110.518 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -82.1 110.89 17.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.028 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 47.0 mt -78.66 -26.31 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.198 0.523 . . . . 0.0 110.089 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -132.67 162.79 30.48 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.42 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.44 151.97 32.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.725 0.298 . . . . 0.0 110.206 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . 0.473 ' HB3' HG12 ' A' ' 303' ' ' VAL . 32.4 t80 -140.69 113.48 8.24 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -144.72 102.32 3.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -108.95 129.04 55.43 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 295' ' ' LEU . 1.8 pt? -111.58 7.78 20.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.836 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -92.2 -41.04 10.66 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.049 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -101.97 122.05 48.55 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.085 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.8 -28.55 59.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.318 2.012 . . . . 0.0 111.612 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 7.3 t -83.95 -3.04 57.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.737 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -70.28 150.21 46.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.618 0.247 . . . . 0.0 110.501 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' A' ' 337' ' ' PHE . 15.7 tp -82.51 153.67 25.45 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.059 0.457 . . . . 0.0 110.77 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.424 ' N ' ' HG ' ' A' ' 301' ' ' LEU . 23.4 p-10 -128.15 119.64 25.7 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.7 p -144.4 146.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.048 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -96.55 142.3 28.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.1 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.37 122.11 12.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.733 0.301 . . . . 0.0 110.335 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.17 40.16 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.72 -0.753 . . . . 0.0 113.028 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.2 169.56 12.95 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.151 0.475 . . . . 0.0 110.151 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.13 128.72 72.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.353 0.597 . . . . 0.0 111.583 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.452 HG12 HD11 ' A' ' 324' ' ' ILE . 68.2 mt -99.3 129.05 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.993 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.8 m -98.0 108.6 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 283' ' ' SER . 19.5 m -93.06 140.13 16.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 120.842 0.353 . . . . 0.0 110.603 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.441 ' H ' HD21 ' A' ' 312' ' ' LEU . 2.6 pt? -82.18 -12.72 57.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.574 0.702 . . . . 0.0 109.46 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -159.33 143.99 15.44 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.582 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.28 -33.09 69.44 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.011 0.195 . . . . 0.0 110.98 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.4 m80 67.77 157.38 0.14 Allowed Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.814 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.35 137.92 63.19 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.001 1.8 . . . . 0.0 110.216 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.24 118.77 7.86 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.768 0.794 . . . . 0.0 111.035 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 161.51 -43.9 0.39 Allowed Glycine 0 C--N 1.31 -0.908 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.608 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -157.57 123.91 4.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 110.043 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 339' ' ' PRO . 45.0 m95 -94.67 174.34 7.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.566 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -156.61 114.13 3.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -145.33 176.68 24.21 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.453 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 333' ' ' ARG . 46.8 m80 -107.17 136.94 46.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.452 HD11 HG12 ' A' ' 309' ' ' ILE . 11.0 tp -130.67 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.643 0.259 . . . . 0.0 110.629 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--O 1.236 0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.335 178.281 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 57.2 ttp85 . . . . . 0 N--CA 1.444 -0.742 0 CA-C-O 120.901 0.381 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 9.1 tp -94.82 140.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.52 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.41 159.1 30.54 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.602 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -101.75 151.78 21.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.818 0.309 . . . . 0.0 110.314 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.548 ' CD1' HD22 ' A' ' 301' ' ' LEU . 16.7 p90 -153.71 151.08 24.38 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.29 133.43 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.714 2.276 . . . . 0.0 112.131 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 320' ' ' TRP . 20.7 Cg_endo -61.4 -17.57 54.18 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.218 2.612 . . . . 0.0 113.023 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -63.89 -19.18 62.99 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.655 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 45.6 pt -107.96 6.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 28.3 m -132.26 161.45 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 111.78 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -160.46 161.97 33.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 -24.53 35.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.58 -178.59 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.095 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.2 m -71.54 161.01 31.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -64.24 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.011 0.434 . . . . 0.0 110.736 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.485 178.867 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.07 167.93 10.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.432 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -129.89 141.49 50.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.02 144.67 31.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.636 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 58.2 mtt85 -102.34 129.46 48.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.05 117.78 24.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.817 0.341 . . . . 0.0 111.159 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.97 -23.32 20.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.237 0.542 . . . . 0.0 109.563 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -117.81 146.35 43.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.54 135.57 36.12 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.328 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -99.25 112.62 24.75 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.36 167.29 21.94 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.453 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -74.82 133.63 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.255 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.42 177.6 4.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.822 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.53 45.09 0.94 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.71 138.21 6.15 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.67 -18.75 42.23 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.268 2.645 . . . . 0.0 113.85 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 2.7 m -80.45 1.14 30.47 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.169 0.509 . . . . 0.0 110.861 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.11 124.5 23.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 21.2 tp -88.84 87.45 7.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.561 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -74.63 97.58 3.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.674 . . . . 0.0 111.116 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.55 139.83 48.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.868 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -99.61 157.05 16.73 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.96 121.67 13.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.746 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.87 26.87 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.297 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -85.63 162.75 18.68 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 122.503 -0.41 . . . . 0.0 110.52 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 30.2 m -114.57 145.2 20.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.292 0.568 . . . . 0.0 112.208 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.02 130.75 72.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.84 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 85.7 m -96.99 120.55 37.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.061 0.458 . . . . 0.0 110.761 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.18 146.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.559 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.38 -78.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.702 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -164.62 98.91 0.79 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.438 0.637 . . . . 0.0 110.792 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -164.62 153.73 13.13 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.335 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -90.63 144.19 30.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.1 49.45 2.29 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.162 2.575 . . . . 0.0 112.661 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -101.9 45.12 0.98 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.112 0.482 . . . . 0.0 110.726 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 149.43 170.01 16.5 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 134.79 56.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.588 0.694 . . . . 0.0 109.606 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.63 -179.64 6.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 -176.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -123.1 145.06 48.9 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -133.47 166.21 23.9 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.358 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -109.94 122.39 47.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.24 137.39 31.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.379 0.609 . . . . 0.0 112.138 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.0 p80 . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.981 175.41 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.763 0.316 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 13.7 tt -124.83 130.93 73.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.61 33.75 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.546 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -88.88 146.69 24.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.664 0.269 . . . . 0.0 111.279 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.69 152.66 18.18 Favored Pre-proline 0 C--O 1.242 0.679 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.489 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.566 ' O ' HG12 ' A' ' 341' ' ' ILE . 72.3 Cg_endo -79.46 133.64 10.74 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.53 2.153 . . . . 0.0 111.72 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.81 -14.92 45.92 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.821 2.347 . . . . 0.0 112.734 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -72.34 -18.8 78.44 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 116.099 -0.5 . . . . 0.0 113.574 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 338' ' ' PRO . 46.9 pt -93.51 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.471 0.635 . . . . 0.0 111.501 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.87 163.45 18.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -146.55 146.24 30.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.725 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.39 -35.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.41 HG13 ' NE ' ' A' ' 348' ' ' ARG . 17.5 t -72.65 158.55 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 30.7 m -72.75 102.77 3.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.656 0.265 . . . . 0.0 111.447 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt 45.39 37.96 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.443 1.097 . . . . 0.0 113.8 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . 0.41 ' NE ' HG13 ' A' ' 345' ' ' VAL . 38.6 ttm180 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.375 -0.822 . . . . 0.0 109.916 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.87 159.2 21.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -131.61 136.2 47.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 25.0 m -115.54 142.41 28.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -101.6 132.71 47.11 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.344 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -80.34 117.53 21.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.56 -21.91 22.64 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -126.32 147.7 49.68 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.679 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.84 153.78 28.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.111 0.482 . . . . 0.0 111.38 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . 0.453 ' HB3' HG12 ' A' ' 303' ' ' VAL . 40.3 t80 -135.65 110.72 8.89 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -174.52 133.85 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -124.13 161.74 25.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.475 HD21 ' H ' ' A' ' 295' ' ' LEU . 2.5 pt? -77.26 -8.74 58.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.64 0.734 . . . . 0.0 109.229 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -126.71 -156.75 0.76 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.538 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.44 91.61 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 123.327 0.392 . . . . 0.0 111.287 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.86 -15.74 26.4 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.445 2.097 . . . . 0.0 112.842 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.6 m -105.67 7.48 32.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 110.886 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -72.38 139.89 48.11 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 21.0 tp -84.36 91.21 7.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.49 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.97 106.17 1.51 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.249 0.547 . . . . 0.0 111.344 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.453 HG12 ' HB3' ' A' ' 292' ' ' PHE . 12.8 p -134.84 135.16 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.563 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -97.01 147.4 24.04 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.959 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.58 125.79 25.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.086 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.41 -18.15 25.56 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.611 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.19 165.29 16.65 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.842 0.353 . . . . 0.0 110.565 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.55 134.94 59.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.17 128.08 53.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.3 m -83.22 108.75 16.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.88 0.372 . . . . 0.0 110.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.78 127.07 62.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.398 0.618 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 2.2 pp -86.41 -9.77 55.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.506 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 117.97 6.7 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -76.97 101.4 5.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.728 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -123.01 84.4 50.8 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.45 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 -2.0 12.14 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 114.236 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -108.12 106.87 17.28 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.479 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 93.79 173.12 39.46 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.779 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -68.46 128.87 38.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 109.897 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -126.3 162.19 26.06 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.537 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -98.69 136.87 38.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.277 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -139.8 171.85 23.63 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.154 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -109.14 128.14 54.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.954 0.407 . . . . 0.0 111.151 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 11.4 tp -124.42 154.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 54.8 t60 . . . . . 0 CA--C 1.54 0.581 0 O-C-N 123.5 0.5 . . . . 0.0 110.417 178.758 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 . . . . . 0 N--CA 1.445 -0.681 0 CA-C-O 121.299 0.571 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 39.8 mm -106.82 129.69 60.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.547 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -140.0 159.94 26.14 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.025 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -97.2 140.76 31.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.882 0.372 . . . . 0.0 110.243 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -148.78 160.56 35.37 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.259 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.464 ' O ' HG12 ' A' ' 341' ' ' ILE . 4.0 Cg_endo -87.11 132.91 3.29 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.763 2.309 . . . . 0.0 112.135 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.81 -14.07 34.34 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.133 2.555 . . . . 0.0 112.472 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.48 -18.84 68.22 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.498 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 338' ' ' PRO . 49.2 pt -101.98 -4.49 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.83 150.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.856 0.36 . . . . 0.0 111.52 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -143.18 146.55 33.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.674 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.41 -34.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.727 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.42 -37.05 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.502 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.2 m -109.24 86.41 2.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.094 0.474 . . . . 0.0 110.204 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -85.89 94.58 9.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.217 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.955 177.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 121.091 0.472 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.405 ' HB2' HG21 ' A' ' 311' ' ' VAL . 73.1 mt -105.6 179.86 4.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.174 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 25.4 pttm -153.05 145.01 23.69 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.287 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.9 m -128.88 157.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.832 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -102.42 127.99 49.22 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.906 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -81.61 128.68 34.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.89 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.25 -9.8 26.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.581 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -133.62 147.3 51.47 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -80.25 122.41 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 302' ' ' ASN . 0.6 OUTLIER -104.94 111.38 24.13 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -162.36 -2.96 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.74 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -56.81 -44.38 81.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.147 0.498 . . . . 0.0 109.689 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 26.4 tp -89.44 120.59 30.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -94.87 0.8 55.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.2 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.24 139.34 96.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.32 -21.24 35.69 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.127 2.551 . . . . 0.0 113.293 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.4 t -78.03 -12.07 59.96 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -87.17 142.11 28.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.819 0.342 . . . . 0.0 110.393 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 337' ' ' PHE . 1.3 tp -82.91 89.33 6.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 292' ' ' PHE . 14.5 m120 -75.27 111.33 10.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 10.6 p -142.89 154.59 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.839 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -95.16 144.56 25.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.247 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -68.48 118.41 11.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 108.19 -2.37 33.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.62 150.88 20.66 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.6 m -97.63 124.09 50.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.418 0.628 . . . . 0.0 111.441 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 285' ' ' LYS . 27.3 mt -88.51 132.38 33.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.479 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.51 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 23.2 m -81.32 107.22 13.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 284' ' ' LEU . 17.6 m -106.59 144.66 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.416 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 3.8 pp -93.78 -8.4 40.72 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.335 0.588 . . . . 0.0 110.25 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.72 171.69 13.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -139.57 13.85 2.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.096 0.474 . . . . 0.0 110.296 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -97.31 115.25 65.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.488 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.76 105.22 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.745 2.297 . . . . 0.0 112.152 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.97 8.13 45.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.653 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.27 107.22 0.34 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 41.05 71.4 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.833 0.825 . . . . 0.0 110.554 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -95.43 174.46 7.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -173.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 336' ' ' TYR . 0.4 OUTLIER -96.07 151.29 19.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.53 171.98 23.77 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.884 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 310' ' ' THR . 8.1 t60 -109.49 122.54 47.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.692 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.5 146.41 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 CA--C 1.513 -0.446 0 O-C-N 123.509 0.505 . . . . 0.0 110.113 -177.037 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 120.92 0.39 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 34.2 mm -107.07 128.15 62.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.129 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.77 155.6 23.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 321' ' ' LYS . 41.1 p90 -96.33 147.74 23.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.492 0.646 . . . . 0.0 111.002 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.451 ' CD1' HD22 ' A' ' 301' ' ' LEU . 39.8 p90 -148.61 145.13 19.37 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.855 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.535 ' O ' HG12 ' A' ' 341' ' ' ILE . 9.4 Cg_exo -73.22 130.01 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.384 2.056 . . . . 0.0 110.606 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.19 -16.35 33.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.726 2.284 . . . . 0.0 112.859 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.63 -22.76 76.8 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.238 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 338' ' ' PRO . 38.6 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.325 0.562 . . . . 0.0 111.975 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.38 170.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.544 0.211 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -158.92 168.0 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.02 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.1 -31.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.915 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.3 -22.94 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.5 m -106.98 22.55 15.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 0.0 109.956 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -63.57 111.96 2.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.824 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 . . . . . 0 C--N 1.313 -0.991 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -177.432 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 120.842 0.353 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 57.0 tp -136.09 166.31 23.66 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -131.9 141.62 49.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.075 0.464 . . . . 0.0 110.95 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.74 146.4 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.994 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -104.47 120.36 41.07 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.666 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 342' ' ' VAL . . . -73.44 124.8 26.5 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.441 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -89.26 -9.93 48.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.21 0.529 . . . . 0.0 109.709 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -143.53 148.08 35.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.115 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.469 ' OD1' ' HA ' ' A' ' 304' ' ' ARG . 24.0 m-20 -68.74 155.7 39.63 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -76.66 113.81 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.328 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -102.78 127.58 49.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -163.79 162.41 23.8 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.27 122.64 10.75 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -43.37 113.55 0.51 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.787 0.679 . . . . 0.0 112.738 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -158.94 135.91 6.79 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.26 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.7 -13.28 39.04 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.126 2.551 . . . . 0.0 114.736 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 34.2 p -95.82 9.12 41.57 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.212 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -75.38 152.54 38.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 tp -79.69 102.43 8.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -80.58 86.32 5.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 0.0 111.904 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.53 137.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.382 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.469 ' HA ' ' OD1' ' A' ' 291' ' ' ASP . 19.1 ttp180 -98.9 147.96 24.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.55 115.13 3.37 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.25 37.84 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.042 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.2 173.16 8.57 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.81 143.98 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -175.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 81.4 mt -111.83 124.38 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.495 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 41.5 m -86.32 110.95 20.02 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.169 0.509 . . . . 0.0 110.784 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 33.9 m -107.17 148.53 11.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.996 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 4.5 tt -88.6 -52.88 4.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.12 131.02 53.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . 0.553 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 55.9 mt-30 -79.08 130.32 35.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.199 0.524 . . . . 0.0 111.804 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -138.85 70.15 43.18 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.857 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.07 81.92 1.63 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 111.733 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -144.93 -62.27 0.36 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.966 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -130.64 -160.55 10.03 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -69.15 101.65 1.5 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 117.39 0.595 . . . . 0.0 110.362 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . 0.553 ' CZ3' ' HA ' ' A' ' 314' ' ' GLN . 1.0 OUTLIER -102.81 169.04 8.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.348 -177.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 25.5 pttm -93.85 152.13 19.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.528 0.68 . . . . 0.0 112.795 -174.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.51 39.63 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.732 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -108.8 122.64 47.58 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.193 0.497 . . . . 0.0 110.402 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 10.1 tp -103.02 156.64 5.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.902 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 . . . . . 0 CA--C 1.531 0.229 0 O-C-N 123.595 0.56 . . . . 0.0 110.188 176.157 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.38 125.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.62 -179.8 17.64 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -104.13 147.68 27.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.892 0.377 . . . . 0.0 110.769 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.64 151.69 36.31 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.54 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.52 135.61 5.17 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.862 2.374 . . . . 0.0 111.642 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.35 -3.5 5.26 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.964 2.443 . . . . 0.0 112.716 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -79.99 -19.6 69.66 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.852 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 37.8 pt -102.61 1.89 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.841 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 288' ' ' ALA . 27.6 m -112.41 150.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.468 0.652 . . . . 0.0 112.665 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.5 133.34 55.95 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.905 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.55 -31.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.807 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.87 -63.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.962 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.8 m -122.52 173.44 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.648 0.261 . . . . 0.0 111.687 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.66 82.58 0.18 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.666 0.786 . . . . 0.0 111.223 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . 0.431 ' H ' ' NE ' ' A' ' 348' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 54.8 m . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.794 0.33 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.45 161.09 18.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -126.26 133.99 51.3 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.723 0.297 . . . . 0.0 110.376 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.48 138.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.057 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -106.06 134.62 48.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.12 131.25 37.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.9 -29.82 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.803 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -127.73 147.56 50.4 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.54 147.0 53.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.762 0.315 . . . . 0.0 110.397 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . 0.423 ' HB2' HG12 ' A' ' 303' ' ' VAL . 69.3 t80 -64.4 133.45 52.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.084 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -77.37 102.39 6.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -66.15 103.49 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.478 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.18 4.64 51.72 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.697 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 66.11 79.56 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.536 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -154.11 135.5 8.87 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.889 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.15 -23.61 66.62 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.044 2.496 . . . . 0.0 113.516 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.6 m -98.05 -1.85 41.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.366 0.603 . . . . 0.0 110.951 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.92 38.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.5 103.66 16.09 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.798 0.332 . . . . 0.0 111.154 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -78.88 123.39 27.19 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 292' ' ' PHE . 11.8 p -141.45 146.36 23.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.032 0.444 . . . . 0.0 111.064 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -98.53 148.49 23.71 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.519 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.1 127.38 31.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 110.127 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.14 -13.15 48.85 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.682 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -87.17 153.97 21.09 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.144 0.472 . . . . 0.0 110.422 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 6.4 t -107.07 128.57 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 111.094 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 303' ' ' VAL . 4.1 mp -102.1 142.37 16.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.315 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 8.2 m -108.36 108.82 19.95 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.22 148.78 5.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.91 0.386 . . . . 0.0 111.17 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.79 -64.42 1.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.519 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.07 134.51 52.09 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -80.37 82.99 6.29 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.497 0.665 . . . . 0.0 110.54 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -70.53 131.78 87.89 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.052 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.79 -41.04 40.65 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.846 2.364 . . . . 0.0 113.483 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -139.66 174.9 10.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 111.116 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.16 -155.7 31.64 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.514 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -110.63 110.47 21.17 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -89.78 157.75 17.8 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.856 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.93 121.89 30.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.772 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -119.09 151.54 17.59 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.129 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.37 121.39 44.73 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 55.6 mt -109.35 137.23 42.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.3 p80 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.463 176.408 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.56 138.68 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 111.676 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -166.26 174.71 41.81 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -99.99 149.07 23.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.363 0.582 . . . . 0.0 111.102 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -154.49 162.63 26.56 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.781 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -87.31 122.59 1.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.119 2.546 . . . . 0.0 112.456 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -56.2 -18.61 24.33 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.417 2.745 . . . . 0.0 112.82 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -62.84 -23.98 66.1 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.877 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 42.8 pt -99.06 4.63 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.542 0.671 . . . . 0.0 112.228 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 288' ' ' ALA . 33.2 m -129.22 165.74 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 112.011 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -149.79 148.13 28.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.074 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.96 -35.81 61.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 18.0 t -89.4 146.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.3 t -69.98 95.77 0.97 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.15 0.5 . . . . 0.0 111.645 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt 64.13 30.42 13.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 113.0 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 312' ' ' LEU . 50.7 m . . . . . 0 C--O 1.235 0.333 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.413 ' HG ' ' N ' ' A' ' 285' ' ' LYS . 43.1 tp -146.35 166.61 25.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.778 0.323 . . . . 0.0 110.642 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . 0.413 ' N ' ' HG ' ' A' ' 284' ' ' LEU . 60.1 pttt -123.12 135.88 54.55 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.74 137.78 55.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -102.75 130.54 49.74 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.731 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -86.04 119.58 26.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.874 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.48 -21.12 24.35 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -123.71 146.08 48.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -72.83 122.21 21.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.05 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . 0.433 ' HB3' ' H ' ' A' ' 303' ' ' VAL . 6.5 t80 -80.6 111.23 16.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -170.37 18.12 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.12 0.486 . . . . 0.0 109.883 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 -8.87 59.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.04 168.07 10.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -105.45 -24.65 12.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.521 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.37 131.91 23.28 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 111.737 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.3 3.36 5.84 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.04 3.16 . . . . 0.0 114.386 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.7 t -73.38 -12.85 60.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.241 0.543 . . . . 0.0 110.47 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -89.17 153.41 20.97 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.792 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 tt -79.78 114.66 18.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.987 0.422 . . . . 0.0 110.137 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -99.01 154.43 18.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.773 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.433 ' H ' ' HB3' ' A' ' 292' ' ' PHE . 7.5 p -156.05 146.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.432 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -87.12 141.54 28.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.58 127.0 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.7 56.79 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.373 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -89.22 164.81 14.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.19 132.37 70.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.399 0.619 . . . . 0.0 111.589 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.49 128.98 49.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.332 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 26.2 m -85.47 110.26 19.05 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.924 0.392 . . . . 0.0 110.799 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.39 148.33 9.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 283' ' ' SER . 5.8 mp -87.37 -79.13 0.29 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.409 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -174.13 118.46 0.24 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.334 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . 0.435 HE21 ' HB2' ' A' ' 320' ' ' TRP . 13.6 pt20 178.51 178.21 0.42 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.7 177.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -83.69 119.91 74.4 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.02 98.7 1.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.247 1.965 . . . . 0.0 111.667 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -140.25 119.22 12.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' A' ' 339' ' ' PRO . . . 76.26 -95.68 1.08 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.909 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -132.74 122.92 25.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . 0.435 ' HB2' HE21 ' A' ' 314' ' ' GLN . 0.2 OUTLIER -116.31 156.41 26.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.112 0.482 . . . . 0.0 111.936 -178.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 8.4 ttpm? -84.06 127.18 33.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.838 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -137.91 172.54 22.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.715 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.481 ' CE1' HD13 ' A' ' 312' ' ' LEU . 48.5 m170 -112.08 124.33 52.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.0 151.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.909 0.385 . . . . 0.0 110.82 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.124 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 65.2 mt -126.38 123.89 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -152.93 171.62 31.97 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.845 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -119.96 137.17 54.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.626 0.213 . . . . 0.0 110.674 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.8 159.08 41.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.956 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.442 ' O ' HG12 ' A' ' 341' ' ' ILE . 71.6 Cg_endo -81.61 125.81 5.1 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.712 2.274 . . . . 0.0 112.1 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 318' ' ' GLY . 29.7 Cg_endo -62.97 -12.37 29.23 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.151 2.567 . . . . 0.0 113.134 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.13 -19.72 68.36 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.541 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 338' ' ' PRO . 43.7 pt -96.84 -1.5 10.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 117.338 0.569 . . . . 0.0 111.761 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.96 156.58 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.076 0.465 . . . . 0.0 111.823 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.53 153.7 47.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.23 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.14 -20.17 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.094 0.473 . . . . 0.0 110.499 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.17 169.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 43.0 m -69.47 156.63 38.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.24 140.56 58.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 111.425 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 . . . . . 0 C--N 1.311 -1.107 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.002 177.381 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 120.859 0.362 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.38 -173.07 2.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.382 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -141.99 141.53 32.89 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.108 0.48 . . . . 0.0 111.306 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.25 142.23 40.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.083 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -102.58 128.13 49.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.901 0.382 . . . . 0.0 111.298 -177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.45 130.19 35.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.546 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.13 -11.96 34.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.876 0.37 . . . . 0.0 110.737 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -145.69 146.58 31.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.29 122.77 16.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.754 0.312 . . . . 0.0 110.214 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -76.58 115.01 15.93 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.995 0.426 . . . . 0.0 110.968 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -75.06 92.29 2.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -60.15 149.28 33.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.889 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.77 -163.45 1.05 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.844 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -82.78 -173.65 4.78 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.134 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 77.34 144.79 0.1 Allowed Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 123.707 0.629 . . . . 0.0 110.834 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.55 2.5 5.72 Favored 'Trans proline' 0 C--O 1.221 -0.338 0 C-N-CA 122.907 2.405 . . . . 0.0 112.566 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 5.0 p -101.52 3.41 40.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.872 0.367 . . . . 0.0 111.412 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -76.85 132.48 39.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 337' ' ' PHE . 0.8 OUTLIER -82.41 151.7 26.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.323 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.454 ' O ' HG12 ' A' ' 324' ' ' ILE . 33.7 m-80 -128.6 123.57 33.67 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.66 149.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.6 0.238 . . . . 0.0 110.558 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -109.34 165.24 11.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.078 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.85 117.12 5.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.041 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.48 -11.58 39.34 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.663 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -88.47 159.36 18.0 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.346 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 12.1 m -117.14 132.25 67.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.448 0.642 . . . . 0.0 112.663 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.81 138.68 21.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.527 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 46.9 m -87.31 110.27 20.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.896 0.379 . . . . 0.0 110.53 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.77 141.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.301 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.59 -75.97 0.39 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.1 96.46 2.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.52 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . 0.435 HE21 ' HB2' ' A' ' 314' ' ' GLN . 0.7 OUTLIER -150.62 176.42 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.72 158.06 76.46 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.409 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.561 ' O ' ' HG3' ' A' ' 339' ' ' PRO . 25.0 Cg_exo -64.32 -20.63 66.76 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.825 2.35 . . . . 0.0 113.121 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.02 109.09 2.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.568 0.699 . . . . 0.0 111.183 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 106.55 -99.59 1.5 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 339' ' ' PRO . 0.0 OUTLIER -156.26 147.86 22.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.664 0.269 . . . . 0.0 110.305 178.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.27 153.07 22.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.09 176.88 21.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.028 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -106.48 122.22 45.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 302' ' ' ASN . 9.0 tp -110.31 152.68 12.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.681 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--N 1.317 -0.831 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.857 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 N--CA 1.443 -0.777 0 CA-C-O 120.551 0.215 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 5.7 mm -117.14 140.5 39.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.59 155.51 23.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.398 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.79 144.52 26.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 0.0 111.437 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 301' ' ' LEU . 24.5 p90 -155.19 148.38 18.32 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 3.0 Cg_exo -75.86 133.74 15.66 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.02 2.48 . . . . 0.0 113.095 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . 0.561 ' HG3' ' O ' ' A' ' 316' ' ' PRO . 30.0 Cg_endo -61.7 -19.74 66.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.176 2.584 . . . . 0.0 112.641 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -61.2 -19.55 57.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.584 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 36.8 pt -111.66 4.49 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.354 0.577 . . . . 0.0 112.355 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 339' ' ' PRO . 27.5 m -129.41 153.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 112.003 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -148.33 150.94 34.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.16 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.57 -40.8 71.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.432 ' C ' ' HG ' ' A' ' 346' ' ' SER . 26.0 t -96.05 -84.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.546 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.432 ' HG ' ' C ' ' A' ' 345' ' ' VAL . 14.7 m -154.32 -179.92 8.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -73.23 -26.74 61.25 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.108 0.48 . . . . 0.0 110.579 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.335 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 121.028 0.442 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.59 161.74 27.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.699 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -122.69 136.26 54.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 308' ' ' VAL . 19.3 m -115.16 148.83 17.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -102.42 128.48 49.01 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.318 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.437 ' HA ' HG13 ' A' ' 342' ' ' VAL . . . -89.63 120.77 31.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.68 -14.74 27.65 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.981 0.42 . . . . 0.0 110.107 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -134.12 157.57 45.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 142.97 33.01 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.995 0.426 . . . . 0.0 111.351 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' PHE . . . . . 0.481 ' HB3' HG12 ' A' ' 303' ' ' VAL . 41.5 t80 -121.76 113.26 19.44 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -161.3 136.31 7.47 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.16 131.79 56.81 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.115 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.09 8.47 4.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.278 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -133.95 133.12 41.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.134 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 8.6 t70 69.52 120.84 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.56 0.744 . . . . 0.0 111.448 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.73 1.94 8.0 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.119 2.546 . . . . 0.0 114.172 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -88.26 23.07 2.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.317 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.08 150.31 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.214 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.7 tp -83.04 114.36 21.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -88.32 109.8 20.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.809 0.337 . . . . 0.0 111.332 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.8 p -142.64 134.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.085 0.469 . . . . 0.0 110.274 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -103.5 151.64 22.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.766 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.41 119.67 8.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.392 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.13 -11.49 31.55 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.971 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -95.06 171.32 8.82 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.641 0.257 . . . . 0.0 110.625 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 286' ' ' VAL . 15.4 m -122.03 135.77 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.7 mt -101.64 143.08 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 2.9 m -91.7 107.18 19.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.096 0.474 . . . . 0.0 110.293 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.9 m -108.53 149.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.574 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.593 ' HG ' ' H ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -89.44 -72.82 0.54 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.593 ' H ' ' HG ' ' A' ' 312' ' ' LEU . 13.3 pt-20 170.74 156.4 0.07 Allowed 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.095 0.958 . . . . 0.0 108.977 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' GLN . . . . . 0.495 ' OE1' ' HB3' ' A' ' 316' ' ' PRO . 35.5 tt0 -173.76 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.281 0.363 . . . . 0.0 111.265 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 48.4 m80 58.69 65.95 2.7 Favored Pre-proline 0 N--CA 1.469 0.512 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.522 ' HG3' ' CG ' ' A' ' 320' ' ' TRP . 64.9 Cg_endo -82.65 168.68 14.14 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.953 2.435 . . . . 0.0 114.088 -172.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.24 -7.88 31.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.943 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -164.71 -138.48 2.42 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.588 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 135.07 56.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.65 0.262 . . . . 0.0 111.046 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' TRP . . . . . 0.528 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 0.3 OUTLIER -132.72 179.07 6.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 33.5 mmtp -86.38 154.1 21.43 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.507 0.67 . . . . 0.0 112.488 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 334' ' ' ILE . . . -161.1 151.43 21.79 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.414 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -108.8 122.69 47.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 10.4 tp -118.97 142.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 . . . . . 0 N--CA 1.441 -0.903 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.352 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 C--O 1.238 0.484 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 322' ' ' GLY . 7.8 tt -133.77 117.44 26.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.095 173.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.66 -169.36 11.55 Favored Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.009 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 23.7 p90 -108.45 142.95 38.08 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.453 ' CE2' HG23 ' A' ' 342' ' ' VAL . 21.4 p90 -151.49 146.64 19.11 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.048 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 340' ' ' GLY . 93.8 Cg_endo -84.1 128.19 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.498 2.132 . . . . 0.0 112.725 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.65 18.99 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.426 2.751 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 338' ' ' PRO . . . -93.96 -19.33 34.22 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 44.5 pt -108.87 -8.73 11.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.061 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.453 HG23 ' CE2' ' A' ' 337' ' ' PHE . 25.0 m -131.81 150.02 33.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.175 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -161.54 167.7 24.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.67 100.95 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 109.941 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 10.3 p -156.93 152.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.429 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.0 m -67.06 -56.07 11.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.927 0.394 . . . . 0.0 110.031 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -157.34 154.95 29.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.318 -0.783 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.77 176.62 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.261 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.4 m 63.92 29.02 14.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.034 0.534 . . . . 0.0 111.38 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.446 HD11 ' N ' ' A' ' 285' ' ' LYS . 2.7 tm? -94.89 141.64 28.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.446 ' N ' HD11 ' A' ' 284' ' ' LEU . 0.0 OUTLIER -116.57 136.8 52.67 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.93 0.395 . . . . 0.0 110.964 -177.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.4 154.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.463 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -102.55 141.78 34.8 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.429 ' HA ' HG11 ' A' ' 342' ' ' VAL . . . -82.73 110.94 18.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.87 -32.23 31.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.34 164.96 16.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.768 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.11 157.52 18.82 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . 0.424 ' HB3' HG12 ' A' ' 303' ' ' VAL . 23.4 t80 -141.15 112.73 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -141.67 119.48 11.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.916 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -150.44 126.88 10.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.79 166.85 10.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 71.94 7.59 5.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.575 0.75 . . . . 0.0 111.042 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -127.71 114.98 20.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.82 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.89 -9.97 26.75 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.966 2.444 . . . . 0.0 113.624 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 22.0 p -107.16 8.04 29.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.179 0.514 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.32 150.09 27.41 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.158 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' A' ' 337' ' ' PHE . 20.7 tp -105.29 152.73 22.54 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.871 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -119.84 105.26 10.94 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 292' ' ' PHE . 8.2 p -148.78 144.39 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.041 0.448 . . . . 0.0 111.255 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -112.74 146.51 38.64 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -52.09 125.6 16.08 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.84 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.82 -22.76 20.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.225 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -76.85 165.23 24.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 13.6 m -116.36 137.86 48.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.313 0.578 . . . . 0.0 111.6 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 3.6 mp -116.7 132.95 64.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.831 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 6.5 m -98.32 107.25 19.67 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.437 ' CG2' ' HB3' ' A' ' 284' ' ' LEU . 35.9 m -93.5 142.81 12.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.475 0.655 . . . . 0.0 112.071 -176.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 60.1 tp -87.88 -14.67 38.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.024 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -91.31 164.7 13.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.149 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -155.3 121.92 5.33 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.5 m80 58.42 75.52 0.52 Allowed Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.408 0.443 . . . . 0.0 110.129 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -95.03 -170.26 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.115 2.543 . . . . 0.0 112.767 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.19 104.98 5.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 92.85 -69.03 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.24 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -148.85 158.19 43.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.652 0.263 . . . . 0.0 110.493 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -137.03 167.98 20.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.505 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -104.73 137.94 41.77 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.93 26.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.957 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -114.79 130.89 56.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 41.6 mm -72.78 135.45 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -73.55 101.53 3.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.33 161.87 16.74 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.373 0.606 . . . . 0.0 112.329 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 14.2 m -101.71 -25.59 13.79 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.024 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -104.83 116.04 31.32 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.606 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -59.69 134.49 57.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.138 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.51 -10.56 46.2 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.847 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 86.6 m -81.03 136.01 35.92 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 23.73 96.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.262 1.425 . . . . 0.0 114.363 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -80.01 -81.05 0.12 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.538 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 47.6 mm -124.08 124.42 68.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.827 0.346 . . . . 0.0 110.815 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.1 21.05 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -102.27 136.83 41.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.863 0.363 . . . . 0.0 110.443 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.518 ' CD1' HD22 ' A' ' 301' ' ' LEU . 4.8 p90 -154.87 154.78 29.55 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.267 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.432 ' O ' HG12 ' A' ' 341' ' ' ILE . 73.8 Cg_endo -77.44 134.33 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.39 2.06 . . . . 0.0 112.176 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.85 -6.88 13.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.867 2.378 . . . . 0.0 112.311 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -74.52 -19.59 79.82 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.157 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 338' ' ' PRO . 39.0 pt -99.58 2.91 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 117.254 0.527 . . . . 0.0 111.733 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 288' ' ' ALA . 29.1 m -133.8 155.32 39.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -160.68 150.13 17.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.048 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.15 -28.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 20.4 m -77.05 168.41 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.853 0.359 . . . . 0.0 111.665 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 162.87 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.54 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -179.23 6.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? . . . . . 0 C--O 1.244 0.816 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.259 177.271 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 112.173 -0.371 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 11.0 p -147.76 99.8 3.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.134 0.493 . . . . 0.0 111.427 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.17 -176.88 3.06 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 7.4 ptpp? -143.7 134.22 24.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 111.36 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 31.3 m -118.55 156.67 20.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.112 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -102.74 134.87 45.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.6 115.52 18.36 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.169 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.401 ' HG ' ' OE2' ' A' ' 343' ' ' GLU . 4.2 mm? -87.77 -17.11 32.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.235 0.54 . . . . 0.0 110.137 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -140.75 147.26 38.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.42 134.44 39.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -78.74 112.58 16.01 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -71.35 -31.96 67.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.54 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -79.83 78.76 6.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.06 -9.85 10.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.13 68.75 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.258 0.551 . . . . 0.0 110.223 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -179.76 126.15 0.24 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.16 -27.69 81.15 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.449 . . . . 0.0 113.531 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.89 -1.79 57.62 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.191 0.52 . . . . 0.0 111.105 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -102.28 150.78 22.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.523 HD22 ' CD1' ' A' ' 337' ' ' PHE . 3.9 tp -90.01 104.49 17.06 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.375 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -79.42 102.24 8.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.07 144.79 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.266 0.555 . . . . 0.0 111.592 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -104.4 147.29 27.72 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.279 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.51 124.44 20.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.385 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.03 40.89 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.928 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.54 158.07 19.61 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.22 139.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.171 0.51 . . . . 0.0 111.632 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 285' ' ' LYS . 20.5 mt -110.94 132.58 59.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.438 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 27.5 m -80.86 108.54 14.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.63 143.44 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 6.2 mp -81.89 -49.73 9.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.19 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -162.47 162.78 27.67 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.608 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.7 132.36 40.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -145.23 81.02 10.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.426 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.87 -0.8 10.91 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.897 2.398 . . . . 0.0 112.398 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -70.3 -21.97 62.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.225 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -180.0 -156.92 19.16 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -65.34 110.72 2.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.088 0.471 . . . . 0.0 110.773 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . 0.464 ' HD1' ' O ' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -85.13 175.5 8.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -119.03 142.1 48.13 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.107 0.48 . . . . 0.0 112.171 -175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -159.72 171.25 36.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.778 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -109.14 129.52 55.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.915 0.388 . . . . 0.0 110.141 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 325' ' ' HIS . 8.2 tp -119.61 149.42 22.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.355 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . 0.422 ' CE1' HG21 ' A' ' 324' ' ' ILE . 8.3 p-80 52.13 179.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.887 1.275 . . . . 0.0 114.144 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.62 -175.24 2.74 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.176 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 17.9 p -86.21 89.92 7.99 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -156.25 150.72 25.69 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.042 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 62.58 33.38 15.88 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.383 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 104.22 65.41 0.69 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.419 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 30.0 m -53.1 135.28 37.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.138 0.494 . . . . 0.0 111.924 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.57 -106.67 0.16 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.603 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 179.29 -54.16 0.01 OUTLIER 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 110.574 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . 0.481 HD11 ' N ' ' A' ' 335' ' ' GLY . 0.0 OUTLIER -179.51 145.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.481 ' N ' HD11 ' A' ' 334' ' ' ILE . . . -138.21 175.79 21.15 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.634 -1.27 . . . . 0.0 113.197 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -111.07 146.12 37.32 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.523 ' CD1' HD22 ' A' ' 301' ' ' LEU . 4.4 p90 -154.01 151.07 23.87 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.003 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.437 ' O ' HG12 ' A' ' 341' ' ' ILE . 70.4 Cg_endo -77.32 127.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.49 2.127 . . . . 0.0 112.109 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.86 -13.28 29.89 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.996 2.464 . . . . 0.0 112.636 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -70.62 -18.9 76.06 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.324 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 338' ' ' PRO . 42.4 pt -103.13 4.3 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 117.4 0.6 . . . . 0.0 111.714 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 288' ' ' ALA . 35.3 m -131.2 150.86 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.87 0.367 . . . . 0.0 111.099 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.401 ' OE2' ' HG ' ' A' ' 289' ' ' LEU . 46.7 mt-10 -137.91 145.38 42.03 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.95 -30.47 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.7 p -83.37 143.31 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 63.7 m -76.94 146.43 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.643 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.68 129.28 34.65 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 . . . . . 0 C--N 1.315 -0.919 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.382 179.302 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 312' ' ' LEU . . . . . . . . 0 N--CA 1.472 1.042 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.4 m -92.23 -15.78 27.05 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 285' ' ' LYS . 2.2 tm? -124.14 141.12 52.32 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.698 -0.401 . . . . 0.0 109.98 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.468 ' N ' HD13 ' A' ' 284' ' ' LEU . 58.9 mtpt -124.69 134.4 52.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.53 142.3 29.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -103.8 132.9 49.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -84.87 125.7 32.85 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.806 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.0 -13.76 30.49 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.052 0.453 . . . . 0.0 110.836 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -132.55 146.47 51.94 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -73.74 120.55 19.49 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.379 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -103.06 113.89 27.74 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -141.53 149.64 41.11 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.511 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -139.62 147.07 40.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.602 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 37.7 tp -75.88 -44.65 39.56 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -161.37 90.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.614 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 15.3 t70 -138.46 126.68 13.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 297' ' ' ASP . 15.9 Cg_exo -68.08 -15.82 43.77 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.047 2.498 . . . . 0.0 114.234 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 20.9 p -113.81 -32.38 6.13 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.52 131.23 48.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.367 0.603 . . . . 0.0 112.53 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 24.0 tp -83.05 153.99 24.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.092 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.405 HD22 HG21 ' A' ' 331' ' ' THR . 5.5 p-10 -110.2 108.13 18.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.02 136.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 111.42 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -88.86 152.84 21.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.87 25.61 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.805 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 100.42 -9.17 58.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.023 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -84.46 164.0 19.1 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.684 0.278 . . . . 0.0 110.528 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 15.8 m -111.2 128.38 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.574 0.702 . . . . 0.0 112.301 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.416 HG23 ' CE1' ' A' ' 337' ' ' PHE . 49.0 mt -97.82 130.4 46.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 7.0 m -93.63 108.08 19.85 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 18.0 m -105.46 148.31 10.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.44 ' HA ' ' HA2' ' A' ' 282' ' ' GLY . 5.6 mp -64.35 -77.81 0.05 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 167.49 134.99 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.486 1.114 . . . . 0.0 108.321 175.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 178.79 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.771 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 16.3 m80 52.85 71.49 1.43 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.253 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.64 173.98 9.05 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.729 2.286 . . . . 0.0 111.316 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.57 125.14 45.1 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 100.69 -32.68 7.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.367 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -151.65 137.52 18.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.875 0.369 . . . . 0.0 111.073 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . 0.412 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 56.1 m95 -110.52 159.03 17.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.406 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -136.48 122.23 19.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.89 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -152.86 175.02 31.55 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.472 -1.346 . . . . 0.0 113.898 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 333' ' ' ARG . 53.5 m80 -107.12 128.27 54.25 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 10.2 tp -111.91 155.54 13.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.563 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -50.37 148.03 3.95 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.455 0.472 . . . . 0.0 110.758 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.8 168.03 19.26 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 55.6 m -149.91 -170.28 3.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.452 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -68.18 -57.76 5.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.705 0.288 . . . . 0.0 111.383 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -143.12 156.18 44.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.988 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 68.85 47.14 57.05 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.088 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' THR . . . . . 0.405 HG21 HD22 ' A' ' 302' ' ' ASN . 22.4 m -137.92 136.44 37.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -121.46 169.94 10.15 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 65.4 mtt180 -87.29 -30.49 20.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.775 0.321 . . . . 0.0 110.752 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 31.3 mm -113.26 121.35 65.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.055 0.455 . . . . 0.0 110.772 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.89 149.69 20.77 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.551 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 67.5 m-85 -107.64 139.15 42.62 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 338' ' ' PRO . 17.0 p90 -140.93 147.19 47.02 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.632 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 4.8 Cg_exo -75.79 130.85 12.83 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.893 2.395 . . . . 0.0 111.979 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.59 -16.57 37.1 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.366 2.711 . . . . 0.0 112.921 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.57 76.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.541 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 41.2 pt -107.99 1.18 9.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 117.386 0.593 . . . . 0.0 112.048 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.409 HG13 ' CD2' ' A' ' 337' ' ' PHE . 35.4 m -124.11 150.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.421 . . . . 0.0 111.362 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -146.98 170.27 17.45 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.326 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.83 -167.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.22 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 37.2 t -67.78 -34.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 54.7 m -70.0 95.07 0.91 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 110.907 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -100.27 136.96 39.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.694 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--O 1.24 0.559 0 CA-C-O 118.651 -0.69 . . . . 0.0 109.801 177.827 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.093 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 25.4 p -149.01 137.06 20.75 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.914 0.388 . . . . 0.0 110.665 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -122.71 175.4 6.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.651 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -144.36 133.81 23.29 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.81 168.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.531 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -124.34 134.48 53.15 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.436 ' HA ' HG13 ' A' ' 342' ' ' VAL . . . -78.05 137.04 38.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.242 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.06 -28.8 22.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.517 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -129.16 146.76 51.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.929 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.87 138.06 47.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.851 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -101.92 110.5 22.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -151.32 119.62 6.37 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -151.4 -43.57 0.11 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.325 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 14.6 mt -150.83 134.03 16.12 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.502 ' HA ' ' OD1' ' A' ' 302' ' ' ASN . 38.7 m80 -84.19 84.44 7.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.81 146.89 28.01 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.245 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.438 ' HG3' ' O ' ' A' ' 331' ' ' THR . 31.7 Cg_exo -57.88 -8.32 4.4 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.073 2.515 . . . . 0.0 113.668 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 8.1 t -87.59 -11.82 47.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.013 0.435 . . . . 0.0 110.369 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -121.76 150.56 41.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.458 HD22 ' CD1' ' A' ' 337' ' ' PHE . 31.3 tp -88.51 104.03 16.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.576 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 296' ' ' HIS . 29.1 m-80 -84.05 94.09 8.24 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.303 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.46 146.1 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.753 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -108.73 161.29 15.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.77 128.03 34.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.675 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 98.28 -13.3 63.2 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.827 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -80.89 161.17 24.49 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 120.688 0.28 . . . . 0.0 110.659 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 26.5 m -98.03 144.71 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.202 0.525 . . . . 0.0 111.678 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 42.9 mt -128.99 129.49 68.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.752 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 23.5 m -86.69 108.82 18.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 10.6 t -90.79 148.15 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.92 -56.05 13.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.804 0.335 . . . . 0.0 110.222 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -176.68 144.63 0.5 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.431 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . 0.479 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 23.9 pt20 -92.29 79.27 5.05 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.743 0.782 . . . . 0.0 110.626 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . 0.464 ' HB3' ' HD3' ' A' ' 316' ' ' PRO . 1.4 t-80 -136.74 -53.73 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.217 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 315' ' ' HIS . 2.0 Cg_endo -83.48 101.03 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.18 1.92 . . . . 0.0 110.501 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.53 146.57 48.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.824 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 126.8 -158.65 20.88 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -80.65 98.62 7.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 0.0 109.575 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . 0.511 ' CZ2' ' HB3' ' A' ' 339' ' ' PRO . 0.2 OUTLIER -89.4 158.91 17.57 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.908 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -85.91 127.8 34.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.255 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -126.05 154.16 18.74 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.971 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -119.72 139.43 52.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 326' ' ' GLU . 37.2 mt -106.94 139.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -90.84 20.7 4.58 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.155 0.502 . . . . 0.0 110.97 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 324' ' ' ILE . 10.5 tp10 -134.63 154.53 51.47 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 22.9 t -138.67 136.34 35.76 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.017 0.437 . . . . 0.0 111.714 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -134.69 -81.09 0.44 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.11 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -131.01 132.05 44.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 106.53 67.29 0.66 Allowed Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.111 -1.042 . . . . 0.0 110.605 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 298' ' ' PRO . 2.9 p -48.36 141.67 6.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.064 0.545 . . . . 0.0 112.152 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 70.32 89.21 0.1 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.126 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.6 69.58 5.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.165 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 19.5 mm -128.06 111.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.304 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -144.35 159.09 27.68 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.555 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 5.4 p90 -104.03 137.71 41.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.458 ' CD1' HD22 ' A' ' 301' ' ' LEU . 20.2 p90 -147.81 155.08 44.58 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.278 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.01 134.59 6.18 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.544 2.162 . . . . 0.0 111.379 176.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . 0.511 ' HB3' ' CZ2' ' A' ' 320' ' ' TRP . 11.1 Cg_endo -54.94 -19.96 21.32 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.2 2.6 . . . . 0.0 113.202 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -60.92 -20.27 57.3 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 114.258 0.463 . . . . 0.0 114.258 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 43.1 pt -100.55 4.84 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.605 0.703 . . . . 0.0 112.259 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 288' ' ' ALA . 31.9 m -132.77 164.19 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.096 0.474 . . . . 0.0 111.596 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.06 149.57 50.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.07 -33.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.1 p -158.25 -20.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 74.0 m -80.24 14.93 1.72 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.981 -0.449 . . . . 0.0 111.981 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -88.67 127.36 35.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.683 177.557 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.2 m -149.62 111.94 4.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 60.0 tp -128.64 148.64 50.82 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -124.82 135.48 52.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.016 0.436 . . . . 0.0 111.266 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.456 HG13 ' CH2' ' A' ' 320' ' ' TRP . 16.0 m -125.11 146.68 30.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.898 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -103.07 139.5 38.52 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.86 119.67 23.06 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.076 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.93 -26.87 17.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.413 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -127.31 146.89 50.29 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.83 122.31 25.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -103.49 113.02 26.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -115.55 104.72 12.01 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.956 0.408 . . . . 0.0 111.469 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -130.69 106.25 8.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.1 pp -107.24 -1.01 22.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.178 0.513 . . . . 0.0 110.703 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.57 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.25 113.6 23.67 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.685 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.13 -0.48 9.17 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.621 2.214 . . . . 0.0 111.978 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 3.4 m -85.26 -16.84 38.83 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.48 0.657 . . . . 0.0 109.564 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -91.94 144.7 25.2 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.379 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.71 110.9 18.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.051 0.453 . . . . 0.0 111.166 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -101.06 121.62 42.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.96 152.34 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.939 0.4 . . . . 0.0 111.253 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -101.74 146.58 27.57 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.28 125.51 23.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.758 0.313 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.33 -16.06 29.79 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.699 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -84.29 156.55 21.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.53 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 8.9 t -112.14 135.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.353 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 20.8 mt -114.7 134.05 58.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.952 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 39.7 m -104.19 120.09 40.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.043 0.449 . . . . 0.0 110.711 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 31.3 m -105.24 146.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.133 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 80.0 mt -83.27 -60.12 2.25 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.312 0.577 . . . . 0.0 109.795 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -114.09 114.21 25.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.065 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 141.93 43.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 320' ' ' TRP . 66.8 m-70 -139.95 89.47 11.3 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.22 -9.21 25.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.874 2.382 . . . . 0.0 113.318 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -123.41 117.8 26.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.3 -102.41 1.82 Allowed Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.964 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -153.62 158.0 40.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . 0.456 ' CH2' HG13 ' A' ' 286' ' ' VAL . 0.1 OUTLIER -148.76 170.69 17.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 178.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -128.25 144.56 51.14 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.439 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.1 34.51 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.997 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' A' ' 333' ' ' ARG . 3.9 p-80 -114.26 133.83 55.36 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 47.2 mt -80.93 150.96 4.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.407 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -76.73 117.58 18.5 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.44 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -82.98 -90.6 0.08 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.039 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 15.5 m 51.98 24.36 2.58 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.981 0.513 . . . . 0.0 112.146 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -175.47 -69.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -169.65 -176.52 2.44 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.03 67.74 0.71 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.095 -1.526 . . . . 0.0 112.092 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 49.8 m -51.95 134.0 32.05 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.685 0.278 . . . . 0.0 111.246 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.9 t70 178.72 143.67 0.12 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.508 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 30.3 tpt180 -120.52 -67.74 0.96 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 14.1 mm -153.77 116.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.35 151.49 21.15 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.439 -1.363 . . . . 0.0 112.563 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -89.14 146.33 24.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -158.38 158.48 29.7 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.896 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.454 ' O ' HG12 ' A' ' 341' ' ' ILE . 78.2 Cg_endo -82.39 132.97 7.15 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.334 2.023 . . . . 0.0 111.942 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.8 -14.83 19.12 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.249 2.633 . . . . 0.0 113.116 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -67.9 -19.86 71.99 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.861 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 338' ' ' PRO . 39.5 pt -94.28 -8.15 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 117.599 0.699 . . . . 0.0 111.835 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 28.8 m -123.05 170.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.974 0.416 . . . . 0.0 111.083 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -157.12 151.19 24.8 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.3 -67.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 73.7 t -104.03 -41.19 6.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.2 m -60.05 133.96 56.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -99.15 158.23 15.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.794 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.908 179.308 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 14.7 p 50.3 84.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.854 0.861 . . . . 0.0 112.53 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.59 173.09 7.39 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.147 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.31 143.16 28.95 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.266 0.555 . . . . 0.0 112.181 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.19 164.04 34.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.86 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -113.64 144.58 42.67 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.131 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.5 118.28 23.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.751 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 -5.96 48.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.29 0.567 . . . . 0.0 110.426 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -138.85 146.49 41.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -80.12 121.92 26.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.663 0.268 . . . . 0.0 110.634 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.83 53.69 1.76 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.511 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.54 ' HB2' ' CE1' ' A' ' 292' ' ' PHE . 50.4 t-20 -66.82 -61.35 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.497 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 13.9 tp -160.48 165.06 31.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -97.38 20.46 11.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.905 0.383 . . . . 0.0 111.936 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.47 153.54 41.36 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.017 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.86 -19.42 65.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.887 2.392 . . . . 0.0 112.829 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.4 m -81.25 -14.99 56.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 110.698 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -109.55 137.65 47.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.963 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.453 HD13 ' CG1' ' A' ' 324' ' ' ILE . 31.4 tp -86.59 111.24 20.44 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.082 0.467 . . . . 0.0 110.978 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.14 102.68 12.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.17 148.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.416 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -96.05 149.25 21.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.78 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.43 27.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.743 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.42 -19.36 26.75 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.382 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -76.98 155.88 32.31 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 116.904 0.352 . . . . 0.0 111.146 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.77 134.13 43.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.344 0.592 . . . . 0.0 111.429 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.44 HG12 ' CD1' ' A' ' 324' ' ' ILE . 56.3 mt -109.24 116.85 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 22.4 m -91.2 114.84 27.47 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.2 142.09 17.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.67 -66.73 0.57 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -178.71 113.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.439 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -158.64 132.49 7.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -64.0 116.94 31.2 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 97.32 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.537 2.158 . . . . 0.0 113.035 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -150.57 129.2 12.28 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.503 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.24 -87.5 0.49 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -151.03 132.03 14.27 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.59 166.3 16.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.663 -175.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -89.16 140.07 29.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 111.886 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.96 156.23 26.33 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.371 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -111.2 121.08 44.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.933 0.397 . . . . 0.0 110.148 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 332' ' ' ASP . 35.3 mm -85.9 121.75 37.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.438 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -109.21 92.04 3.89 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -75.28 133.4 41.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.241 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.4 m -86.54 -14.03 44.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.682 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -75.39 -78.98 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -176.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -3.3 58.88 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 120.729 0.299 . . . . 0.0 110.849 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 66.07 51.08 47.78 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.77 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.9 t -118.86 158.07 26.38 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 324' ' ' ILE . 5.6 m-20 -126.88 130.51 50.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.156 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -136.67 132.83 35.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.543 0.211 . . . . 0.0 110.945 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 15.8 tt -101.44 140.25 20.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.847 0.356 . . . . 0.0 110.337 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.05 179.26 35.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -110.9 143.98 40.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.693 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -149.14 156.51 40.17 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.115 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.418 ' O ' HG12 ' A' ' 341' ' ' ILE . 3.5 Cg_exo -81.72 131.04 7.03 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.822 2.348 . . . . 0.0 111.363 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.17 -15.79 36.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.862 2.375 . . . . 0.0 112.789 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.38 -19.55 74.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.594 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 338' ' ' PRO . 41.1 pt -100.25 1.7 10.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.539 0.669 . . . . 0.0 111.803 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 33.5 m -128.18 164.5 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.182 0.515 . . . . 0.0 111.581 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -160.35 151.83 19.59 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.4 HG11 HG12 ' A' ' 345' ' ' VAL . 7.2 p -66.54 -40.92 87.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.4 HG12 HG11 ' A' ' 344' ' ' VAL . 7.9 p -157.09 122.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.411 . . . . 0.0 110.752 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 49.6 m -163.96 -23.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.22 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -64.56 121.09 13.62 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.653 -0.689 . . . . 0.0 109.657 179.489 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.383 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 311' ' ' VAL . 30.5 p -75.83 135.18 40.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.886 0.374 . . . . 0.0 111.109 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 311' ' ' VAL . 24.6 tp -144.39 157.48 44.23 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.24 133.44 56.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.789 0.328 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.98 152.08 36.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -105.41 137.43 43.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.696 0.284 . . . . 0.0 110.518 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -82.1 110.89 17.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.028 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 47.0 mt -78.66 -26.31 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.198 0.523 . . . . 0.0 110.089 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -132.67 162.79 30.48 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.42 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.44 151.97 32.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.725 0.298 . . . . 0.0 110.206 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . 0.473 ' HB3' HG12 ' A' ' 303' ' ' VAL . 32.4 t80 -140.69 113.48 8.24 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -144.72 102.32 3.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -108.95 129.04 55.43 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 295' ' ' LEU . 1.8 pt? -111.58 7.78 20.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.836 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -92.2 -41.04 10.66 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.049 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -101.97 122.05 48.55 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.085 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.8 -28.55 59.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.318 2.012 . . . . 0.0 111.612 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 7.3 t -83.95 -3.04 57.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.737 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -70.28 150.21 46.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.618 0.247 . . . . 0.0 110.501 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' A' ' 337' ' ' PHE . 15.7 tp -82.51 153.67 25.45 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.059 0.457 . . . . 0.0 110.77 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.424 ' N ' ' HG ' ' A' ' 301' ' ' LEU . 23.4 p-10 -128.15 119.64 25.7 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.7 p -144.4 146.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.048 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -96.55 142.3 28.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.1 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.37 122.11 12.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.733 0.301 . . . . 0.0 110.335 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.17 40.16 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.72 -0.753 . . . . 0.0 113.028 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.2 169.56 12.95 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.151 0.475 . . . . 0.0 110.151 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.13 128.72 72.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.353 0.597 . . . . 0.0 111.583 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.452 HG12 HD11 ' A' ' 324' ' ' ILE . 68.2 mt -99.3 129.05 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.993 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.8 m -98.0 108.6 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 283' ' ' SER . 19.5 m -93.06 140.13 16.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 120.842 0.353 . . . . 0.0 110.603 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.441 ' H ' HD21 ' A' ' 312' ' ' LEU . 2.6 pt? -82.18 -12.72 57.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.574 0.702 . . . . 0.0 109.46 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -159.33 143.99 15.44 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.582 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.28 -33.09 69.44 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.011 0.195 . . . . 0.0 110.98 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.4 m80 67.77 157.38 0.14 Allowed Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.814 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.35 137.92 63.19 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.001 1.8 . . . . 0.0 110.216 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.24 118.77 7.86 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.768 0.794 . . . . 0.0 111.035 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 161.51 -43.9 0.39 Allowed Glycine 0 C--N 1.31 -0.908 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.608 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -157.57 123.91 4.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 110.043 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 339' ' ' PRO . 45.0 m95 -94.67 174.34 7.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.566 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -156.61 114.13 3.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -145.33 176.68 24.21 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.453 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 333' ' ' ARG . 46.8 m80 -107.17 136.94 46.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.452 HD11 HG12 ' A' ' 309' ' ' ILE . 11.0 tp -130.67 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.643 0.259 . . . . 0.0 110.629 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -95.51 10.09 37.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.335 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -66.56 -30.51 70.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 43.4 m -62.81 113.64 3.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -62.41 -16.58 55.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.577 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -62.77 -13.92 38.85 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.522 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 101.31 -52.15 0.9 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.142 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.9 t -68.35 152.24 45.72 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.117 0.484 . . . . 0.0 111.507 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.74 93.38 0.73 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.212 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 57.2 ttp85 -77.35 142.58 39.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.901 0.381 . . . . 0.0 110.366 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 9.1 tp -94.82 140.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.52 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.41 159.1 30.54 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.602 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -101.75 151.78 21.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.818 0.309 . . . . 0.0 110.314 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.548 ' CD1' HD22 ' A' ' 301' ' ' LEU . 16.7 p90 -153.71 151.08 24.38 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.29 133.43 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.714 2.276 . . . . 0.0 112.131 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 320' ' ' TRP . 20.7 Cg_endo -61.4 -17.57 54.18 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.218 2.612 . . . . 0.0 113.023 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -63.89 -19.18 62.99 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.655 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 45.6 pt -107.96 6.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 28.3 m -132.26 161.45 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 111.78 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -160.46 161.97 33.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 -24.53 35.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.58 -178.59 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.095 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.2 m -71.54 161.01 31.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -64.24 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.011 0.434 . . . . 0.0 110.736 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.485 178.867 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.0 p -161.33 108.43 1.44 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.07 167.93 10.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.432 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -129.89 141.49 50.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.02 144.67 31.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.636 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 58.2 mtt85 -102.34 129.46 48.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.05 117.78 24.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.817 0.341 . . . . 0.0 111.159 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.97 -23.32 20.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.237 0.542 . . . . 0.0 109.563 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -117.81 146.35 43.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.54 135.57 36.12 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.328 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -99.25 112.62 24.75 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.36 167.29 21.94 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.453 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -74.82 133.63 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.255 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.42 177.6 4.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.822 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.53 45.09 0.94 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.71 138.21 6.15 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.67 -18.75 42.23 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.268 2.645 . . . . 0.0 113.85 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 2.7 m -80.45 1.14 30.47 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.169 0.509 . . . . 0.0 110.861 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.11 124.5 23.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 21.2 tp -88.84 87.45 7.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.561 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -74.63 97.58 3.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.674 . . . . 0.0 111.116 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.55 139.83 48.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.868 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -99.61 157.05 16.73 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.96 121.67 13.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.746 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.87 26.87 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.297 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -85.63 162.75 18.68 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 122.503 -0.41 . . . . 0.0 110.52 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 30.2 m -114.57 145.2 20.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.292 0.568 . . . . 0.0 112.208 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 4.4 mp -118.02 130.75 72.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.84 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 85.7 m -96.99 120.55 37.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.061 0.458 . . . . 0.0 110.761 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.18 146.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.559 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.38 -78.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.702 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -164.62 98.91 0.79 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.438 0.637 . . . . 0.0 110.792 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -164.62 153.73 13.13 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.335 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -90.63 144.19 30.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.1 49.45 2.29 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.162 2.575 . . . . 0.0 112.661 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -101.9 45.12 0.98 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.112 0.482 . . . . 0.0 110.726 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 149.43 170.01 16.5 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 134.79 56.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.588 0.694 . . . . 0.0 109.606 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.63 -179.64 6.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 -176.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -123.1 145.06 48.9 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -133.47 166.21 23.9 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.358 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -109.94 122.39 47.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.24 137.39 31.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.379 0.609 . . . . 0.0 112.138 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -146.69 103.54 3.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.981 175.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.99 -171.77 2.44 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.691 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 33.0 m -62.21 -23.83 66.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.651 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -82.96 115.93 22.02 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.54 142.13 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.857 0.361 . . . . 0.0 110.658 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.34 -21.12 35.96 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.671 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 40.2 p -69.68 137.39 52.09 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -156.43 121.59 4.7 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.115 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -157.95 139.89 14.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.018 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 13.7 tt -124.83 130.93 73.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.61 33.75 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.546 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -88.88 146.69 24.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.664 0.269 . . . . 0.0 111.279 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.69 152.66 18.18 Favored Pre-proline 0 C--O 1.242 0.679 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.489 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.566 ' O ' HG12 ' A' ' 341' ' ' ILE . 72.3 Cg_endo -79.46 133.64 10.74 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.53 2.153 . . . . 0.0 111.72 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.81 -14.92 45.92 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.821 2.347 . . . . 0.0 112.734 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -72.34 -18.8 78.44 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 116.099 -0.5 . . . . 0.0 113.574 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 338' ' ' PRO . 46.9 pt -93.51 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.471 0.635 . . . . 0.0 111.501 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.87 163.45 18.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -146.55 146.24 30.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.725 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.39 -35.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.41 HG13 ' NE ' ' A' ' 348' ' ' ARG . 17.5 t -72.65 158.55 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 30.7 m -72.75 102.77 3.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.656 0.265 . . . . 0.0 111.447 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt 45.39 37.96 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.443 1.097 . . . . 0.0 113.8 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.41 ' NE ' HG13 ' A' ' 345' ' ' VAL . 38.6 ttm180 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.375 -0.822 . . . . 0.0 109.916 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.042 0 N-CA-C 112.196 -0.362 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 51.0 m -143.05 93.11 2.46 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.87 159.2 21.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -131.61 136.2 47.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 25.0 m -115.54 142.41 28.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -101.6 132.71 47.11 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.344 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -80.34 117.53 21.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.56 -21.91 22.64 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -126.32 147.7 49.68 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.679 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.84 153.78 28.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.111 0.482 . . . . 0.0 111.38 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . 0.453 ' HB3' HG12 ' A' ' 303' ' ' VAL . 40.3 t80 -135.65 110.72 8.89 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -174.52 133.85 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -124.13 161.74 25.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.475 HD21 ' H ' ' A' ' 295' ' ' LEU . 2.5 pt? -77.26 -8.74 58.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.64 0.734 . . . . 0.0 109.229 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -126.71 -156.75 0.76 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.538 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.44 91.61 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 123.327 0.392 . . . . 0.0 111.287 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.86 -15.74 26.4 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.445 2.097 . . . . 0.0 112.842 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.6 m -105.67 7.48 32.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 110.886 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -72.38 139.89 48.11 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 21.0 tp -84.36 91.21 7.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.49 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.97 106.17 1.51 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.249 0.547 . . . . 0.0 111.344 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.453 HG12 ' HB3' ' A' ' 292' ' ' PHE . 12.8 p -134.84 135.16 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.563 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -97.01 147.4 24.04 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.959 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.58 125.79 25.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.086 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.41 -18.15 25.56 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.611 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.19 165.29 16.65 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.842 0.353 . . . . 0.0 110.565 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.55 134.94 59.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.17 128.08 53.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.3 m -83.22 108.75 16.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.88 0.372 . . . . 0.0 110.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.78 127.07 62.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.398 0.618 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 2.2 pp -86.41 -9.77 55.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.506 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 117.97 6.7 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -76.97 101.4 5.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.728 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -123.01 84.4 50.8 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.45 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 -2.0 12.14 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 114.236 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -108.12 106.87 17.28 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.479 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 93.79 173.12 39.46 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.779 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -68.46 128.87 38.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 109.897 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -126.3 162.19 26.06 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.537 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -98.69 136.87 38.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.277 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -139.8 171.85 23.63 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.154 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -109.14 128.14 54.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.954 0.407 . . . . 0.0 111.151 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 11.4 tp -124.42 154.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 54.8 t60 71.99 166.27 0.3 Allowed 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.5 0.5 . . . . 0.0 110.417 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.07 154.5 41.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.839 0.352 . . . . 0.0 110.603 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 6.2 p -101.83 108.48 19.98 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.118 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.14 179.74 7.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.685 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -73.09 117.09 14.41 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.102 0.477 . . . . 0.0 111.927 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 102.52 -53.12 0.79 Allowed Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.945 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.23 157.64 46.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.209 0.504 . . . . 0.0 111.516 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -146.23 -170.89 3.6 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -115.1 108.83 17.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.392 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 39.8 mm -106.82 129.69 60.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.547 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -140.0 159.94 26.14 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.025 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -97.2 140.76 31.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.882 0.372 . . . . 0.0 110.243 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -148.78 160.56 35.37 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.259 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.464 ' O ' HG12 ' A' ' 341' ' ' ILE . 4.0 Cg_endo -87.11 132.91 3.29 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.763 2.309 . . . . 0.0 112.135 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.81 -14.07 34.34 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.133 2.555 . . . . 0.0 112.472 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.48 -18.84 68.22 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.498 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 338' ' ' PRO . 49.2 pt -101.98 -4.49 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.83 150.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.856 0.36 . . . . 0.0 111.52 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -143.18 146.55 33.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.674 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.41 -34.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.727 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.42 -37.05 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.502 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.2 m -109.24 86.41 2.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.094 0.474 . . . . 0.0 110.204 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -85.89 94.58 9.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.217 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.955 177.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.084 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.3 m -85.0 107.25 17.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.091 0.472 . . . . 0.0 110.885 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.405 ' HB2' HG21 ' A' ' 311' ' ' VAL . 73.1 mt -105.6 179.86 4.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.174 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 25.4 pttm -153.05 145.01 23.69 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.287 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.9 m -128.88 157.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.832 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -102.42 127.99 49.22 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.906 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -81.61 128.68 34.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.89 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.25 -9.8 26.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.581 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -133.62 147.3 51.47 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -80.25 122.41 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 302' ' ' ASN . 0.6 OUTLIER -104.94 111.38 24.13 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -162.36 -2.96 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.74 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -56.81 -44.38 81.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.147 0.498 . . . . 0.0 109.689 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 26.4 tp -89.44 120.59 30.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -94.87 0.8 55.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.2 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.24 139.34 96.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.32 -21.24 35.69 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.127 2.551 . . . . 0.0 113.293 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.4 t -78.03 -12.07 59.96 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -87.17 142.11 28.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.819 0.342 . . . . 0.0 110.393 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 337' ' ' PHE . 1.3 tp -82.91 89.33 6.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 292' ' ' PHE . 14.5 m120 -75.27 111.33 10.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 10.6 p -142.89 154.59 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.839 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -95.16 144.56 25.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.247 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -68.48 118.41 11.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 108.19 -2.37 33.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.62 150.88 20.66 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.6 m -97.63 124.09 50.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.418 0.628 . . . . 0.0 111.441 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 285' ' ' LYS . 27.3 mt -88.51 132.38 33.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.479 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.51 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 23.2 m -81.32 107.22 13.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 284' ' ' LEU . 17.6 m -106.59 144.66 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.416 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 3.8 pp -93.78 -8.4 40.72 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.335 0.588 . . . . 0.0 110.25 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.72 171.69 13.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -139.57 13.85 2.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.096 0.474 . . . . 0.0 110.296 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -97.31 115.25 65.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.488 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.76 105.22 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.745 2.297 . . . . 0.0 112.152 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.97 8.13 45.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.653 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.27 107.22 0.34 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 41.05 71.4 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.833 0.825 . . . . 0.0 110.554 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -95.43 174.46 7.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -173.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 336' ' ' TYR . 0.4 OUTLIER -96.07 151.29 19.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.53 171.98 23.77 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.884 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 310' ' ' THR . 8.1 t60 -109.49 122.54 47.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.692 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.5 146.41 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 69.58 88.0 0.11 Allowed 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 123.509 0.505 . . . . 0.0 110.113 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.96 -26.77 38.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.985 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.8 t -115.36 104.02 11.38 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -97.3 167.81 10.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.879 0.371 . . . . 0.0 111.854 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -128.95 105.94 8.55 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.424 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 79.58 -52.44 4.14 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.842 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 20.8 m -139.21 146.91 41.09 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -88.73 -172.47 3.73 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.012 0.434 . . . . 0.0 111.174 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -135.53 107.51 7.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 34.2 mm -107.07 128.15 62.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.129 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.77 155.6 23.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 321' ' ' LYS . 41.1 p90 -96.33 147.74 23.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.492 0.646 . . . . 0.0 111.002 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.451 ' CD1' HD22 ' A' ' 301' ' ' LEU . 39.8 p90 -148.61 145.13 19.37 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.855 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.535 ' O ' HG12 ' A' ' 341' ' ' ILE . 9.4 Cg_exo -73.22 130.01 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.384 2.056 . . . . 0.0 110.606 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.19 -16.35 33.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.726 2.284 . . . . 0.0 112.859 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.63 -22.76 76.8 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.238 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 338' ' ' PRO . 38.6 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.325 0.562 . . . . 0.0 111.975 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.38 170.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.544 0.211 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -158.92 168.0 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.02 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.1 -31.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.915 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.3 -22.94 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.5 m -106.98 22.55 15.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 0.0 109.956 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -63.57 111.96 2.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.824 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 . . . . . 0 C--N 1.313 -0.991 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -177.432 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 37.4 p -155.07 138.31 15.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.842 0.353 . . . . 0.0 110.784 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 57.0 tp -136.09 166.31 23.66 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -131.9 141.62 49.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.075 0.464 . . . . 0.0 110.95 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.74 146.4 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.994 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -104.47 120.36 41.07 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.666 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 342' ' ' VAL . . . -73.44 124.8 26.5 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.441 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -89.26 -9.93 48.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.21 0.529 . . . . 0.0 109.709 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -143.53 148.08 35.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.115 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.469 ' OD1' ' HA ' ' A' ' 304' ' ' ARG . 24.0 m-20 -68.74 155.7 39.63 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -76.66 113.81 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.328 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -102.78 127.58 49.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -163.79 162.41 23.8 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.27 122.64 10.75 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -43.37 113.55 0.51 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.787 0.679 . . . . 0.0 112.738 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -158.94 135.91 6.79 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.26 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.7 -13.28 39.04 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.126 2.551 . . . . 0.0 114.736 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 34.2 p -95.82 9.12 41.57 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.212 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -75.38 152.54 38.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 tp -79.69 102.43 8.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -80.58 86.32 5.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 0.0 111.904 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.53 137.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.382 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.469 ' HA ' ' OD1' ' A' ' 291' ' ' ASP . 19.1 ttp180 -98.9 147.96 24.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.55 115.13 3.37 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.25 37.84 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.042 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.2 173.16 8.57 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.81 143.98 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -175.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 81.4 mt -111.83 124.38 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.495 178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 41.5 m -86.32 110.95 20.02 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.169 0.509 . . . . 0.0 110.784 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 33.9 m -107.17 148.53 11.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.996 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 4.5 tt -88.6 -52.88 4.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.12 131.02 53.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . 0.553 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 55.9 mt-30 -79.08 130.32 35.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.199 0.524 . . . . 0.0 111.804 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -138.85 70.15 43.18 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.857 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.07 81.92 1.63 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 111.733 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -144.93 -62.27 0.36 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.966 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -130.64 -160.55 10.03 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -69.15 101.65 1.5 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 117.39 0.595 . . . . 0.0 110.362 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . 0.553 ' CZ3' ' HA ' ' A' ' 314' ' ' GLN . 1.0 OUTLIER -102.81 169.04 8.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.348 -177.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 25.5 pttm -93.85 152.13 19.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.528 0.68 . . . . 0.0 112.795 -174.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.51 39.63 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.732 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -108.8 122.64 47.58 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.193 0.497 . . . . 0.0 110.402 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 10.1 tp -103.02 156.64 5.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.902 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -46.88 142.88 3.17 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.595 0.56 . . . . 0.0 110.188 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.72 108.09 19.6 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.824 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 29.1 m -58.74 143.42 47.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.371 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -74.67 -18.24 60.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.295 0.569 . . . . 0.0 110.26 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -119.46 101.21 7.79 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 84.27 65.41 1.53 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.4 t -49.86 137.24 16.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.337 0.589 . . . . 0.0 111.673 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.17 171.49 8.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.324 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -148.58 -164.37 2.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.57 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.38 125.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.62 -179.8 17.64 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -104.13 147.68 27.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.892 0.377 . . . . 0.0 110.769 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.64 151.69 36.31 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.54 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.52 135.61 5.17 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.862 2.374 . . . . 0.0 111.642 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.35 -3.5 5.26 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.964 2.443 . . . . 0.0 112.716 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -79.99 -19.6 69.66 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.852 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 37.8 pt -102.61 1.89 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.841 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 288' ' ' ALA . 27.6 m -112.41 150.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.468 0.652 . . . . 0.0 112.665 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.5 133.34 55.95 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.905 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.55 -31.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.807 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.87 -63.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.962 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.8 m -122.52 173.44 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.648 0.261 . . . . 0.0 111.687 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.66 82.58 0.18 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.666 0.786 . . . . 0.0 111.223 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . 0.431 ' H ' ' NE ' ' A' ' 348' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 54.8 m -157.83 107.93 2.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.794 0.33 . . . . 0.0 110.309 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.45 161.09 18.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -126.26 133.99 51.3 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.723 0.297 . . . . 0.0 110.376 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.48 138.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.057 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -106.06 134.62 48.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.453 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.12 131.25 37.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.9 -29.82 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.803 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -127.73 147.56 50.4 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.54 147.0 53.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.762 0.315 . . . . 0.0 110.397 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . 0.423 ' HB2' HG12 ' A' ' 303' ' ' VAL . 69.3 t80 -64.4 133.45 52.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.084 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -77.37 102.39 6.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -66.15 103.49 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.478 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.18 4.64 51.72 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.697 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 66.11 79.56 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.536 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -154.11 135.5 8.87 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.889 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.15 -23.61 66.62 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.044 2.496 . . . . 0.0 113.516 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.6 m -98.05 -1.85 41.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.366 0.603 . . . . 0.0 110.951 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.92 38.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.5 103.66 16.09 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.798 0.332 . . . . 0.0 111.154 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -78.88 123.39 27.19 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 292' ' ' PHE . 11.8 p -141.45 146.36 23.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.032 0.444 . . . . 0.0 111.064 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -98.53 148.49 23.71 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.519 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.1 127.38 31.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 110.127 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.14 -13.15 48.85 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.682 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -87.17 153.97 21.09 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.144 0.472 . . . . 0.0 110.422 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 6.4 t -107.07 128.57 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 111.094 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 303' ' ' VAL . 4.1 mp -102.1 142.37 16.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.315 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 8.2 m -108.36 108.82 19.95 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.22 148.78 5.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.91 0.386 . . . . 0.0 111.17 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.79 -64.42 1.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.519 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.07 134.51 52.09 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -80.37 82.99 6.29 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.497 0.665 . . . . 0.0 110.54 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -70.53 131.78 87.89 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.052 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.79 -41.04 40.65 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.846 2.364 . . . . 0.0 113.483 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -139.66 174.9 10.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 111.116 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.16 -155.7 31.64 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.514 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -110.63 110.47 21.17 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -89.78 157.75 17.8 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.856 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.93 121.89 30.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.772 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -119.09 151.54 17.59 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.129 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.37 121.39 44.73 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 332' ' ' ASP . 55.6 mt -109.35 137.23 42.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -154.37 112.35 3.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.463 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -91.43 179.29 5.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 15.7 m -67.71 -59.84 3.01 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -62.36 -74.32 0.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.765 0.317 . . . . 0.0 111.479 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -131.39 -135.39 0.2 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 65.97 66.27 2.49 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.638 -1.268 . . . . 0.0 111.938 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.8 p -56.29 154.78 7.65 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.445 0.164 . . . . 0.0 111.189 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 324' ' ' ILE . 9.9 m-20 -41.81 110.14 0.16 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -116.41 138.84 51.03 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.055 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.56 138.68 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 111.676 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -166.26 174.71 41.81 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -99.99 149.07 23.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.363 0.582 . . . . 0.0 111.102 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -154.49 162.63 26.56 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.781 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -87.31 122.59 1.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.119 2.546 . . . . 0.0 112.456 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -56.2 -18.61 24.33 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.417 2.745 . . . . 0.0 112.82 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -62.84 -23.98 66.1 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.877 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 42.8 pt -99.06 4.63 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.542 0.671 . . . . 0.0 112.228 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 288' ' ' ALA . 33.2 m -129.22 165.74 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 112.011 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -149.79 148.13 28.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.074 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.96 -35.81 61.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 18.0 t -89.4 146.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.3 t -69.98 95.77 0.97 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.15 0.5 . . . . 0.0 111.645 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt 64.13 30.42 13.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 113.0 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 112.109 -0.396 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 312' ' ' LEU . 50.7 m -148.72 158.99 44.54 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.413 ' HG ' ' N ' ' A' ' 285' ' ' LYS . 43.1 tp -146.35 166.61 25.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.778 0.323 . . . . 0.0 110.642 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . 0.413 ' N ' ' HG ' ' A' ' 284' ' ' LEU . 60.1 pttt -123.12 135.88 54.55 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.74 137.78 55.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -102.75 130.54 49.74 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.731 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -86.04 119.58 26.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.874 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.48 -21.12 24.35 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -123.71 146.08 48.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -72.83 122.21 21.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.05 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . 0.433 ' HB3' ' H ' ' A' ' 303' ' ' VAL . 6.5 t80 -80.6 111.23 16.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -170.37 18.12 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.12 0.486 . . . . 0.0 109.883 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 -8.87 59.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.04 168.07 10.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -105.45 -24.65 12.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.521 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.37 131.91 23.28 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 111.737 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.3 3.36 5.84 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.04 3.16 . . . . 0.0 114.386 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.7 t -73.38 -12.85 60.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.241 0.543 . . . . 0.0 110.47 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -89.17 153.41 20.97 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.792 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 tt -79.78 114.66 18.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.987 0.422 . . . . 0.0 110.137 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -99.01 154.43 18.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.773 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.433 ' H ' ' HB3' ' A' ' 292' ' ' PHE . 7.5 p -156.05 146.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.432 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -87.12 141.54 28.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.58 127.0 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.7 56.79 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.373 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -89.22 164.81 14.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.19 132.37 70.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.399 0.619 . . . . 0.0 111.589 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.49 128.98 49.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.332 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 26.2 m -85.47 110.26 19.05 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.924 0.392 . . . . 0.0 110.799 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.39 148.33 9.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 283' ' ' SER . 5.8 mp -87.37 -79.13 0.29 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.409 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -174.13 118.46 0.24 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.334 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . 0.435 HE21 ' HB2' ' A' ' 320' ' ' TRP . 13.6 pt20 178.51 178.21 0.42 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.7 177.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -83.69 119.91 74.4 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.02 98.7 1.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.247 1.965 . . . . 0.0 111.667 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -140.25 119.22 12.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' A' ' 339' ' ' PRO . . . 76.26 -95.68 1.08 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.909 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -132.74 122.92 25.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . 0.435 ' HB2' HE21 ' A' ' 314' ' ' GLN . 0.2 OUTLIER -116.31 156.41 26.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.112 0.482 . . . . 0.0 111.936 -178.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 8.4 ttpm? -84.06 127.18 33.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.838 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -137.91 172.54 22.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.715 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.481 ' CE1' HD13 ' A' ' 312' ' ' LEU . 48.5 m170 -112.08 124.33 52.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.0 151.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.909 0.385 . . . . 0.0 110.82 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -92.21 114.49 27.05 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.06 152.38 45.28 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 49.4 m -78.41 -37.89 42.82 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.167 -177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -91.9 154.45 18.85 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.25 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -59.48 150.0 28.04 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 90.46 40.09 5.8 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 72.4 p -69.41 149.2 48.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.123 -0.539 . . . . 0.0 111.997 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -114.25 173.72 6.31 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -119.47 -12.47 9.34 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.947 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 65.2 mt -126.38 123.89 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -152.93 171.62 31.97 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.845 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -119.96 137.17 54.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.626 0.213 . . . . 0.0 110.674 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.8 159.08 41.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.956 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.442 ' O ' HG12 ' A' ' 341' ' ' ILE . 71.6 Cg_endo -81.61 125.81 5.1 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.712 2.274 . . . . 0.0 112.1 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 318' ' ' GLY . 29.7 Cg_endo -62.97 -12.37 29.23 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.151 2.567 . . . . 0.0 113.134 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.13 -19.72 68.36 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.541 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 338' ' ' PRO . 43.7 pt -96.84 -1.5 10.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 117.338 0.569 . . . . 0.0 111.761 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.96 156.58 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.076 0.465 . . . . 0.0 111.823 -178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.53 153.7 47.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.23 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.14 -20.17 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.094 0.473 . . . . 0.0 110.499 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.17 169.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 43.0 m -69.47 156.63 38.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.24 140.56 58.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 111.425 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 . . . . . 0 C--N 1.311 -1.107 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.002 177.381 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.188 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.4 p -155.46 125.24 6.49 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.859 0.362 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.38 -173.07 2.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.382 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -141.99 141.53 32.89 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.108 0.48 . . . . 0.0 111.306 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.25 142.23 40.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.083 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -102.58 128.13 49.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.901 0.382 . . . . 0.0 111.298 -177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.45 130.19 35.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.546 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.13 -11.96 34.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.876 0.37 . . . . 0.0 110.737 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -145.69 146.58 31.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.29 122.77 16.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.754 0.312 . . . . 0.0 110.214 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -76.58 115.01 15.93 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.995 0.426 . . . . 0.0 110.968 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -75.06 92.29 2.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -60.15 149.28 33.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.889 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.77 -163.45 1.05 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.844 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -82.78 -173.65 4.78 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.134 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 77.34 144.79 0.1 Allowed Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 123.707 0.629 . . . . 0.0 110.834 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.55 2.5 5.72 Favored 'Trans proline' 0 C--O 1.221 -0.338 0 C-N-CA 122.907 2.405 . . . . 0.0 112.566 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 5.0 p -101.52 3.41 40.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.872 0.367 . . . . 0.0 111.412 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -76.85 132.48 39.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 337' ' ' PHE . 0.8 OUTLIER -82.41 151.7 26.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.323 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.454 ' O ' HG12 ' A' ' 324' ' ' ILE . 33.7 m-80 -128.6 123.57 33.67 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.66 149.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.6 0.238 . . . . 0.0 110.558 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -109.34 165.24 11.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.078 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.85 117.12 5.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.041 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.48 -11.58 39.34 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.663 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -88.47 159.36 18.0 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.346 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 12.1 m -117.14 132.25 67.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.448 0.642 . . . . 0.0 112.663 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.81 138.68 21.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.527 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 46.9 m -87.31 110.27 20.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.896 0.379 . . . . 0.0 110.53 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.77 141.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.301 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.59 -75.97 0.39 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.1 96.46 2.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.52 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . 0.435 HE21 ' HB2' ' A' ' 314' ' ' GLN . 0.7 OUTLIER -150.62 176.42 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.72 158.06 76.46 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.409 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.561 ' O ' ' HG3' ' A' ' 339' ' ' PRO . 25.0 Cg_exo -64.32 -20.63 66.76 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.825 2.35 . . . . 0.0 113.121 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.02 109.09 2.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.568 0.699 . . . . 0.0 111.183 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 106.55 -99.59 1.5 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 339' ' ' PRO . 0.0 OUTLIER -156.26 147.86 22.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.664 0.269 . . . . 0.0 110.305 178.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.27 153.07 22.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.09 176.88 21.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.028 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -106.48 122.22 45.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 302' ' ' ASN . 9.0 tp -110.31 152.68 12.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.681 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -77.36 103.04 7.06 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -103.02 148.7 25.37 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.813 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 45.6 m -88.83 -3.28 58.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.235 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -128.17 151.57 49.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.033 0.444 . . . . 0.0 112.043 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 168.49 9.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.389 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 104.77 -40.74 2.36 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 85.4 m -72.4 142.51 48.71 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.48 153.03 42.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.044 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -64.25 -25.66 68.16 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.439 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 5.7 mm -117.14 140.5 39.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.59 155.51 23.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.398 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.79 144.52 26.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 0.0 111.437 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 301' ' ' LEU . 24.5 p90 -155.19 148.38 18.32 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 3.0 Cg_exo -75.86 133.74 15.66 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.02 2.48 . . . . 0.0 113.095 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . 0.561 ' HG3' ' O ' ' A' ' 316' ' ' PRO . 30.0 Cg_endo -61.7 -19.74 66.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.176 2.584 . . . . 0.0 112.641 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -61.2 -19.55 57.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.584 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 36.8 pt -111.66 4.49 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.354 0.577 . . . . 0.0 112.355 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 339' ' ' PRO . 27.5 m -129.41 153.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 112.003 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -148.33 150.94 34.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.16 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.57 -40.8 71.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.432 ' C ' ' HG ' ' A' ' 346' ' ' SER . 26.0 t -96.05 -84.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.546 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.432 ' HG ' ' C ' ' A' ' 345' ' ' VAL . 14.7 m -154.32 -179.92 8.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -73.23 -26.74 61.25 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.108 0.48 . . . . 0.0 110.579 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.335 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.376 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 48.2 m -102.33 115.46 30.62 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.028 0.442 . . . . 0.0 110.295 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.59 161.74 27.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.699 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -122.69 136.26 54.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 308' ' ' VAL . 19.3 m -115.16 148.83 17.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -102.42 128.48 49.01 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.318 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.437 ' HA ' HG13 ' A' ' 342' ' ' VAL . . . -89.63 120.77 31.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.68 -14.74 27.65 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.981 0.42 . . . . 0.0 110.107 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -134.12 157.57 45.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 142.97 33.01 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.995 0.426 . . . . 0.0 111.351 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' PHE . . . . . 0.481 ' HB3' HG12 ' A' ' 303' ' ' VAL . 41.5 t80 -121.76 113.26 19.44 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -161.3 136.31 7.47 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.16 131.79 56.81 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.115 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.09 8.47 4.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.278 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -133.95 133.12 41.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.134 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 8.6 t70 69.52 120.84 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.56 0.744 . . . . 0.0 111.448 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.73 1.94 8.0 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.119 2.546 . . . . 0.0 114.172 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -88.26 23.07 2.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.317 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.08 150.31 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.214 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.7 tp -83.04 114.36 21.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -88.32 109.8 20.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.809 0.337 . . . . 0.0 111.332 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.8 p -142.64 134.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.085 0.469 . . . . 0.0 110.274 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -103.5 151.64 22.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.766 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.41 119.67 8.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.392 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.13 -11.49 31.55 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.971 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -95.06 171.32 8.82 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.641 0.257 . . . . 0.0 110.625 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 286' ' ' VAL . 15.4 m -122.03 135.77 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.7 mt -101.64 143.08 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 2.9 m -91.7 107.18 19.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.096 0.474 . . . . 0.0 110.293 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.9 m -108.53 149.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.574 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.593 ' HG ' ' H ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -89.44 -72.82 0.54 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.593 ' H ' ' HG ' ' A' ' 312' ' ' LEU . 13.3 pt-20 170.74 156.4 0.07 Allowed 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.095 0.958 . . . . 0.0 108.977 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' GLN . . . . . 0.495 ' OE1' ' HB3' ' A' ' 316' ' ' PRO . 35.5 tt0 -173.76 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.281 0.363 . . . . 0.0 111.265 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 48.4 m80 58.69 65.95 2.7 Favored Pre-proline 0 N--CA 1.469 0.512 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.522 ' HG3' ' CG ' ' A' ' 320' ' ' TRP . 64.9 Cg_endo -82.65 168.68 14.14 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.953 2.435 . . . . 0.0 114.088 -172.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.24 -7.88 31.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.943 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -164.71 -138.48 2.42 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.588 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 135.07 56.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.65 0.262 . . . . 0.0 111.046 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' TRP . . . . . 0.528 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 0.3 OUTLIER -132.72 179.07 6.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 33.5 mmtp -86.38 154.1 21.43 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.507 0.67 . . . . 0.0 112.488 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 334' ' ' ILE . . . -161.1 151.43 21.79 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.414 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -108.8 122.69 47.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 10.4 tp -118.97 142.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -101.05 75.88 1.7 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -85.91 171.36 11.54 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.645 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 6.2 m -83.47 80.69 9.02 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.674 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.438 ' HG3' ' H ' ' A' ' 329' ' ' ARG . 4.4 tp60 -136.85 -170.3 2.66 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ARG . . . . . 0.438 ' H ' ' HG3' ' A' ' 328' ' ' GLN . 68.3 ttt180 -82.11 58.43 3.97 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 60.53 30.2 71.29 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 121.318 -0.468 . . . . 0.0 112.854 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 3.6 p -74.15 149.87 40.74 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.713 0.292 . . . . 0.0 111.205 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -61.06 -56.88 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.036 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 63.01 89.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 322' ' ' GLY . 7.8 tt -133.77 117.44 26.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.095 173.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.66 -169.36 11.55 Favored Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.009 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 23.7 p90 -108.45 142.95 38.08 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.453 ' CE2' HG23 ' A' ' 342' ' ' VAL . 21.4 p90 -151.49 146.64 19.11 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.048 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 340' ' ' GLY . 93.8 Cg_endo -84.1 128.19 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.498 2.132 . . . . 0.0 112.725 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.65 18.99 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.426 2.751 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 338' ' ' PRO . . . -93.96 -19.33 34.22 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 44.5 pt -108.87 -8.73 11.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.061 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.453 HG23 ' CE2' ' A' ' 337' ' ' PHE . 25.0 m -131.81 150.02 33.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.175 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -161.54 167.7 24.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.67 100.95 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 109.941 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 10.3 p -156.93 152.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.429 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.0 m -67.06 -56.07 11.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.927 0.394 . . . . 0.0 110.031 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -157.34 154.95 29.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.318 -0.783 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.77 176.62 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 285' ' ' LYS . 2.7 tm? -94.89 141.64 28.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -116.57 136.8 52.67 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.93 0.395 . . . . 0.0 110.964 -177.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 342' ' ' VAL . 16.9 m -132.4 154.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.463 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -102.55 141.78 34.8 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.419 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -82.73 110.94 18.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.87 -32.23 31.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.34 164.96 16.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.768 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.11 157.52 18.82 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.473 ' HB3' HG12 ' A' ' 303' ' ' VAL . 23.4 t80 -141.15 112.73 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -141.67 119.48 11.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.916 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.404 ' HB3' ' HB1' ' A' ' 300' ' ' ALA . 55.4 t30 -150.44 126.88 10.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.433 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.79 166.85 10.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 71.94 7.59 5.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.575 0.75 . . . . 0.0 111.042 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -127.71 114.98 20.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.82 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.89 -9.97 26.75 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.966 2.444 . . . . 0.0 113.624 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 22.0 p -107.16 8.04 29.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.179 0.514 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 294' ' ' ASN . . . -82.32 150.09 27.41 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.158 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 337' ' ' PHE . 20.7 tp -105.29 152.73 22.54 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.871 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -119.84 105.26 10.94 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' A' ' 292' ' ' PHE . 8.2 p -148.78 144.39 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.041 0.448 . . . . 0.0 111.255 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.467 ' HD3' ' N ' ' A' ' 305' ' ' ALA . 4.7 tmt_? -112.74 146.51 38.64 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.467 ' N ' ' HD3' ' A' ' 304' ' ' ARG . . . -52.09 125.6 16.08 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.84 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.82 -22.76 20.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.225 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -76.85 165.23 24.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 13.6 m -116.36 137.86 48.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.313 0.578 . . . . 0.0 111.6 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 303' ' ' VAL . 3.6 mp -116.7 132.95 64.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.831 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 6.5 m -98.32 107.25 19.67 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 284' ' ' LEU . 35.9 m -93.5 142.81 12.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.475 0.655 . . . . 0.0 112.071 -176.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 60.1 tp -87.88 -14.67 38.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.024 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -91.31 164.7 13.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.149 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -155.3 121.92 5.33 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.5 m80 58.42 75.52 0.52 Allowed Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.408 0.443 . . . . 0.0 110.129 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -95.03 -170.26 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.115 2.543 . . . . 0.0 112.767 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.19 104.98 5.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 92.85 -69.03 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.24 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -148.85 158.19 43.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.652 0.263 . . . . 0.0 110.493 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -137.03 167.98 20.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.505 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -104.73 137.94 41.77 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.93 26.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.957 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -114.79 130.89 56.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 41.6 mm -72.78 135.45 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.877 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 333' ' ' ARG . 53.2 mtt180 . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 120.621 0.248 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 47.6 mm -124.08 124.42 68.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.827 0.346 . . . . 0.0 110.815 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.1 21.05 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -102.27 136.83 41.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.863 0.363 . . . . 0.0 110.443 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.527 ' CD1' HD22 ' A' ' 301' ' ' LEU . 4.8 p90 -154.87 154.78 29.55 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.267 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.448 ' O ' HG12 ' A' ' 341' ' ' ILE . 73.8 Cg_endo -77.44 134.33 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.39 2.06 . . . . 0.0 112.176 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.85 -6.88 13.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.867 2.378 . . . . 0.0 112.311 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -74.52 -19.59 79.82 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.157 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.491 HG13 HG13 ' A' ' 342' ' ' VAL . 39.0 pt -99.58 2.91 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 117.254 0.527 . . . . 0.0 111.733 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.491 HG13 HG13 ' A' ' 341' ' ' ILE . 29.1 m -133.8 155.32 39.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 345' ' ' VAL . 11.5 tp10 -160.68 150.13 17.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.048 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.15 -28.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' A' ' 343' ' ' GLU . 20.4 m -77.05 168.41 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.853 0.359 . . . . 0.0 111.665 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 162.87 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.54 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -179.23 6.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? . . . . . 0 C--O 1.244 0.816 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.259 177.271 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 121.134 0.493 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.17 -176.88 3.06 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 7.4 ptpp? -143.7 134.22 24.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 111.36 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 31.3 m -118.55 156.67 20.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.112 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -102.74 134.87 45.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.6 115.52 18.36 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.169 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.403 ' HG ' ' OE2' ' A' ' 343' ' ' GLU . 4.2 mm? -87.77 -17.11 32.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.235 0.54 . . . . 0.0 110.137 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -140.75 147.26 38.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.42 134.44 39.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.499 ' HD2' ' O ' ' A' ' 301' ' ' LEU . 3.8 t80 -78.74 112.58 16.01 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -71.35 -31.96 67.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.54 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -79.83 78.76 6.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.06 -9.85 10.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.13 68.75 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.258 0.551 . . . . 0.0 110.223 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -179.76 126.15 0.24 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.16 -27.69 81.15 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.449 . . . . 0.0 113.531 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.89 -1.79 57.62 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.191 0.52 . . . . 0.0 111.105 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -102.28 150.78 22.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.539 HD22 ' CG ' ' A' ' 337' ' ' PHE . 3.9 tp -90.01 104.49 17.06 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.375 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -79.42 102.24 8.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.07 144.79 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.266 0.555 . . . . 0.0 111.592 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -104.4 147.29 27.72 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.279 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.51 124.44 20.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.385 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.03 40.89 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.928 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.54 158.07 19.61 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.22 139.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.171 0.51 . . . . 0.0 111.632 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 285' ' ' LYS . 20.5 mt -110.94 132.58 59.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.438 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 27.5 m -80.86 108.54 14.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.63 143.44 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 6.2 mp -81.89 -49.73 9.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.19 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -162.47 162.78 27.67 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.608 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.7 132.36 40.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 320' ' ' TRP . 9.8 m-70 -145.23 81.02 10.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.426 177.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.87 -0.8 10.91 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.897 2.398 . . . . 0.0 112.398 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -70.3 -21.97 62.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.225 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -180.0 -156.92 19.16 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 319' ' ' ARG . 6.2 ptt180 -65.34 110.72 2.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.088 0.471 . . . . 0.0 110.773 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.468 ' HD1' ' O ' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -85.13 175.5 8.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.477 ' HB2' HD11 ' A' ' 334' ' ' ILE . 12.2 ptmm? -119.03 142.1 48.13 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.107 0.48 . . . . 0.0 112.171 -175.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -159.72 171.25 36.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.778 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -109.14 129.52 55.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.915 0.388 . . . . 0.0 110.141 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.438 HG23 ' CE1' ' A' ' 325' ' ' HIS . 8.2 tp -119.61 149.42 22.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.355 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' HIS . . . . . 0.438 ' CE1' HG23 ' A' ' 324' ' ' ILE . 8.3 p-80 . . . . . 0 N--CA 1.486 1.339 0 C-N-CA 124.887 1.275 . . . . 0.0 114.144 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 334' ' ' ILE . 32.7 ptt180 . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 335' ' ' GLY . 0.0 OUTLIER -179.51 145.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.489 ' N ' HD13 ' A' ' 334' ' ' ILE . . . -138.21 175.79 21.15 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.634 -1.27 . . . . 0.0 113.197 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -111.07 146.12 37.32 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.539 ' CG ' HD22 ' A' ' 301' ' ' LEU . 4.4 p90 -154.01 151.07 23.87 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.003 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.454 ' O ' HG12 ' A' ' 341' ' ' ILE . 70.4 Cg_endo -77.32 127.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.49 2.127 . . . . 0.0 112.109 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.448 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.6 Cg_endo -61.86 -13.28 29.89 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.996 2.464 . . . . 0.0 112.636 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -70.62 -18.9 76.06 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.324 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 338' ' ' PRO . 42.4 pt -103.13 4.3 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 117.4 0.6 . . . . 0.0 111.714 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 288' ' ' ALA . 35.3 m -131.2 150.86 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.87 0.367 . . . . 0.0 111.099 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.403 ' OE2' ' HG ' ' A' ' 289' ' ' LEU . 46.7 mt-10 -137.91 145.38 42.03 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.95 -30.47 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.7 p -83.37 143.31 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 63.7 m -76.94 146.43 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.643 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.68 129.28 34.65 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 . . . . . 0 C--N 1.315 -0.919 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.382 179.302 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 285' ' ' LYS . 2.2 tm? -124.14 141.12 52.32 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.698 -0.401 . . . . 0.0 109.98 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 284' ' ' LEU . 58.9 mtpt -124.69 134.4 52.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.53 142.3 29.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 308' ' ' VAL . 58.4 mtp180 -103.8 132.9 49.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -84.87 125.7 32.85 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.806 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.0 -13.76 30.49 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.052 0.453 . . . . 0.0 110.836 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 291' ' ' ASP . 14.2 tmtt? -132.55 146.47 51.94 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.464 ' N ' ' HD3' ' A' ' 290' ' ' LYS . 11.4 m-20 -73.74 120.55 19.49 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.379 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.451 ' HB3' HG12 ' A' ' 303' ' ' VAL . 3.1 t80 -103.06 113.89 27.74 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -141.53 149.64 41.11 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.511 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -139.62 147.07 40.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.602 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 37.7 tp -75.88 -44.65 39.56 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -161.37 90.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.614 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 15.3 t70 -138.46 126.68 13.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 297' ' ' ASP . 15.9 Cg_exo -68.08 -15.82 43.77 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.047 2.498 . . . . 0.0 114.234 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 20.9 p -113.81 -32.38 6.13 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.52 131.23 48.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.367 0.603 . . . . 0.0 112.53 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.402 HD11 ' HB ' ' A' ' 324' ' ' ILE . 24.0 tp -83.05 153.99 24.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.092 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -110.2 108.13 18.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.451 HG12 ' HB3' ' A' ' 292' ' ' PHE . 8.2 p -146.02 136.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 111.42 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.448 ' HG3' ' HB2' ' A' ' 307' ' ' ASP . 32.9 ptt180 -88.86 152.84 21.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.87 25.61 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.805 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 100.42 -9.17 58.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.023 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.448 ' HB2' ' HG3' ' A' ' 304' ' ' ARG . 1.2 t70 -84.46 164.0 19.1 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.684 0.278 . . . . 0.0 110.528 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.468 HG12 ' HG2' ' A' ' 287' ' ' ARG . 15.8 m -111.2 128.38 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.574 0.702 . . . . 0.0 112.301 -177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 337' ' ' PHE . 49.0 mt -97.82 130.4 46.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 7.0 m -93.63 108.08 19.85 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 18.0 m -105.46 148.31 10.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 312' ' ' LEU . 5.6 mp -64.35 -77.81 0.05 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 312' ' ' LEU . 0.1 OUTLIER 167.49 134.99 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.486 1.114 . . . . 0.0 108.321 175.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 178.79 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.771 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 16.3 m80 52.85 71.49 1.43 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.253 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.64 173.98 9.05 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.729 2.286 . . . . 0.0 111.316 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.57 125.14 45.1 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 100.69 -32.68 7.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.367 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -151.65 137.52 18.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.875 0.369 . . . . 0.0 111.073 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 56.1 m95 -110.52 159.03 17.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.406 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -136.48 122.23 19.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.89 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -152.86 175.02 31.55 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.472 -1.346 . . . . 0.0 113.898 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 333' ' ' ARG . 53.5 m80 -107.12 128.27 54.25 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.402 ' HB ' HD11 ' A' ' 301' ' ' LEU . 10.2 tp -111.91 155.54 13.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.563 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 . . . . . 0 CA--C 1.533 0.312 0 O-C-N 123.455 0.472 . . . . 0.0 110.758 177.585 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 65.4 mtt180 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 120.775 0.321 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 31.3 mm -113.26 121.35 65.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.055 0.455 . . . . 0.0 110.772 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.89 149.69 20.77 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.551 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 67.5 m-85 -107.64 139.15 42.62 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.461 ' CD2' HG11 ' A' ' 342' ' ' VAL . 17.0 p90 -140.93 147.19 47.02 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.632 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 4.8 Cg_exo -75.79 130.85 12.83 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.893 2.395 . . . . 0.0 111.979 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.2 Cg_endo -59.59 -16.57 37.1 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.366 2.711 . . . . 0.0 112.921 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.57 76.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.541 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 41.2 pt -107.99 1.18 9.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 117.386 0.593 . . . . 0.0 112.048 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 339' ' ' PRO . 35.4 m -124.11 150.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.421 . . . . 0.0 111.362 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -146.98 170.27 17.45 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.326 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.83 -167.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.22 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 37.2 t -67.78 -34.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 54.7 m -70.0 95.07 0.91 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 110.907 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -100.27 136.96 39.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.694 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--O 1.24 0.559 0 CA-C-O 118.651 -0.69 . . . . 0.0 109.801 177.827 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 120.914 0.388 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -122.71 175.4 6.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.651 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -144.36 133.81 23.29 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.81 168.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.531 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -124.34 134.48 53.15 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.05 137.04 38.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.242 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 343' ' ' GLU . 4.6 mm? -87.06 -28.8 22.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.517 176.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -129.16 146.76 51.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.929 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 304' ' ' ARG . 0.1 OUTLIER -71.87 138.06 47.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.851 178.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -101.92 110.5 22.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -151.32 119.62 6.37 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -151.4 -43.57 0.11 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.325 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 14.6 mt -150.83 134.03 16.12 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.519 ' HA ' ' OD1' ' A' ' 302' ' ' ASN . 38.7 m80 -84.19 84.44 7.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.81 146.89 28.01 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.245 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.88 -8.32 4.4 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.073 2.515 . . . . 0.0 113.668 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 8.1 t -87.59 -11.82 47.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.013 0.435 . . . . 0.0 110.369 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -121.76 150.56 41.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 337' ' ' PHE . 31.3 tp -88.51 104.03 16.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.576 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 296' ' ' HIS . 29.1 m-80 -84.05 94.09 8.24 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.303 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.46 146.1 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.753 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 291' ' ' ASP . 77.5 mtm180 -108.73 161.29 15.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.77 128.03 34.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.675 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 98.28 -13.3 63.2 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.827 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -80.89 161.17 24.49 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 120.688 0.28 . . . . 0.0 110.659 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 26.5 m -98.03 144.71 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.202 0.525 . . . . 0.0 111.678 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.407 HD13 HD21 ' A' ' 301' ' ' LEU . 42.9 mt -128.99 129.49 68.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.752 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 23.5 m -86.69 108.82 18.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 10.6 t -90.79 148.15 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.92 -56.05 13.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.804 0.335 . . . . 0.0 110.222 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -176.68 144.63 0.5 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.431 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLN . . . . . 0.508 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 23.9 pt20 -92.29 79.27 5.05 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.743 0.782 . . . . 0.0 110.626 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 316' ' ' PRO . 1.4 t-80 -136.74 -53.73 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.217 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 315' ' ' HIS . 2.0 Cg_endo -83.48 101.03 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.18 1.92 . . . . 0.0 110.501 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.53 146.57 48.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.824 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 126.8 -158.65 20.88 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 319' ' ' ARG . 33.2 ptt180 -80.65 98.62 7.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 0.0 109.575 177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.511 ' CZ2' ' HB3' ' A' ' 339' ' ' PRO . 0.2 OUTLIER -89.4 158.91 17.57 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.908 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -85.91 127.8 34.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.255 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -126.05 154.16 18.74 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.971 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -119.72 139.43 52.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 37.2 mt -106.94 139.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.155 0.502 . . . . 0.0 110.97 -177.858 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.211 0.529 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 19.5 mm -128.06 111.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.304 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -144.35 159.09 27.68 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.555 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 5.4 p90 -104.03 137.71 41.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 301' ' ' LEU . 20.2 p90 -147.81 155.08 44.58 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.278 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.405 ' O ' HG12 ' A' ' 341' ' ' ILE . 98.3 Cg_endo -84.01 134.59 6.18 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.544 2.162 . . . . 0.0 111.379 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.511 ' HB3' ' CZ2' ' A' ' 320' ' ' TRP . 11.1 Cg_endo -54.94 -19.96 21.32 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.2 2.6 . . . . 0.0 113.202 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -60.92 -20.27 57.3 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 114.258 0.463 . . . . 0.0 114.258 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.469 HG13 HG13 ' A' ' 342' ' ' VAL . 43.1 pt -100.55 4.84 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.605 0.703 . . . . 0.0 112.259 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 341' ' ' ILE . 31.9 m -132.77 164.19 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.096 0.474 . . . . 0.0 111.596 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.485 ' HB2' HD21 ' A' ' 289' ' ' LEU . 0.4 OUTLIER -135.06 149.57 50.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.07 -33.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.1 p -158.25 -20.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 74.0 m -80.24 14.93 1.72 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.981 -0.449 . . . . 0.0 111.981 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 348' ' ' ARG . 8.6 tmtt? -88.67 127.36 35.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ARG . . . . . 0.539 ' N ' ' HD3' ' A' ' 347' ' ' LYS . 40.5 ttm180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.683 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.444 -0.742 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 60.0 tp -128.64 148.64 50.82 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -124.82 135.48 52.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.016 0.436 . . . . 0.0 111.266 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.465 HG11 ' CH2' ' A' ' 320' ' ' TRP . 16.0 m -125.11 146.68 30.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.898 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -103.07 139.5 38.52 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.86 119.67 23.06 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.076 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.93 -26.87 17.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.413 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -127.31 146.89 50.29 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.83 122.31 25.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -103.49 113.02 26.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.417 ' HE1' HD23 ' A' ' 295' ' ' LEU . 19.8 t-105 -115.55 104.72 12.01 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.956 0.408 . . . . 0.0 111.469 -173.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -130.69 106.25 8.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.417 HD23 ' HE1' ' A' ' 293' ' ' TRP . 2.1 pp -107.24 -1.01 22.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.178 0.513 . . . . 0.0 110.703 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.57 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.25 113.6 23.67 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.685 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.13 -0.48 9.17 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.621 2.214 . . . . 0.0 111.978 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 3.4 m -85.26 -16.84 38.83 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.48 0.657 . . . . 0.0 109.564 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -91.94 144.7 25.2 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.379 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.71 110.9 18.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.051 0.453 . . . . 0.0 111.166 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -101.06 121.62 42.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.96 152.34 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.939 0.4 . . . . 0.0 111.253 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.554 ' HB2' ' OD2' ' A' ' 307' ' ' ASP . 61.2 mtm180 -101.74 146.58 27.57 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.28 125.51 23.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.758 0.313 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.33 -16.06 29.79 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.699 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.554 ' OD2' ' HB2' ' A' ' 304' ' ' ARG . 33.4 m-20 -84.29 156.55 21.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.53 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 8.9 t -112.14 135.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.353 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 20.8 mt -114.7 134.05 58.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.952 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 39.7 m -104.19 120.09 40.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.043 0.449 . . . . 0.0 110.711 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 31.3 m -105.24 146.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.133 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 80.0 mt -83.27 -60.12 2.25 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.312 0.577 . . . . 0.0 109.795 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -114.09 114.21 25.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.065 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 141.93 43.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 320' ' ' TRP . 66.8 m-70 -139.95 89.47 11.3 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.22 -9.21 25.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.874 2.382 . . . . 0.0 113.318 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -123.41 117.8 26.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.3 -102.41 1.82 Allowed Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.964 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -153.62 158.0 40.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.465 ' CH2' HG11 ' A' ' 286' ' ' VAL . 0.1 OUTLIER -148.76 170.69 17.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 178.003 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 24.9 pttm -128.25 144.56 51.14 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.439 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.1 34.51 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.997 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 333' ' ' ARG . 3.9 p-80 -114.26 133.83 55.36 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 47.2 mt -80.93 150.96 4.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.407 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 . . . . . 0 CA--C 1.508 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.44 177.628 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 30.3 tpt180 . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 14.1 mm -153.77 116.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -137.35 151.49 21.15 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.439 -1.363 . . . . 0.0 112.563 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -89.14 146.33 24.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -158.38 158.48 29.7 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.896 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 341' ' ' ILE . 78.2 Cg_endo -82.39 132.97 7.15 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.334 2.023 . . . . 0.0 111.942 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.8 -14.83 19.12 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.249 2.633 . . . . 0.0 113.116 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -67.9 -19.86 71.99 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.861 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.492 HG13 HG13 ' A' ' 342' ' ' VAL . 39.5 pt -94.28 -8.15 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 117.599 0.699 . . . . 0.0 111.835 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 341' ' ' ILE . 28.8 m -123.05 170.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.974 0.416 . . . . 0.0 111.083 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 346' ' ' SER . 6.9 tp10 -157.12 151.19 24.8 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.3 -67.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 73.7 t -104.03 -41.19 6.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.488 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 35.2 m -60.05 133.96 56.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -177.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -99.15 158.23 15.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.794 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.908 179.308 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.433 0.635 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.59 173.09 7.39 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.147 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -146.31 143.16 28.95 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.266 0.555 . . . . 0.0 112.181 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.19 164.04 34.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.86 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ARG . . . . . 0.484 ' HG2' HG12 ' A' ' 308' ' ' VAL . 74.9 mtp180 -113.64 144.58 42.67 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.131 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.5 118.28 23.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.751 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 -5.96 48.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.29 0.567 . . . . 0.0 110.426 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -138.85 146.49 41.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -80.12 121.92 26.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.663 0.268 . . . . 0.0 110.634 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.55 ' CE1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.83 53.69 1.76 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.511 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.55 ' HB2' ' CE1' ' A' ' 292' ' ' PHE . 50.4 t-20 -66.82 -61.35 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.497 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 13.9 tp -160.48 165.06 31.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -97.38 20.46 11.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.905 0.383 . . . . 0.0 111.936 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.47 153.54 41.36 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.017 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.86 -19.42 65.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.887 2.392 . . . . 0.0 112.829 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.4 m -81.25 -14.99 56.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 110.698 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -109.55 137.65 47.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.963 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.476 HD11 ' CG1' ' A' ' 324' ' ' ILE . 31.4 tp -86.59 111.24 20.44 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.082 0.467 . . . . 0.0 110.978 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -106.14 102.68 12.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.17 148.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.416 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -96.05 149.25 21.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.78 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.43 27.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.743 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.42 -19.36 26.75 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.382 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -76.98 155.88 32.31 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 116.904 0.352 . . . . 0.0 111.146 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.484 HG12 ' HG2' ' A' ' 287' ' ' ARG . 34.4 m -101.77 134.13 43.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.344 0.592 . . . . 0.0 111.429 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.453 HG12 ' CD1' ' A' ' 324' ' ' ILE . 56.3 mt -109.24 116.85 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 22.4 m -91.2 114.84 27.47 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.2 142.09 17.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.67 -66.73 0.57 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 313' ' ' GLU . 11.0 pt-20 -178.71 113.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.439 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -158.64 132.49 7.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -64.0 116.94 31.2 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 97.32 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.537 2.158 . . . . 0.0 113.035 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -150.57 129.2 12.28 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.503 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.24 -87.5 0.49 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -151.03 132.03 14.27 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.403 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -125.59 166.3 16.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.663 -175.283 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -89.16 140.07 29.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 111.886 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.96 156.23 26.33 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.371 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -111.2 121.08 44.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.933 0.397 . . . . 0.0 110.148 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.476 ' CG1' HD11 ' A' ' 301' ' ' LEU . 35.3 mm -85.9 121.75 37.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.438 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 C--N 1.311 -1.086 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.457 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 . . . . . 0 C--O 1.224 -0.271 0 CA-C-O 120.543 0.211 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 15.8 tt -101.44 140.25 20.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.847 0.356 . . . . 0.0 110.337 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.05 179.26 35.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -110.9 143.98 40.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.693 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 301' ' ' LEU . 9.5 p90 -149.14 156.51 40.17 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.115 -177.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.438 ' O ' HG12 ' A' ' 341' ' ' ILE . 3.5 Cg_exo -81.72 131.04 7.03 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.822 2.348 . . . . 0.0 111.363 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.0 Cg_endo -60.17 -15.79 36.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.862 2.375 . . . . 0.0 112.789 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.38 -19.55 74.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.594 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.463 HG13 HG13 ' A' ' 342' ' ' VAL . 41.1 pt -100.25 1.7 10.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.539 0.669 . . . . 0.0 111.803 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.463 HG13 HG13 ' A' ' 341' ' ' ILE . 33.5 m -128.18 164.5 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.182 0.515 . . . . 0.0 111.581 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.428 ' HG2' ' OG ' ' A' ' 346' ' ' SER . 8.6 tp10 -160.35 151.83 19.59 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.465 HG13 HG12 ' A' ' 345' ' ' VAL . 7.2 p -66.54 -40.92 87.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.465 HG12 HG13 ' A' ' 344' ' ' VAL . 7.9 p -157.09 122.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.411 . . . . 0.0 110.752 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 343' ' ' GLU . 49.6 m -163.96 -23.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.22 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -64.56 121.09 13.62 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.653 -0.689 . . . . 0.0 109.657 179.489 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 311' ' ' VAL . 30.5 p . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 120.886 0.374 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 311' ' ' VAL . 24.6 tp -144.39 157.48 44.23 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.24 133.44 56.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.789 0.328 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.98 152.08 36.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -105.41 137.43 43.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.696 0.284 . . . . 0.0 110.518 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -82.1 110.89 17.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.028 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 47.0 mt -78.66 -26.31 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.198 0.523 . . . . 0.0 110.089 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -132.67 162.79 30.48 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.42 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.568 ' OD2' ' HD2' ' A' ' 304' ' ' ARG . 10.0 m-20 -78.44 151.97 32.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.725 0.298 . . . . 0.0 110.206 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.558 ' HB3' HG12 ' A' ' 303' ' ' VAL . 32.4 t80 -140.69 113.48 8.24 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -144.72 102.32 3.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -108.95 129.04 55.43 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 295' ' ' LEU . 1.8 pt? -111.58 7.78 20.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.836 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -92.2 -41.04 10.66 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.049 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 300' ' ' ALA . 29.5 m-20 -101.97 122.05 48.55 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.085 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.8 -28.55 59.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.318 2.012 . . . . 0.0 111.612 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 7.3 t -83.95 -3.04 57.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.737 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 297' ' ' ASP . . . -70.28 150.21 46.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.618 0.247 . . . . 0.0 110.501 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.563 HD22 ' CD1' ' A' ' 337' ' ' PHE . 15.7 tp -82.51 153.67 25.45 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.059 0.457 . . . . 0.0 110.77 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.434 ' N ' ' HG ' ' A' ' 301' ' ' LEU . 23.4 p-10 -128.15 119.64 25.7 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.558 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.7 p -144.4 146.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.048 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.568 ' HD2' ' OD2' ' A' ' 291' ' ' ASP . 10.3 tpt180 -96.55 142.3 28.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.1 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.37 122.11 12.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.733 0.301 . . . . 0.0 110.335 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.17 40.16 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.72 -0.753 . . . . 0.0 113.028 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.2 169.56 12.95 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.151 0.475 . . . . 0.0 110.151 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.13 128.72 72.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.353 0.597 . . . . 0.0 111.583 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.529 HG12 HD13 ' A' ' 324' ' ' ILE . 68.2 mt -99.3 129.05 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.993 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.8 m -98.0 108.6 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 283' ' ' SER . 19.5 m -93.06 140.13 16.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 120.842 0.353 . . . . 0.0 110.603 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 312' ' ' LEU . 2.6 pt? -82.18 -12.72 57.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.574 0.702 . . . . 0.0 109.46 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -159.33 143.99 15.44 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.582 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.28 -33.09 69.44 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.011 0.195 . . . . 0.0 110.98 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.4 m80 67.77 157.38 0.14 Allowed Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.814 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.35 137.92 63.19 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.001 1.8 . . . . 0.0 110.216 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.24 118.77 7.86 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.768 0.794 . . . . 0.0 111.035 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 161.51 -43.9 0.39 Allowed Glycine 0 C--N 1.31 -0.908 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.608 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -157.57 123.91 4.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 110.043 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 339' ' ' PRO . 45.0 m95 -94.67 174.34 7.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.566 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.505 ' HG2' HD11 ' A' ' 334' ' ' ILE . 86.4 tttt -156.61 114.13 3.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -145.33 176.68 24.21 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.453 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 333' ' ' ARG . 46.8 m80 -107.17 136.94 46.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.529 HD13 HG12 ' A' ' 309' ' ' ILE . 11.0 tp -130.67 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.643 0.259 . . . . 0.0 110.629 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--O 1.236 0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.335 178.281 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 57.2 ttp85 . . . . . 0 N--CA 1.444 -0.742 0 CA-C-O 120.901 0.381 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.505 HD11 ' HG2' ' A' ' 321' ' ' LYS . 9.1 tp -94.82 140.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.52 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.41 159.1 30.54 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.602 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 321' ' ' LYS . 36.3 p90 -101.75 151.78 21.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.818 0.309 . . . . 0.0 110.314 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.563 ' CD1' HD22 ' A' ' 301' ' ' LEU . 16.7 p90 -153.71 151.08 24.38 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 341' ' ' ILE . 62.3 Cg_endo -75.29 133.43 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.714 2.276 . . . . 0.0 112.131 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 320' ' ' TRP . 20.7 Cg_endo -61.4 -17.57 54.18 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.218 2.612 . . . . 0.0 113.023 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -63.89 -19.18 62.99 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.655 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 338' ' ' PRO . 45.6 pt -107.96 6.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 339' ' ' PRO . 28.3 m -132.26 161.45 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 111.78 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -160.46 161.97 33.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 -24.53 35.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.58 -178.59 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.095 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.2 m -71.54 161.01 31.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -64.24 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.011 0.434 . . . . 0.0 110.736 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.485 178.867 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.07 167.93 10.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.432 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -129.89 141.49 50.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.02 144.67 31.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.636 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ARG . . . . . 0.428 ' HG2' HG12 ' A' ' 308' ' ' VAL . 58.2 mtt85 -102.34 129.46 48.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.05 117.78 24.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.817 0.341 . . . . 0.0 111.159 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.97 -23.32 20.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.237 0.542 . . . . 0.0 109.563 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 341' ' ' ILE . 57.9 tptt -117.81 146.35 43.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.54 135.57 36.12 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.328 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.478 ' HD2' ' O ' ' A' ' 301' ' ' LEU . 35.6 t80 -99.25 112.62 24.75 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.36 167.29 21.94 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.453 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -74.82 133.63 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.255 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.42 177.6 4.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.822 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.53 45.09 0.94 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.71 138.21 6.15 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.67 -18.75 42.23 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.268 2.645 . . . . 0.0 113.85 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 2.7 m -80.45 1.14 30.47 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.169 0.509 . . . . 0.0 110.861 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.11 124.5 23.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.478 ' O ' ' HD2' ' A' ' 292' ' ' PHE . 21.2 tp -88.84 87.45 7.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.561 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -74.63 97.58 3.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.674 . . . . 0.0 111.116 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.45 HG21 HD11 ' A' ' 309' ' ' ILE . 13.0 p -123.55 139.83 48.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.868 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 307' ' ' ASP . 51.4 mtm180 -99.61 157.05 16.73 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -178.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.96 121.67 13.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.746 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.87 26.87 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.297 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 304' ' ' ARG . 26.7 m-20 -85.63 162.75 18.68 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 122.503 -0.41 . . . . 0.0 110.52 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.428 HG12 ' HG2' ' A' ' 287' ' ' ARG . 30.2 m -114.57 145.2 20.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.292 0.568 . . . . 0.0 112.208 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 303' ' ' VAL . 4.4 mp -118.02 130.75 72.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.84 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 85.7 m -96.99 120.55 37.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.061 0.458 . . . . 0.0 110.761 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.18 146.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.559 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.38 -78.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.702 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -164.62 98.91 0.79 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.438 0.637 . . . . 0.0 110.792 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -164.62 153.73 13.13 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.335 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' HIS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 316' ' ' PRO . 9.3 m170 -90.63 144.19 30.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 315' ' ' HIS . 6.4 Cg_exo -75.1 49.45 2.29 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.162 2.575 . . . . 0.0 112.661 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -101.9 45.12 0.98 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.112 0.482 . . . . 0.0 110.726 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 149.43 170.01 16.5 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.437 ' H ' ' HD3' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -62.8 134.79 56.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.588 0.694 . . . . 0.0 109.606 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.41 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -139.63 -179.64 6.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 -176.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -123.1 145.06 48.9 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -133.47 166.21 23.9 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.358 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -109.94 122.39 47.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.24 137.39 31.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.379 0.609 . . . . 0.0 112.138 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.0 p80 . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.981 175.41 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.763 0.316 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 13.7 tt -124.83 130.93 73.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.61 33.75 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.546 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -88.88 146.69 24.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.664 0.269 . . . . 0.0 111.279 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.69 152.66 18.18 Favored Pre-proline 0 C--O 1.242 0.679 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.489 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.584 ' O ' HG12 ' A' ' 341' ' ' ILE . 72.3 Cg_endo -79.46 133.64 10.74 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.53 2.153 . . . . 0.0 111.72 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.81 -14.92 45.92 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.821 2.347 . . . . 0.0 112.734 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -72.34 -18.8 78.44 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 116.099 -0.5 . . . . 0.0 113.574 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 338' ' ' PRO . 46.9 pt -93.51 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.471 0.635 . . . . 0.0 111.501 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.418 HG13 HG13 ' A' ' 341' ' ' ILE . 35.6 m -120.87 163.45 18.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -146.55 146.24 30.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.725 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.39 -35.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.426 HG11 ' NE ' ' A' ' 348' ' ' ARG . 17.5 t -72.65 158.55 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 30.7 m -72.75 102.77 3.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.656 0.265 . . . . 0.0 111.447 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt 45.39 37.96 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.443 1.097 . . . . 0.0 113.8 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ARG . . . . . 0.426 ' NE ' HG11 ' A' ' 345' ' ' VAL . 38.6 ttm180 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.375 -0.822 . . . . 0.0 109.916 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.87 159.2 21.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -131.61 136.2 47.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 25.0 m -115.54 142.41 28.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -101.6 132.71 47.11 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.344 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -80.34 117.53 21.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.56 -21.91 22.64 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -126.32 147.7 49.68 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.679 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.84 153.78 28.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.111 0.482 . . . . 0.0 111.38 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.555 ' HB3' HG12 ' A' ' 303' ' ' VAL . 40.3 t80 -135.65 110.72 8.89 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -174.52 133.85 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -124.13 161.74 25.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 295' ' ' LEU . 2.5 pt? -77.26 -8.74 58.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.64 0.734 . . . . 0.0 109.229 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -126.71 -156.75 0.76 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.538 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 6.4 m-20 66.44 91.61 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 123.327 0.392 . . . . 0.0 111.287 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.86 -15.74 26.4 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.445 2.097 . . . . 0.0 112.842 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.6 m -105.67 7.48 32.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 110.886 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 297' ' ' ASP . . . -72.38 139.89 48.11 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.451 ' O ' ' HD2' ' A' ' 292' ' ' PHE . 21.0 tp -84.36 91.21 7.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.49 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.97 106.17 1.51 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.249 0.547 . . . . 0.0 111.344 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 292' ' ' PHE . 12.8 p -134.84 135.16 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.563 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.431 ' HB3' ' OD2' ' A' ' 307' ' ' ASP . 37.6 ttp180 -97.01 147.4 24.04 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.959 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.58 125.79 25.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.086 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.41 -18.15 25.56 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.611 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 304' ' ' ARG . 18.0 m-20 -86.19 165.29 16.65 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.842 0.353 . . . . 0.0 110.565 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.55 134.94 59.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.17 128.08 53.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.3 m -83.22 108.75 16.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.88 0.372 . . . . 0.0 110.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.78 127.07 62.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.398 0.618 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 312' ' ' LEU . 2.2 pp -86.41 -9.77 55.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.506 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 117.97 6.7 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -76.97 101.4 5.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.728 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -123.01 84.4 50.8 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.45 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 -2.0 12.14 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 114.236 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -108.12 106.87 17.28 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.479 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 93.79 173.12 39.46 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.779 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -68.46 128.87 38.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 109.897 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.416 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -126.3 162.19 26.06 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.537 -176.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -98.69 136.87 38.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.277 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -139.8 171.85 23.63 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.154 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -109.14 128.14 54.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.954 0.407 . . . . 0.0 111.151 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 11.4 tp -124.42 154.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 54.8 t60 . . . . . 0 CA--C 1.54 0.581 0 O-C-N 123.5 0.5 . . . . 0.0 110.417 178.758 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 . . . . . 0 N--CA 1.445 -0.681 0 CA-C-O 121.299 0.571 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 39.8 mm -106.82 129.69 60.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.547 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -140.0 159.94 26.14 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.025 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -97.2 140.76 31.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.882 0.372 . . . . 0.0 110.243 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.458 ' HE2' HG21 ' A' ' 342' ' ' VAL . 5.9 p90 -148.78 160.56 35.37 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.259 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.484 ' O ' HG12 ' A' ' 341' ' ' ILE . 4.0 Cg_endo -87.11 132.91 3.29 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.763 2.309 . . . . 0.0 112.135 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.81 -14.07 34.34 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.133 2.555 . . . . 0.0 112.472 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.48 -18.84 68.22 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.498 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.485 HG13 HG13 ' A' ' 342' ' ' VAL . 49.2 pt -101.98 -4.49 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.485 HG13 HG13 ' A' ' 341' ' ' ILE . 27.6 m -126.83 150.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.856 0.36 . . . . 0.0 111.52 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -143.18 146.55 33.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.674 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.41 -34.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.727 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.42 -37.05 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.502 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.2 m -109.24 86.41 2.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.094 0.474 . . . . 0.0 110.204 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 347' ' ' LYS . 14.6 tmtt? -85.89 94.58 9.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.217 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.955 177.951 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 121.091 0.472 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.443 ' HB2' HG23 ' A' ' 311' ' ' VAL . 73.1 mt -105.6 179.86 4.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.174 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 25.4 pttm -153.05 145.01 23.69 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.287 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.9 m -128.88 157.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.832 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -102.42 127.99 49.22 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.906 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -81.61 128.68 34.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.89 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.25 -9.8 26.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.581 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LYS . . . . . 0.473 ' HB3' ' HB ' ' A' ' 341' ' ' ILE . 54.6 tptt -133.62 147.3 51.47 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -80.25 122.41 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 302' ' ' ASN . 0.6 OUTLIER -104.94 111.38 24.13 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -162.36 -2.96 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.74 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -56.81 -44.38 81.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.147 0.498 . . . . 0.0 109.689 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 300' ' ' ALA . 26.4 tp -89.44 120.59 30.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -94.87 0.8 55.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.2 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 2.6 m-20 -66.24 139.34 96.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 297' ' ' ASP . 52.1 Cg_exo -56.32 -21.24 35.69 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.127 2.551 . . . . 0.0 113.293 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.4 t -78.03 -12.07 59.96 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.437 ' HB2' HD23 ' A' ' 295' ' ' LEU . . . -87.17 142.11 28.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.819 0.342 . . . . 0.0 110.393 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 309' ' ' ILE . 1.3 tp -82.91 89.33 6.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 292' ' ' PHE . 88.2 m-20 -75.27 111.33 10.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 10.6 p -142.89 154.59 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.839 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -95.16 144.56 25.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.247 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -68.48 118.41 11.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 108.19 -2.37 33.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.62 150.88 20.66 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.6 m -97.63 124.09 50.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.418 0.628 . . . . 0.0 111.441 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.49 HD13 HD21 ' A' ' 301' ' ' LEU . 27.3 mt -88.51 132.38 33.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.479 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 23.2 m -81.32 107.22 13.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 284' ' ' LEU . 17.6 m -106.59 144.66 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.416 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 3.8 pp -93.78 -8.4 40.72 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.335 0.588 . . . . 0.0 110.25 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.72 171.69 13.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -139.57 13.85 2.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.096 0.474 . . . . 0.0 110.296 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -97.31 115.25 65.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.488 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.76 105.22 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.745 2.297 . . . . 0.0 112.152 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.97 8.13 45.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.653 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.27 107.22 0.34 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 41.05 71.4 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.833 0.825 . . . . 0.0 110.554 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -95.43 174.46 7.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -173.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 336' ' ' TYR . 0.4 OUTLIER -96.07 151.29 19.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.53 171.98 23.77 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.884 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.521 ' HB3' ' O ' ' A' ' 310' ' ' THR . 8.1 t60 -109.49 122.54 47.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.692 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.5 146.41 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 CA--C 1.513 -0.446 0 O-C-N 123.509 0.505 . . . . 0.0 110.113 -177.037 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 333' ' ' ARG . 1.5 tpp180 . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 120.92 0.39 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 34.2 mm -107.07 128.15 62.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.129 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.77 155.6 23.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 321' ' ' LYS . 41.1 p90 -96.33 147.74 23.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.492 0.646 . . . . 0.0 111.002 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 338' ' ' PRO . 39.8 p90 -148.61 145.13 19.37 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.855 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 341' ' ' ILE . 9.4 Cg_exo -73.22 130.01 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.384 2.056 . . . . 0.0 110.606 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.19 -16.35 33.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.726 2.284 . . . . 0.0 112.859 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.63 -22.76 76.8 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.238 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 338' ' ' PRO . 38.6 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.325 0.562 . . . . 0.0 111.975 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.38 170.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.544 0.211 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -158.92 168.0 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.02 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.1 -31.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.915 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.3 -22.94 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.5 m -106.98 22.55 15.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 0.0 109.956 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -63.57 111.96 2.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.824 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 . . . . . 0 C--N 1.313 -0.991 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -177.432 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 120.842 0.353 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 285' ' ' LYS . 57.0 tp -136.09 166.31 23.66 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.407 ' N ' ' HG ' ' A' ' 284' ' ' LEU . 21.7 pttm -131.9 141.62 49.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.075 0.464 . . . . 0.0 110.95 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.74 146.4 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.994 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -104.47 120.36 41.07 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.666 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 342' ' ' VAL . . . -73.44 124.8 26.5 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.441 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 289' ' ' LEU . 1.4 pt? -89.26 -9.93 48.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.21 0.529 . . . . 0.0 109.709 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -143.53 148.08 35.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.115 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 304' ' ' ARG . 24.0 m-20 -68.74 155.7 39.63 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.428 ' HB2' HG12 ' A' ' 303' ' ' VAL . 94.2 t80 -76.66 113.81 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.328 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -102.78 127.58 49.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -163.79 162.41 23.8 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.27 122.64 10.75 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -43.37 113.55 0.51 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.787 0.679 . . . . 0.0 112.738 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -158.94 135.91 6.79 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.26 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.7 -13.28 39.04 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.126 2.551 . . . . 0.0 114.736 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 34.2 p -95.82 9.12 41.57 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.212 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -75.38 152.54 38.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 tp -79.69 102.43 8.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -80.58 86.32 5.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 0.0 111.904 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 292' ' ' PHE . 7.3 p -107.53 137.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.382 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.478 ' HA ' ' OD1' ' A' ' 291' ' ' ASP . 19.1 ttp180 -98.9 147.96 24.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.55 115.13 3.37 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.25 37.84 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.042 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.2 173.16 8.57 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.81 143.98 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -175.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.403 HG12 HD13 ' A' ' 324' ' ' ILE . 81.4 mt -111.83 124.38 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.495 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 41.5 m -86.32 110.95 20.02 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.169 0.509 . . . . 0.0 110.784 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 33.9 m -107.17 148.53 11.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.996 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 4.5 tt -88.6 -52.88 4.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.12 131.02 53.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' GLN . . . . . 0.566 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 55.9 mt-30 -79.08 130.32 35.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.199 0.524 . . . . 0.0 111.804 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -138.85 70.15 43.18 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.857 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.07 81.92 1.63 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 111.733 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -144.93 -62.27 0.36 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.966 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -130.64 -160.55 10.03 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -69.15 101.65 1.5 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 117.39 0.595 . . . . 0.0 110.362 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.566 ' CZ3' ' HA ' ' A' ' 314' ' ' GLN . 1.0 OUTLIER -102.81 169.04 8.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.348 -177.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 25.5 pttm -93.85 152.13 19.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.528 0.68 . . . . 0.0 112.795 -174.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.51 39.63 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.732 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -108.8 122.64 47.58 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.193 0.497 . . . . 0.0 110.402 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.403 HD13 HG12 ' A' ' 309' ' ' ILE . 10.1 tp -103.02 156.64 5.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.902 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 . . . . . 0 CA--C 1.531 0.229 0 O-C-N 123.595 0.56 . . . . 0.0 110.188 176.157 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.38 125.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.62 -179.8 17.64 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -104.13 147.68 27.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.892 0.377 . . . . 0.0 110.769 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.64 151.69 36.31 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.54 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.52 135.61 5.17 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.862 2.374 . . . . 0.0 111.642 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.485 ' HA ' HG22 ' A' ' 342' ' ' VAL . 30.5 Cg_endo -63.35 -3.5 5.26 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.964 2.443 . . . . 0.0 112.716 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -79.99 -19.6 69.66 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.852 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 37.8 pt -102.61 1.89 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.841 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 288' ' ' ALA . 27.6 m -112.41 150.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.468 0.652 . . . . 0.0 112.665 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.5 133.34 55.95 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.905 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.55 -31.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.807 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.87 -63.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.962 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.8 m -122.52 173.44 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.648 0.261 . . . . 0.0 111.687 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.66 82.58 0.18 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.666 0.786 . . . . 0.0 111.223 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ARG . . . . . 0.512 ' H ' ' NE ' ' A' ' 348' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 54.8 m . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.794 0.33 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.45 161.09 18.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -126.26 133.99 51.3 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.723 0.297 . . . . 0.0 110.376 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.48 138.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.057 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -106.06 134.62 48.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.425 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.12 131.25 37.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.9 -29.82 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.803 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -127.73 147.56 50.4 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.54 147.0 53.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.762 0.315 . . . . 0.0 110.397 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.542 ' HB2' HG12 ' A' ' 303' ' ' VAL . 69.3 t80 -64.4 133.45 52.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.084 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -77.37 102.39 6.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -66.15 103.49 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.478 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.18 4.64 51.72 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.697 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 66.11 79.56 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.536 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -154.11 135.5 8.87 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.889 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.15 -23.61 66.62 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.044 2.496 . . . . 0.0 113.516 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.6 m -98.05 -1.85 41.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.366 0.603 . . . . 0.0 110.951 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.92 38.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.5 103.66 16.09 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.798 0.332 . . . . 0.0 111.154 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -78.88 123.39 27.19 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 292' ' ' PHE . 11.8 p -141.45 146.36 23.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.032 0.444 . . . . 0.0 111.064 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.497 ' HB3' ' OD2' ' A' ' 307' ' ' ASP . 17.2 ttm-85 -98.53 148.49 23.71 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.519 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.1 127.38 31.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 110.127 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.14 -13.15 48.85 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.682 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 304' ' ' ARG . 81.8 m-20 -87.17 153.97 21.09 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.144 0.472 . . . . 0.0 110.422 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 6.4 t -107.07 128.57 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 111.094 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 303' ' ' VAL . 4.1 mp -102.1 142.37 16.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.315 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 8.2 m -108.36 108.82 19.95 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.22 148.78 5.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.91 0.386 . . . . 0.0 111.17 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.79 -64.42 1.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.519 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.07 134.51 52.09 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -80.37 82.99 6.29 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.497 0.665 . . . . 0.0 110.54 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -70.53 131.78 87.89 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.052 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.79 -41.04 40.65 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.846 2.364 . . . . 0.0 113.483 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -139.66 174.9 10.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 111.116 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.16 -155.7 31.64 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.514 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.409 ' HB3' ' HB2' ' A' ' 336' ' ' TYR . 9.5 mpt_? -110.63 110.47 21.17 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -89.78 157.75 17.8 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.856 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.93 121.89 30.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.772 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -119.09 151.54 17.59 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.129 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -112.37 121.39 44.73 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 55.6 mt -109.35 137.23 42.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.3 p80 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.463 176.408 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.56 138.68 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 111.676 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -166.26 174.71 41.81 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 319' ' ' ARG . 22.4 p90 -99.99 149.07 23.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.363 0.582 . . . . 0.0 111.102 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -154.49 162.63 26.56 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.781 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.401 ' O ' HG12 ' A' ' 341' ' ' ILE . 4.0 Cg_endo -87.31 122.59 1.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.119 2.546 . . . . 0.0 112.456 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 342' ' ' VAL . 49.2 Cg_exo -56.2 -18.61 24.33 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.417 2.745 . . . . 0.0 112.82 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -62.84 -23.98 66.1 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.877 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.402 HG13 HG13 ' A' ' 342' ' ' VAL . 42.8 pt -99.06 4.63 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.542 0.671 . . . . 0.0 112.228 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 288' ' ' ALA . 33.2 m -129.22 165.74 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 112.011 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 345' ' ' VAL . 10.5 tp10 -149.79 148.13 28.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.074 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.96 -35.81 61.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.465 ' H ' ' HG3' ' A' ' 343' ' ' GLU . 18.0 t -89.4 146.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.3 t -69.98 95.77 0.97 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.15 0.5 . . . . 0.0 111.645 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt 64.13 30.42 13.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 113.0 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ARG . . . . . 0.491 ' C ' ' HD3' ' A' ' 348' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 312' ' ' LEU . 50.7 m . . . . . 0 C--O 1.235 0.333 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 285' ' ' LYS . 43.1 tp -146.35 166.61 25.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.778 0.323 . . . . 0.0 110.642 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LYS . . . . . 0.425 ' N ' ' HG ' ' A' ' 284' ' ' LEU . 60.1 pttt -123.12 135.88 54.55 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.74 137.78 55.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -102.75 130.54 49.74 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.731 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -86.04 119.58 26.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.874 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.48 -21.12 24.35 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 291' ' ' ASP . 9.7 tmtm? -123.71 146.08 48.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 290' ' ' LYS . 13.7 m-20 -72.83 122.21 21.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.05 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.453 ' HB3' ' H ' ' A' ' 303' ' ' VAL . 6.5 t80 -80.6 111.23 16.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -170.37 18.12 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.12 0.486 . . . . 0.0 109.883 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 -8.87 59.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.04 168.07 10.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -105.45 -24.65 12.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.521 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.37 131.91 23.28 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 111.737 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.3 3.36 5.84 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.04 3.16 . . . . 0.0 114.386 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.7 t -73.38 -12.85 60.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.241 0.543 . . . . 0.0 110.47 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -89.17 153.41 20.97 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.792 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 tt -79.78 114.66 18.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.987 0.422 . . . . 0.0 110.137 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -99.01 154.43 18.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.773 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.453 ' H ' ' HB3' ' A' ' 292' ' ' PHE . 7.5 p -156.05 146.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.432 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -87.12 141.54 28.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.58 127.0 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.7 56.79 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.373 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -89.22 164.81 14.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.19 132.37 70.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.399 0.619 . . . . 0.0 111.589 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.49 128.98 49.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.332 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 26.2 m -85.47 110.26 19.05 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.924 0.392 . . . . 0.0 110.799 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.39 148.33 9.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 283' ' ' SER . 5.8 mp -87.37 -79.13 0.29 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.409 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -174.13 118.46 0.24 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.334 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 178.51 178.21 0.42 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.7 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -83.69 119.91 74.4 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.02 98.7 1.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.247 1.965 . . . . 0.0 111.667 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -140.25 119.22 12.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' A' ' 339' ' ' PRO . . . 76.26 -95.68 1.08 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.909 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -132.74 122.92 25.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.492 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -116.31 156.41 26.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.112 0.482 . . . . 0.0 111.936 -178.199 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 8.4 ttpm? -84.06 127.18 33.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.838 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -137.91 172.54 22.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.715 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -112.08 124.33 52.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.0 151.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.909 0.385 . . . . 0.0 110.82 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.124 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.418 HG23 ' HD2' ' A' ' 321' ' ' LYS . 65.2 mt -126.38 123.89 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -152.93 171.62 31.97 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.845 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -119.96 137.17 54.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.626 0.213 . . . . 0.0 110.674 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.8 159.08 41.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.956 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.458 ' O ' HG12 ' A' ' 341' ' ' ILE . 71.6 Cg_endo -81.61 125.81 5.1 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.712 2.274 . . . . 0.0 112.1 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 318' ' ' GLY . 29.7 Cg_endo -62.97 -12.37 29.23 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.151 2.567 . . . . 0.0 113.134 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.13 -19.72 68.36 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.541 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.463 HG13 HG13 ' A' ' 342' ' ' VAL . 43.7 pt -96.84 -1.5 10.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 117.338 0.569 . . . . 0.0 111.761 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.463 HG13 HG13 ' A' ' 341' ' ' ILE . 31.5 m -123.96 156.58 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.076 0.465 . . . . 0.0 111.823 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.53 153.7 47.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.23 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.14 -20.17 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.094 0.473 . . . . 0.0 110.499 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 346' ' ' SER . 10.7 t -110.17 169.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 345' ' ' VAL . 43.0 m -69.47 156.63 38.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.24 140.56 58.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 111.425 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 . . . . . 0 C--N 1.311 -1.107 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.002 177.381 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 120.859 0.362 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.38 -173.07 2.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.382 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -141.99 141.53 32.89 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.108 0.48 . . . . 0.0 111.306 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.25 142.23 40.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.083 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -102.58 128.13 49.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.901 0.382 . . . . 0.0 111.298 -177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.45 130.19 35.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.546 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.13 -11.96 34.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.876 0.37 . . . . 0.0 110.737 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 291' ' ' ASP . 2.0 tmtp? -145.69 146.58 31.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.49 ' N ' ' HD3' ' A' ' 290' ' ' LYS . 0.9 OUTLIER -62.29 122.77 16.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.754 0.312 . . . . 0.0 110.214 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -76.58 115.01 15.93 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.995 0.426 . . . . 0.0 110.968 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -75.06 92.29 2.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -60.15 149.28 33.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.889 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.77 -163.45 1.05 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.844 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' ' 297' ' ' ASP . 41.4 m170 -82.78 -173.65 4.78 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.134 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 296' ' ' HIS . 17.4 m-20 77.34 144.79 0.1 Allowed Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 123.707 0.629 . . . . 0.0 110.834 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.55 2.5 5.72 Favored 'Trans proline' 0 C--O 1.221 -0.338 0 C-N-CA 122.907 2.405 . . . . 0.0 112.566 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 5.0 p -101.52 3.41 40.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.872 0.367 . . . . 0.0 111.412 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -76.85 132.48 39.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.508 HD22 ' CD1' ' A' ' 337' ' ' PHE . 0.8 OUTLIER -82.41 151.7 26.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.323 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.469 ' O ' HG12 ' A' ' 324' ' ' ILE . 33.7 m-80 -128.6 123.57 33.67 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.66 149.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.6 0.238 . . . . 0.0 110.558 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -109.34 165.24 11.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.078 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.85 117.12 5.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.041 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.48 -11.58 39.34 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.663 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -88.47 159.36 18.0 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.346 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 12.1 m -117.14 132.25 67.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.448 0.642 . . . . 0.0 112.663 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.478 HG13 HD13 ' A' ' 324' ' ' ILE . 3.8 mp -97.81 138.68 21.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.527 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 46.9 m -87.31 110.27 20.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.896 0.379 . . . . 0.0 110.53 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.77 141.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.301 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.59 -75.97 0.39 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.1 96.46 2.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.52 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -150.62 176.42 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.72 158.06 76.46 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.409 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.567 ' O ' ' HG3' ' A' ' 339' ' ' PRO . 25.0 Cg_exo -64.32 -20.63 66.76 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.825 2.35 . . . . 0.0 113.121 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.02 109.09 2.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.568 0.699 . . . . 0.0 111.183 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 106.55 -99.59 1.5 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 339' ' ' PRO . 0.0 OUTLIER -156.26 147.86 22.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.664 0.269 . . . . 0.0 110.305 178.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.27 153.07 22.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.545 ' HG2' HG22 ' A' ' 334' ' ' ILE . 88.8 tttt -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.09 176.88 21.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.028 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -106.48 122.22 45.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.478 HD13 HG13 ' A' ' 309' ' ' ILE . 9.0 tp -110.31 152.68 12.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.681 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--N 1.317 -0.831 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.857 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.489 ' HG3' HG12 ' A' ' 334' ' ' ILE . 14.5 ptm180 . . . . . 0 N--CA 1.443 -0.777 0 CA-C-O 120.551 0.215 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.545 HG22 ' HG2' ' A' ' 321' ' ' LYS . 5.7 mm -117.14 140.5 39.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.59 155.51 23.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.398 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.79 144.52 26.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 0.0 111.437 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.508 ' CD1' HD22 ' A' ' 301' ' ' LEU . 24.5 p90 -155.19 148.38 18.32 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 3.0 Cg_exo -75.86 133.74 15.66 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.02 2.48 . . . . 0.0 113.095 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' PRO . . . . . 0.567 ' HG3' ' O ' ' A' ' 316' ' ' PRO . 30.0 Cg_endo -61.7 -19.74 66.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.176 2.584 . . . . 0.0 112.641 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -61.2 -19.55 57.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.584 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 36.8 pt -111.66 4.49 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.354 0.577 . . . . 0.0 112.355 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 339' ' ' PRO . 27.5 m -129.41 153.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 112.003 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 345' ' ' VAL . 10.0 tp10 -148.33 150.94 34.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.16 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.57 -40.8 71.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.43 ' H ' ' HG3' ' A' ' 343' ' ' GLU . 26.0 t -96.05 -84.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.546 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 14.7 m -154.32 -179.92 8.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -73.23 -26.74 61.25 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.108 0.48 . . . . 0.0 110.579 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ARG . . . . . 0.599 ' HD3' ' O ' ' A' ' 348' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.335 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 121.028 0.442 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.59 161.74 27.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.699 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -122.69 136.26 54.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 308' ' ' VAL . 19.3 m -115.16 148.83 17.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 345' ' ' VAL . 13.1 mmm180 -102.42 128.48 49.01 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.318 -176.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.57 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -89.63 120.77 31.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.68 -14.74 27.65 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.981 0.42 . . . . 0.0 110.107 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -134.12 157.57 45.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 142.97 33.01 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.995 0.426 . . . . 0.0 111.351 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 303' ' ' VAL . 41.5 t80 -121.76 113.26 19.44 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -161.3 136.31 7.47 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.16 131.79 56.81 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.115 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.09 8.47 4.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.278 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -133.95 133.12 41.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.134 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 8.6 t70 69.52 120.84 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.56 0.744 . . . . 0.0 111.448 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.73 1.94 8.0 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.119 2.546 . . . . 0.0 114.172 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -88.26 23.07 2.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.317 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.08 150.31 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.214 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.7 tp -83.04 114.36 21.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -88.32 109.8 20.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.809 0.337 . . . . 0.0 111.332 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' VAL . . . . . 0.594 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.8 p -142.64 134.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.085 0.469 . . . . 0.0 110.274 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -103.5 151.64 22.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.766 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.41 119.67 8.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.392 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.13 -11.49 31.55 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.971 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -95.06 171.32 8.82 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.641 0.257 . . . . 0.0 110.625 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 286' ' ' VAL . 15.4 m -122.03 135.77 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.7 mt -101.64 143.08 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 2.9 m -91.7 107.18 19.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.096 0.474 . . . . 0.0 110.293 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.9 m -108.53 149.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.574 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.627 ' HG ' ' H ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -89.44 -72.82 0.54 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.627 ' H ' ' HG ' ' A' ' 312' ' ' LEU . 13.3 pt-20 170.74 156.4 0.07 Allowed 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.095 0.958 . . . . 0.0 108.977 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' GLN . . . . . 0.505 ' OE1' ' HB3' ' A' ' 316' ' ' PRO . 35.5 tt0 -173.76 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.281 0.363 . . . . 0.0 111.265 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 48.4 m80 58.69 65.95 2.7 Favored Pre-proline 0 N--CA 1.469 0.512 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.532 ' HG3' ' CG ' ' A' ' 320' ' ' TRP . 64.9 Cg_endo -82.65 168.68 14.14 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.953 2.435 . . . . 0.0 114.088 -172.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.24 -7.88 31.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.943 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -164.71 -138.48 2.42 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.588 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 135.07 56.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.65 0.262 . . . . 0.0 111.046 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' TRP . . . . . 0.542 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 0.3 OUTLIER -132.72 179.07 6.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 33.5 mmtp -86.38 154.1 21.43 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.507 0.67 . . . . 0.0 112.488 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 334' ' ' ILE . . . -161.1 151.43 21.79 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.414 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -108.8 122.69 47.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 10.4 tp -118.97 142.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 . . . . . 0 N--CA 1.441 -0.903 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.352 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 C--O 1.238 0.484 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 334' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 322' ' ' GLY . 7.8 tt -133.77 117.44 26.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.095 173.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.66 -169.36 11.55 Favored Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.009 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 23.7 p90 -108.45 142.95 38.08 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.477 ' CE2' HG21 ' A' ' 342' ' ' VAL . 21.4 p90 -151.49 146.64 19.11 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.048 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 340' ' ' GLY . 93.8 Cg_endo -84.1 128.19 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.498 2.132 . . . . 0.0 112.725 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.65 18.99 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.426 2.751 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 338' ' ' PRO . . . -93.96 -19.33 34.22 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' ILE . . . . . 0.494 HG13 HG13 ' A' ' 342' ' ' VAL . 44.5 pt -108.87 -8.73 11.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.061 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 288' ' ' ALA . 25.0 m -131.81 150.02 33.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.175 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -161.54 167.7 24.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.67 100.95 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 109.941 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.648 ' O ' ' HG3' ' A' ' 287' ' ' ARG . 10.3 p -156.93 152.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.429 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.0 m -67.06 -56.07 11.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.927 0.394 . . . . 0.0 110.031 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -157.34 154.95 29.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.318 -0.783 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.77 176.62 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.261 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.4 m 63.92 29.02 14.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.034 0.534 . . . . 0.0 111.38 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 285' ' ' LYS . 2.7 tm? -94.89 141.64 28.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -116.57 136.8 52.67 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.93 0.395 . . . . 0.0 110.964 -177.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 342' ' ' VAL . 16.9 m -132.4 154.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.463 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -102.55 141.78 34.8 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.419 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -82.73 110.94 18.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.87 -32.23 31.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.34 164.96 16.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.768 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.11 157.52 18.82 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.473 ' HB3' HG12 ' A' ' 303' ' ' VAL . 23.4 t80 -141.15 112.73 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -141.67 119.48 11.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.916 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.404 ' HB3' ' HB1' ' A' ' 300' ' ' ALA . 55.4 t30 -150.44 126.88 10.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.433 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.79 166.85 10.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 71.94 7.59 5.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.575 0.75 . . . . 0.0 111.042 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -127.71 114.98 20.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.82 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.89 -9.97 26.75 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.966 2.444 . . . . 0.0 113.624 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 22.0 p -107.16 8.04 29.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.179 0.514 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 294' ' ' ASN . . . -82.32 150.09 27.41 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.158 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 337' ' ' PHE . 20.7 tp -105.29 152.73 22.54 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.871 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -119.84 105.26 10.94 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' A' ' 292' ' ' PHE . 8.2 p -148.78 144.39 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.041 0.448 . . . . 0.0 111.255 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.467 ' HD3' ' N ' ' A' ' 305' ' ' ALA . 4.7 tmt_? -112.74 146.51 38.64 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.467 ' N ' ' HD3' ' A' ' 304' ' ' ARG . . . -52.09 125.6 16.08 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.84 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.82 -22.76 20.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.225 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -76.85 165.23 24.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 13.6 m -116.36 137.86 48.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.313 0.578 . . . . 0.0 111.6 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 303' ' ' VAL . 3.6 mp -116.7 132.95 64.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.831 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 6.5 m -98.32 107.25 19.67 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 284' ' ' LEU . 35.9 m -93.5 142.81 12.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.475 0.655 . . . . 0.0 112.071 -176.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 60.1 tp -87.88 -14.67 38.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.024 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -91.31 164.7 13.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.149 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -155.3 121.92 5.33 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.5 m80 58.42 75.52 0.52 Allowed Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.408 0.443 . . . . 0.0 110.129 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -95.03 -170.26 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.115 2.543 . . . . 0.0 112.767 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.19 104.98 5.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 92.85 -69.03 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.24 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -148.85 158.19 43.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.652 0.263 . . . . 0.0 110.493 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -137.03 167.98 20.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.505 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -104.73 137.94 41.77 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.93 26.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.957 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -114.79 130.89 56.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 326' ' ' GLU . 41.6 mm -72.78 135.45 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -73.55 101.53 3.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 324' ' ' ILE . 0.0 OUTLIER -113.33 161.87 16.74 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.373 0.606 . . . . 0.0 112.329 -176.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 14.2 m -101.71 -25.59 13.79 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.024 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -104.83 116.04 31.32 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.606 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -59.69 134.49 57.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.138 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.51 -10.56 46.2 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.847 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 86.6 m -81.03 136.01 35.92 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 23.73 96.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.262 1.425 . . . . 0.0 114.363 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 333' ' ' ARG . 53.2 mtt180 -80.01 -81.05 0.12 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.538 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 47.6 mm -124.08 124.42 68.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.827 0.346 . . . . 0.0 110.815 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.1 21.05 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -102.27 136.83 41.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.863 0.363 . . . . 0.0 110.443 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.527 ' CD1' HD22 ' A' ' 301' ' ' LEU . 4.8 p90 -154.87 154.78 29.55 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.267 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.448 ' O ' HG12 ' A' ' 341' ' ' ILE . 73.8 Cg_endo -77.44 134.33 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.39 2.06 . . . . 0.0 112.176 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.85 -6.88 13.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.867 2.378 . . . . 0.0 112.311 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -74.52 -19.59 79.82 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.157 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.491 HG13 HG13 ' A' ' 342' ' ' VAL . 39.0 pt -99.58 2.91 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 117.254 0.527 . . . . 0.0 111.733 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.491 HG13 HG13 ' A' ' 341' ' ' ILE . 29.1 m -133.8 155.32 39.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 345' ' ' VAL . 11.5 tp10 -160.68 150.13 17.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.048 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.15 -28.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' A' ' 343' ' ' GLU . 20.4 m -77.05 168.41 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.853 0.359 . . . . 0.0 111.665 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 162.87 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.54 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -179.23 6.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? . . . . . 0 C--O 1.244 0.816 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.259 177.271 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 112.173 -0.371 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 11.0 p -147.76 99.8 3.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.134 0.493 . . . . 0.0 111.427 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.17 -176.88 3.06 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 7.4 ptpp? -143.7 134.22 24.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 111.36 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 31.3 m -118.55 156.67 20.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.112 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -102.74 134.87 45.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.6 115.52 18.36 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.169 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.403 ' HG ' ' OE2' ' A' ' 343' ' ' GLU . 4.2 mm? -87.77 -17.11 32.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.235 0.54 . . . . 0.0 110.137 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -140.75 147.26 38.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.42 134.44 39.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.499 ' HD2' ' O ' ' A' ' 301' ' ' LEU . 3.8 t80 -78.74 112.58 16.01 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -71.35 -31.96 67.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.54 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -79.83 78.76 6.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.06 -9.85 10.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.13 68.75 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.258 0.551 . . . . 0.0 110.223 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -179.76 126.15 0.24 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.16 -27.69 81.15 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.449 . . . . 0.0 113.531 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.89 -1.79 57.62 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.191 0.52 . . . . 0.0 111.105 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -102.28 150.78 22.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.539 HD22 ' CG ' ' A' ' 337' ' ' PHE . 3.9 tp -90.01 104.49 17.06 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.375 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -79.42 102.24 8.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.07 144.79 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.266 0.555 . . . . 0.0 111.592 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -104.4 147.29 27.72 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.279 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.51 124.44 20.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.385 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.03 40.89 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.928 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.54 158.07 19.61 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.22 139.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.171 0.51 . . . . 0.0 111.632 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 285' ' ' LYS . 20.5 mt -110.94 132.58 59.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.438 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 27.5 m -80.86 108.54 14.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.63 143.44 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 6.2 mp -81.89 -49.73 9.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.19 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -162.47 162.78 27.67 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.608 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.7 132.36 40.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 320' ' ' TRP . 9.8 m-70 -145.23 81.02 10.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.426 177.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.87 -0.8 10.91 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.897 2.398 . . . . 0.0 112.398 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -70.3 -21.97 62.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.225 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -180.0 -156.92 19.16 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 319' ' ' ARG . 6.2 ptt180 -65.34 110.72 2.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.088 0.471 . . . . 0.0 110.773 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.468 ' HD1' ' O ' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -85.13 175.5 8.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.477 ' HB2' HD11 ' A' ' 334' ' ' ILE . 12.2 ptmm? -119.03 142.1 48.13 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.107 0.48 . . . . 0.0 112.171 -175.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -159.72 171.25 36.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.778 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -109.14 129.52 55.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.915 0.388 . . . . 0.0 110.141 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.438 HG23 ' CE1' ' A' ' 325' ' ' HIS . 8.2 tp -119.61 149.42 22.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.355 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' HIS . . . . . 0.438 ' CE1' HG23 ' A' ' 324' ' ' ILE . 8.3 p-80 52.13 179.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.887 1.275 . . . . 0.0 114.144 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.62 -175.24 2.74 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.176 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 17.9 p -86.21 89.92 7.99 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -156.25 150.72 25.69 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.042 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 62.58 33.38 15.88 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.383 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 104.22 65.41 0.69 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.419 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 30.0 m -53.1 135.28 37.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.138 0.494 . . . . 0.0 111.924 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.57 -106.67 0.16 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.603 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 334' ' ' ILE . 32.7 ptt180 179.29 -54.16 0.01 OUTLIER 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 110.574 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 335' ' ' GLY . 0.0 OUTLIER -179.51 145.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.489 ' N ' HD13 ' A' ' 334' ' ' ILE . . . -138.21 175.79 21.15 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.634 -1.27 . . . . 0.0 113.197 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -111.07 146.12 37.32 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.539 ' CG ' HD22 ' A' ' 301' ' ' LEU . 4.4 p90 -154.01 151.07 23.87 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.003 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.454 ' O ' HG12 ' A' ' 341' ' ' ILE . 70.4 Cg_endo -77.32 127.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.49 2.127 . . . . 0.0 112.109 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.448 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.6 Cg_endo -61.86 -13.28 29.89 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.996 2.464 . . . . 0.0 112.636 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -70.62 -18.9 76.06 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.324 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 338' ' ' PRO . 42.4 pt -103.13 4.3 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 117.4 0.6 . . . . 0.0 111.714 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 288' ' ' ALA . 35.3 m -131.2 150.86 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.87 0.367 . . . . 0.0 111.099 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.403 ' OE2' ' HG ' ' A' ' 289' ' ' LEU . 46.7 mt-10 -137.91 145.38 42.03 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.95 -30.47 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.7 p -83.37 143.31 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 63.7 m -76.94 146.43 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.643 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.68 129.28 34.65 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 . . . . . 0 C--N 1.315 -0.919 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.382 179.302 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 312' ' ' LEU . . . . . . . . 0 N--CA 1.472 1.042 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.4 m -92.23 -15.78 27.05 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 285' ' ' LYS . 2.2 tm? -124.14 141.12 52.32 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.698 -0.401 . . . . 0.0 109.98 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 284' ' ' LEU . 58.9 mtpt -124.69 134.4 52.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.53 142.3 29.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 308' ' ' VAL . 58.4 mtp180 -103.8 132.9 49.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -84.87 125.7 32.85 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.806 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.0 -13.76 30.49 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.052 0.453 . . . . 0.0 110.836 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 291' ' ' ASP . 14.2 tmtt? -132.55 146.47 51.94 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.464 ' N ' ' HD3' ' A' ' 290' ' ' LYS . 11.4 m-20 -73.74 120.55 19.49 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.379 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.451 ' HB3' HG12 ' A' ' 303' ' ' VAL . 3.1 t80 -103.06 113.89 27.74 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -141.53 149.64 41.11 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.511 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -139.62 147.07 40.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.602 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 37.7 tp -75.88 -44.65 39.56 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -161.37 90.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.614 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 15.3 t70 -138.46 126.68 13.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 297' ' ' ASP . 15.9 Cg_exo -68.08 -15.82 43.77 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.047 2.498 . . . . 0.0 114.234 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 20.9 p -113.81 -32.38 6.13 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.52 131.23 48.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.367 0.603 . . . . 0.0 112.53 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.402 HD11 ' HB ' ' A' ' 324' ' ' ILE . 24.0 tp -83.05 153.99 24.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.092 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -110.2 108.13 18.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.451 HG12 ' HB3' ' A' ' 292' ' ' PHE . 8.2 p -146.02 136.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 111.42 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.448 ' HG3' ' HB2' ' A' ' 307' ' ' ASP . 32.9 ptt180 -88.86 152.84 21.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.87 25.61 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.805 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 100.42 -9.17 58.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.023 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.448 ' HB2' ' HG3' ' A' ' 304' ' ' ARG . 1.2 t70 -84.46 164.0 19.1 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.684 0.278 . . . . 0.0 110.528 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.468 HG12 ' HG2' ' A' ' 287' ' ' ARG . 15.8 m -111.2 128.38 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.574 0.702 . . . . 0.0 112.301 -177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 337' ' ' PHE . 49.0 mt -97.82 130.4 46.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 7.0 m -93.63 108.08 19.85 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 18.0 m -105.46 148.31 10.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 312' ' ' LEU . 5.6 mp -64.35 -77.81 0.05 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 312' ' ' LEU . 0.1 OUTLIER 167.49 134.99 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.486 1.114 . . . . 0.0 108.321 175.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 178.79 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.771 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 16.3 m80 52.85 71.49 1.43 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.253 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.64 173.98 9.05 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.729 2.286 . . . . 0.0 111.316 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.57 125.14 45.1 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 100.69 -32.68 7.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.367 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -151.65 137.52 18.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.875 0.369 . . . . 0.0 111.073 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 56.1 m95 -110.52 159.03 17.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.406 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -136.48 122.23 19.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.89 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -152.86 175.02 31.55 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.472 -1.346 . . . . 0.0 113.898 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 333' ' ' ARG . 53.5 m80 -107.12 128.27 54.25 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.402 ' HB ' HD11 ' A' ' 301' ' ' LEU . 10.2 tp -111.91 155.54 13.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.563 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -50.37 148.03 3.95 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.455 0.472 . . . . 0.0 110.758 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.41 ' HA ' HG21 ' A' ' 331' ' ' THR . 0.0 OUTLIER -80.8 168.03 19.26 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 55.6 m -149.91 -170.28 3.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.452 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -68.18 -57.76 5.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.705 0.288 . . . . 0.0 111.383 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -143.12 156.18 44.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.988 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 68.85 47.14 57.05 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.088 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' THR . . . . . 0.41 HG21 ' HA ' ' A' ' 326' ' ' GLU . 22.4 m -137.92 136.44 37.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -121.46 169.94 10.15 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 65.4 mtt180 -87.29 -30.49 20.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.775 0.321 . . . . 0.0 110.752 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 31.3 mm -113.26 121.35 65.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.055 0.455 . . . . 0.0 110.772 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.89 149.69 20.77 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.551 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 67.5 m-85 -107.64 139.15 42.62 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.461 ' CD2' HG11 ' A' ' 342' ' ' VAL . 17.0 p90 -140.93 147.19 47.02 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.632 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 4.8 Cg_exo -75.79 130.85 12.83 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.893 2.395 . . . . 0.0 111.979 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.2 Cg_endo -59.59 -16.57 37.1 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.366 2.711 . . . . 0.0 112.921 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.57 76.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.541 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 41.2 pt -107.99 1.18 9.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 117.386 0.593 . . . . 0.0 112.048 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 339' ' ' PRO . 35.4 m -124.11 150.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.421 . . . . 0.0 111.362 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -146.98 170.27 17.45 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.326 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.83 -167.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.22 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 37.2 t -67.78 -34.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 54.7 m -70.0 95.07 0.91 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 110.907 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -100.27 136.96 39.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.694 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--O 1.24 0.559 0 CA-C-O 118.651 -0.69 . . . . 0.0 109.801 177.827 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.093 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 25.4 p -149.01 137.06 20.75 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.914 0.388 . . . . 0.0 110.665 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -122.71 175.4 6.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.651 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -144.36 133.81 23.29 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.81 168.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.531 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -124.34 134.48 53.15 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.05 137.04 38.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.242 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 343' ' ' GLU . 4.6 mm? -87.06 -28.8 22.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.517 176.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -129.16 146.76 51.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.929 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 304' ' ' ARG . 0.1 OUTLIER -71.87 138.06 47.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.851 178.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -101.92 110.5 22.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -151.32 119.62 6.37 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -151.4 -43.57 0.11 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.325 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 14.6 mt -150.83 134.03 16.12 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.519 ' HA ' ' OD1' ' A' ' 302' ' ' ASN . 38.7 m80 -84.19 84.44 7.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.81 146.89 28.01 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.245 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.44 ' HG3' ' O ' ' A' ' 331' ' ' THR . 31.7 Cg_exo -57.88 -8.32 4.4 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.073 2.515 . . . . 0.0 113.668 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 8.1 t -87.59 -11.82 47.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.013 0.435 . . . . 0.0 110.369 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -121.76 150.56 41.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 337' ' ' PHE . 31.3 tp -88.51 104.03 16.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.576 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 296' ' ' HIS . 29.1 m-80 -84.05 94.09 8.24 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.303 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.46 146.1 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.753 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 291' ' ' ASP . 77.5 mtm180 -108.73 161.29 15.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.77 128.03 34.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.675 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 98.28 -13.3 63.2 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.827 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -80.89 161.17 24.49 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 120.688 0.28 . . . . 0.0 110.659 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 26.5 m -98.03 144.71 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.202 0.525 . . . . 0.0 111.678 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.407 HD13 HD21 ' A' ' 301' ' ' LEU . 42.9 mt -128.99 129.49 68.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.752 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 23.5 m -86.69 108.82 18.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 10.6 t -90.79 148.15 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.92 -56.05 13.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.804 0.335 . . . . 0.0 110.222 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -176.68 144.63 0.5 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.431 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLN . . . . . 0.508 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 23.9 pt20 -92.29 79.27 5.05 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.743 0.782 . . . . 0.0 110.626 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 316' ' ' PRO . 1.4 t-80 -136.74 -53.73 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.217 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 315' ' ' HIS . 2.0 Cg_endo -83.48 101.03 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.18 1.92 . . . . 0.0 110.501 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.53 146.57 48.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.824 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 126.8 -158.65 20.88 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 319' ' ' ARG . 33.2 ptt180 -80.65 98.62 7.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 0.0 109.575 177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.511 ' CZ2' ' HB3' ' A' ' 339' ' ' PRO . 0.2 OUTLIER -89.4 158.91 17.57 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.908 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -85.91 127.8 34.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.255 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -126.05 154.16 18.74 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.971 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -119.72 139.43 52.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 326' ' ' GLU . 37.2 mt -106.94 139.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -90.84 20.7 4.58 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.155 0.502 . . . . 0.0 110.97 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 324' ' ' ILE . 10.5 tp10 -134.63 154.53 51.47 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 22.9 t -138.67 136.34 35.76 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.017 0.437 . . . . 0.0 111.714 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -134.69 -81.09 0.44 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.11 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -131.01 132.05 44.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 106.53 67.29 0.66 Allowed Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.111 -1.042 . . . . 0.0 110.605 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' THR . . . . . 0.44 ' O ' ' HG3' ' A' ' 298' ' ' PRO . 2.9 p -48.36 141.67 6.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.064 0.545 . . . . 0.0 112.152 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.404 ' H ' ' NH1' ' A' ' 333' ' ' ARG . 2.7 m-20 70.32 89.21 0.1 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.126 -175.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 0.1 OUTLIER -79.6 69.58 5.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.165 -175.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 19.5 mm -128.06 111.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.304 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -144.35 159.09 27.68 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.555 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 5.4 p90 -104.03 137.71 41.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 301' ' ' LEU . 20.2 p90 -147.81 155.08 44.58 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.278 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.405 ' O ' HG12 ' A' ' 341' ' ' ILE . 98.3 Cg_endo -84.01 134.59 6.18 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.544 2.162 . . . . 0.0 111.379 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.511 ' HB3' ' CZ2' ' A' ' 320' ' ' TRP . 11.1 Cg_endo -54.94 -19.96 21.32 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.2 2.6 . . . . 0.0 113.202 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -60.92 -20.27 57.3 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 114.258 0.463 . . . . 0.0 114.258 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.469 HG13 HG13 ' A' ' 342' ' ' VAL . 43.1 pt -100.55 4.84 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.605 0.703 . . . . 0.0 112.259 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 341' ' ' ILE . 31.9 m -132.77 164.19 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.096 0.474 . . . . 0.0 111.596 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.485 ' HB2' HD21 ' A' ' 289' ' ' LEU . 0.4 OUTLIER -135.06 149.57 50.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.07 -33.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.1 p -158.25 -20.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 74.0 m -80.24 14.93 1.72 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.981 -0.449 . . . . 0.0 111.981 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 348' ' ' ARG . 8.6 tmtt? -88.67 127.36 35.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.539 ' N ' ' HD3' ' A' ' 347' ' ' LYS . 40.5 ttm180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.683 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.2 m -149.62 111.94 4.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 60.0 tp -128.64 148.64 50.82 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -124.82 135.48 52.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.016 0.436 . . . . 0.0 111.266 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.465 HG11 ' CH2' ' A' ' 320' ' ' TRP . 16.0 m -125.11 146.68 30.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.898 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -103.07 139.5 38.52 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.86 119.67 23.06 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.076 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.93 -26.87 17.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.413 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -127.31 146.89 50.29 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.83 122.31 25.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -103.49 113.02 26.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.417 ' HE1' HD23 ' A' ' 295' ' ' LEU . 19.8 t-105 -115.55 104.72 12.01 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.956 0.408 . . . . 0.0 111.469 -173.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -130.69 106.25 8.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.417 HD23 ' HE1' ' A' ' 293' ' ' TRP . 2.1 pp -107.24 -1.01 22.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.178 0.513 . . . . 0.0 110.703 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.57 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.25 113.6 23.67 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.685 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.13 -0.48 9.17 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.621 2.214 . . . . 0.0 111.978 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 3.4 m -85.26 -16.84 38.83 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.48 0.657 . . . . 0.0 109.564 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -91.94 144.7 25.2 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.379 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.71 110.9 18.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.051 0.453 . . . . 0.0 111.166 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -101.06 121.62 42.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.96 152.34 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.939 0.4 . . . . 0.0 111.253 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.554 ' HB2' ' OD2' ' A' ' 307' ' ' ASP . 61.2 mtm180 -101.74 146.58 27.57 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.28 125.51 23.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.758 0.313 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.33 -16.06 29.79 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.699 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.554 ' OD2' ' HB2' ' A' ' 304' ' ' ARG . 33.4 m-20 -84.29 156.55 21.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.53 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 8.9 t -112.14 135.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.353 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 20.8 mt -114.7 134.05 58.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.952 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 39.7 m -104.19 120.09 40.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.043 0.449 . . . . 0.0 110.711 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 31.3 m -105.24 146.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.133 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 80.0 mt -83.27 -60.12 2.25 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.312 0.577 . . . . 0.0 109.795 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -114.09 114.21 25.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.065 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 141.93 43.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 320' ' ' TRP . 66.8 m-70 -139.95 89.47 11.3 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.22 -9.21 25.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.874 2.382 . . . . 0.0 113.318 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -123.41 117.8 26.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.3 -102.41 1.82 Allowed Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.964 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -153.62 158.0 40.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.465 ' CH2' HG11 ' A' ' 286' ' ' VAL . 0.1 OUTLIER -148.76 170.69 17.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 178.003 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 24.9 pttm -128.25 144.56 51.14 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.439 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.1 34.51 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.997 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 333' ' ' ARG . 3.9 p-80 -114.26 133.83 55.36 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 47.2 mt -80.93 150.96 4.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.407 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -76.73 117.58 18.5 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.44 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -82.98 -90.6 0.08 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.039 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 15.5 m 51.98 24.36 2.58 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.981 0.513 . . . . 0.0 112.146 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -175.47 -69.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 329' ' ' ARG . 1.0 OUTLIER -169.65 -176.52 2.44 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.03 67.74 0.71 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.095 -1.526 . . . . 0.0 112.092 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 49.8 m -51.95 134.0 32.05 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.685 0.278 . . . . 0.0 111.246 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.9 t70 178.72 143.67 0.12 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.508 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 30.3 tpt180 -120.52 -67.74 0.96 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 14.1 mm -153.77 116.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -137.35 151.49 21.15 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.439 -1.363 . . . . 0.0 112.563 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -89.14 146.33 24.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -158.38 158.48 29.7 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.896 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 341' ' ' ILE . 78.2 Cg_endo -82.39 132.97 7.15 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.334 2.023 . . . . 0.0 111.942 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.8 -14.83 19.12 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.249 2.633 . . . . 0.0 113.116 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -67.9 -19.86 71.99 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.861 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.492 HG13 HG13 ' A' ' 342' ' ' VAL . 39.5 pt -94.28 -8.15 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 117.599 0.699 . . . . 0.0 111.835 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 341' ' ' ILE . 28.8 m -123.05 170.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.974 0.416 . . . . 0.0 111.083 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 346' ' ' SER . 6.9 tp10 -157.12 151.19 24.8 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.3 -67.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 73.7 t -104.03 -41.19 6.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.488 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 35.2 m -60.05 133.96 56.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -177.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -99.15 158.23 15.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.794 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.908 179.308 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 14.7 p 50.3 84.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.854 0.861 . . . . 0.0 112.53 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.59 173.09 7.39 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.147 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -146.31 143.16 28.95 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.266 0.555 . . . . 0.0 112.181 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.19 164.04 34.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.86 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ARG . . . . . 0.484 ' HG2' HG12 ' A' ' 308' ' ' VAL . 74.9 mtp180 -113.64 144.58 42.67 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.131 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.5 118.28 23.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.751 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 -5.96 48.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.29 0.567 . . . . 0.0 110.426 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -138.85 146.49 41.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -80.12 121.92 26.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.663 0.268 . . . . 0.0 110.634 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.55 ' CE1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.83 53.69 1.76 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.511 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.55 ' HB2' ' CE1' ' A' ' 292' ' ' PHE . 50.4 t-20 -66.82 -61.35 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.497 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 13.9 tp -160.48 165.06 31.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -97.38 20.46 11.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.905 0.383 . . . . 0.0 111.936 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.47 153.54 41.36 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.017 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.86 -19.42 65.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.887 2.392 . . . . 0.0 112.829 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.4 m -81.25 -14.99 56.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 110.698 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -109.55 137.65 47.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.963 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.476 HD11 ' CG1' ' A' ' 324' ' ' ILE . 31.4 tp -86.59 111.24 20.44 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.082 0.467 . . . . 0.0 110.978 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -106.14 102.68 12.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.17 148.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.416 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -96.05 149.25 21.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.78 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.43 27.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.743 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.42 -19.36 26.75 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.382 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -76.98 155.88 32.31 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 116.904 0.352 . . . . 0.0 111.146 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.484 HG12 ' HG2' ' A' ' 287' ' ' ARG . 34.4 m -101.77 134.13 43.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.344 0.592 . . . . 0.0 111.429 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.453 HG12 ' CD1' ' A' ' 324' ' ' ILE . 56.3 mt -109.24 116.85 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 22.4 m -91.2 114.84 27.47 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.2 142.09 17.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.67 -66.73 0.57 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 313' ' ' GLU . 11.0 pt-20 -178.71 113.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.439 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -158.64 132.49 7.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -64.0 116.94 31.2 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 97.32 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.537 2.158 . . . . 0.0 113.035 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -150.57 129.2 12.28 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.503 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.24 -87.5 0.49 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -151.03 132.03 14.27 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.403 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -125.59 166.3 16.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.663 -175.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -89.16 140.07 29.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 111.886 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.96 156.23 26.33 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.371 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.628 ' CE1' ' HB3' ' A' ' 332' ' ' ASP . 6.5 t-80 -111.2 121.08 44.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.933 0.397 . . . . 0.0 110.148 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 332' ' ' ASP . 35.3 mm -85.9 121.75 37.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.438 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -109.21 92.04 3.89 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.571 ' HG2' ' H ' ' A' ' 328' ' ' GLN . 22.2 tt0 -75.28 133.4 41.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.241 -175.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.4 m -86.54 -14.03 44.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.682 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.571 ' H ' ' HG2' ' A' ' 326' ' ' GLU . 91.4 mt-30 -75.39 -78.98 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -3.3 58.88 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 120.729 0.299 . . . . 0.0 110.849 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 66.07 51.08 47.78 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.77 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.9 t -118.86 158.07 26.38 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.628 ' HB3' ' CE1' ' A' ' 323' ' ' HIS . 5.6 m-20 -126.88 130.51 50.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.156 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -136.67 132.83 35.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.543 0.211 . . . . 0.0 110.945 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 15.8 tt -101.44 140.25 20.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.847 0.356 . . . . 0.0 110.337 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.05 179.26 35.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -110.9 143.98 40.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.693 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 301' ' ' LEU . 9.5 p90 -149.14 156.51 40.17 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.115 -177.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.438 ' O ' HG12 ' A' ' 341' ' ' ILE . 3.5 Cg_exo -81.72 131.04 7.03 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.822 2.348 . . . . 0.0 111.363 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.0 Cg_endo -60.17 -15.79 36.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.862 2.375 . . . . 0.0 112.789 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.38 -19.55 74.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.594 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.463 HG13 HG13 ' A' ' 342' ' ' VAL . 41.1 pt -100.25 1.7 10.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.539 0.669 . . . . 0.0 111.803 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.463 HG13 HG13 ' A' ' 341' ' ' ILE . 33.5 m -128.18 164.5 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.182 0.515 . . . . 0.0 111.581 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.428 ' HG2' ' OG ' ' A' ' 346' ' ' SER . 8.6 tp10 -160.35 151.83 19.59 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.465 HG13 HG12 ' A' ' 345' ' ' VAL . 7.2 p -66.54 -40.92 87.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.465 HG12 HG13 ' A' ' 344' ' ' VAL . 7.9 p -157.09 122.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.411 . . . . 0.0 110.752 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 343' ' ' GLU . 49.6 m -163.96 -23.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.22 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -64.56 121.09 13.62 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.653 -0.689 . . . . 0.0 109.657 179.489 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.383 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 311' ' ' VAL . 30.5 p -75.83 135.18 40.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.886 0.374 . . . . 0.0 111.109 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 311' ' ' VAL . 24.6 tp -144.39 157.48 44.23 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.24 133.44 56.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.789 0.328 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.98 152.08 36.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -105.41 137.43 43.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.696 0.284 . . . . 0.0 110.518 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -82.1 110.89 17.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.028 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 47.0 mt -78.66 -26.31 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.198 0.523 . . . . 0.0 110.089 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -132.67 162.79 30.48 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.42 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.568 ' OD2' ' HD2' ' A' ' 304' ' ' ARG . 10.0 m-20 -78.44 151.97 32.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.725 0.298 . . . . 0.0 110.206 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.558 ' HB3' HG12 ' A' ' 303' ' ' VAL . 32.4 t80 -140.69 113.48 8.24 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -144.72 102.32 3.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -108.95 129.04 55.43 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 295' ' ' LEU . 1.8 pt? -111.58 7.78 20.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.836 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -92.2 -41.04 10.66 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.049 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 300' ' ' ALA . 29.5 m-20 -101.97 122.05 48.55 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.085 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.8 -28.55 59.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.318 2.012 . . . . 0.0 111.612 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 7.3 t -83.95 -3.04 57.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.737 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 297' ' ' ASP . . . -70.28 150.21 46.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.618 0.247 . . . . 0.0 110.501 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.563 HD22 ' CD1' ' A' ' 337' ' ' PHE . 15.7 tp -82.51 153.67 25.45 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.059 0.457 . . . . 0.0 110.77 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.434 ' N ' ' HG ' ' A' ' 301' ' ' LEU . 23.4 p-10 -128.15 119.64 25.7 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.558 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.7 p -144.4 146.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.048 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.568 ' HD2' ' OD2' ' A' ' 291' ' ' ASP . 10.3 tpt180 -96.55 142.3 28.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.1 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.37 122.11 12.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.733 0.301 . . . . 0.0 110.335 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.17 40.16 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.72 -0.753 . . . . 0.0 113.028 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.2 169.56 12.95 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.151 0.475 . . . . 0.0 110.151 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.13 128.72 72.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.353 0.597 . . . . 0.0 111.583 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.529 HG12 HD13 ' A' ' 324' ' ' ILE . 68.2 mt -99.3 129.05 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.993 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.8 m -98.0 108.6 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 283' ' ' SER . 19.5 m -93.06 140.13 16.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 120.842 0.353 . . . . 0.0 110.603 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 312' ' ' LEU . 2.6 pt? -82.18 -12.72 57.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.574 0.702 . . . . 0.0 109.46 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -159.33 143.99 15.44 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.582 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.28 -33.09 69.44 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.011 0.195 . . . . 0.0 110.98 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.4 m80 67.77 157.38 0.14 Allowed Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.814 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.35 137.92 63.19 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.001 1.8 . . . . 0.0 110.216 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.24 118.77 7.86 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.768 0.794 . . . . 0.0 111.035 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 161.51 -43.9 0.39 Allowed Glycine 0 C--N 1.31 -0.908 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.608 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -157.57 123.91 4.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 110.043 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 339' ' ' PRO . 45.0 m95 -94.67 174.34 7.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.566 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.505 ' HG2' HD11 ' A' ' 334' ' ' ILE . 86.4 tttt -156.61 114.13 3.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -145.33 176.68 24.21 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.453 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 332' ' ' ASP . 46.8 m80 -107.17 136.94 46.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.673 HG13 ' H ' ' A' ' 326' ' ' GLU . 11.0 tp -130.67 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.643 0.259 . . . . 0.0 110.629 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -95.51 10.09 37.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.335 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.673 ' H ' HG13 ' A' ' 324' ' ' ILE . 17.9 tp10 -66.56 -30.51 70.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 43.4 m -62.81 113.64 3.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -62.41 -16.58 55.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.577 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -62.77 -13.92 38.85 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.522 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 101.31 -52.15 0.9 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.142 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.9 t -68.35 152.24 45.72 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.117 0.484 . . . . 0.0 111.507 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' A' ' 323' ' ' HIS . 3.0 m-20 -69.74 93.38 0.73 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.212 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 57.2 ttp85 -77.35 142.58 39.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.901 0.381 . . . . 0.0 110.366 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.505 HD11 ' HG2' ' A' ' 321' ' ' LYS . 9.1 tp -94.82 140.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.52 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.41 159.1 30.54 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.602 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 321' ' ' LYS . 36.3 p90 -101.75 151.78 21.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.818 0.309 . . . . 0.0 110.314 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.563 ' CD1' HD22 ' A' ' 301' ' ' LEU . 16.7 p90 -153.71 151.08 24.38 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 341' ' ' ILE . 62.3 Cg_endo -75.29 133.43 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.714 2.276 . . . . 0.0 112.131 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 320' ' ' TRP . 20.7 Cg_endo -61.4 -17.57 54.18 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.218 2.612 . . . . 0.0 113.023 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -63.89 -19.18 62.99 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.655 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 338' ' ' PRO . 45.6 pt -107.96 6.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 339' ' ' PRO . 28.3 m -132.26 161.45 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 111.78 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -160.46 161.97 33.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 -24.53 35.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.58 -178.59 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.095 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.2 m -71.54 161.01 31.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -64.24 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.011 0.434 . . . . 0.0 110.736 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.485 178.867 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.0 p -161.33 108.43 1.44 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.07 167.93 10.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.432 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -129.89 141.49 50.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.02 144.67 31.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.636 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ARG . . . . . 0.428 ' HG2' HG12 ' A' ' 308' ' ' VAL . 58.2 mtt85 -102.34 129.46 48.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.05 117.78 24.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.817 0.341 . . . . 0.0 111.159 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.97 -23.32 20.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.237 0.542 . . . . 0.0 109.563 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 341' ' ' ILE . 57.9 tptt -117.81 146.35 43.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.54 135.57 36.12 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.328 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.478 ' HD2' ' O ' ' A' ' 301' ' ' LEU . 35.6 t80 -99.25 112.62 24.75 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.36 167.29 21.94 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.453 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -74.82 133.63 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.255 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.42 177.6 4.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.822 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.53 45.09 0.94 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.71 138.21 6.15 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.67 -18.75 42.23 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.268 2.645 . . . . 0.0 113.85 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 2.7 m -80.45 1.14 30.47 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.169 0.509 . . . . 0.0 110.861 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.11 124.5 23.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.478 ' O ' ' HD2' ' A' ' 292' ' ' PHE . 21.2 tp -88.84 87.45 7.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.561 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -74.63 97.58 3.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.674 . . . . 0.0 111.116 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.45 HG21 HD11 ' A' ' 309' ' ' ILE . 13.0 p -123.55 139.83 48.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.868 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 307' ' ' ASP . 51.4 mtm180 -99.61 157.05 16.73 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -178.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.96 121.67 13.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.746 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.87 26.87 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.297 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 304' ' ' ARG . 26.7 m-20 -85.63 162.75 18.68 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 122.503 -0.41 . . . . 0.0 110.52 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.428 HG12 ' HG2' ' A' ' 287' ' ' ARG . 30.2 m -114.57 145.2 20.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.292 0.568 . . . . 0.0 112.208 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 303' ' ' VAL . 4.4 mp -118.02 130.75 72.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.84 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 85.7 m -96.99 120.55 37.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.061 0.458 . . . . 0.0 110.761 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.18 146.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.559 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.38 -78.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.702 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -164.62 98.91 0.79 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.438 0.637 . . . . 0.0 110.792 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -164.62 153.73 13.13 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.335 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' HIS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 316' ' ' PRO . 9.3 m170 -90.63 144.19 30.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 315' ' ' HIS . 6.4 Cg_exo -75.1 49.45 2.29 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.162 2.575 . . . . 0.0 112.661 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -101.9 45.12 0.98 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.112 0.482 . . . . 0.0 110.726 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 149.43 170.01 16.5 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.437 ' H ' ' HD3' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -62.8 134.79 56.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.588 0.694 . . . . 0.0 109.606 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.41 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -139.63 -179.64 6.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 -176.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -123.1 145.06 48.9 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -133.47 166.21 23.9 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.358 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -109.94 122.39 47.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.24 137.39 31.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.379 0.609 . . . . 0.0 112.138 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -146.69 103.54 3.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.981 175.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.99 -171.77 2.44 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.691 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 33.0 m -62.21 -23.83 66.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.651 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -82.96 115.93 22.02 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ARG . . . . . 0.553 ' H ' ' HD2' ' A' ' 329' ' ' ARG . 0.0 OUTLIER -65.54 142.13 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.857 0.361 . . . . 0.0 110.658 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.34 -21.12 35.96 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.671 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 40.2 p -69.68 137.39 52.09 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -156.43 121.59 4.7 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.115 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -157.95 139.89 14.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.018 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 13.7 tt -124.83 130.93 73.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.61 33.75 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.546 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -88.88 146.69 24.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.664 0.269 . . . . 0.0 111.279 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.69 152.66 18.18 Favored Pre-proline 0 C--O 1.242 0.679 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.489 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.584 ' O ' HG12 ' A' ' 341' ' ' ILE . 72.3 Cg_endo -79.46 133.64 10.74 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.53 2.153 . . . . 0.0 111.72 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.81 -14.92 45.92 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.821 2.347 . . . . 0.0 112.734 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -72.34 -18.8 78.44 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 116.099 -0.5 . . . . 0.0 113.574 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 338' ' ' PRO . 46.9 pt -93.51 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.471 0.635 . . . . 0.0 111.501 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.418 HG13 HG13 ' A' ' 341' ' ' ILE . 35.6 m -120.87 163.45 18.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -146.55 146.24 30.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.725 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.39 -35.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.426 HG11 ' NE ' ' A' ' 348' ' ' ARG . 17.5 t -72.65 158.55 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 30.7 m -72.75 102.77 3.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.656 0.265 . . . . 0.0 111.447 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt 45.39 37.96 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.443 1.097 . . . . 0.0 113.8 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.426 ' NE ' HG11 ' A' ' 345' ' ' VAL . 38.6 ttm180 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.375 -0.822 . . . . 0.0 109.916 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.042 0 N-CA-C 112.196 -0.362 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 51.0 m -143.05 93.11 2.46 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.87 159.2 21.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -131.61 136.2 47.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 25.0 m -115.54 142.41 28.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -101.6 132.71 47.11 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.344 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -80.34 117.53 21.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.56 -21.91 22.64 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -126.32 147.7 49.68 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.679 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.84 153.78 28.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.111 0.482 . . . . 0.0 111.38 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.555 ' HB3' HG12 ' A' ' 303' ' ' VAL . 40.3 t80 -135.65 110.72 8.89 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -174.52 133.85 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -124.13 161.74 25.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 295' ' ' LEU . 2.5 pt? -77.26 -8.74 58.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.64 0.734 . . . . 0.0 109.229 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -126.71 -156.75 0.76 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.538 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 6.4 m-20 66.44 91.61 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 123.327 0.392 . . . . 0.0 111.287 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.86 -15.74 26.4 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.445 2.097 . . . . 0.0 112.842 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.6 m -105.67 7.48 32.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 110.886 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 297' ' ' ASP . . . -72.38 139.89 48.11 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.451 ' O ' ' HD2' ' A' ' 292' ' ' PHE . 21.0 tp -84.36 91.21 7.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.49 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.97 106.17 1.51 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.249 0.547 . . . . 0.0 111.344 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 292' ' ' PHE . 12.8 p -134.84 135.16 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.563 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.431 ' HB3' ' OD2' ' A' ' 307' ' ' ASP . 37.6 ttp180 -97.01 147.4 24.04 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.959 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.58 125.79 25.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.086 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.41 -18.15 25.56 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.611 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 304' ' ' ARG . 18.0 m-20 -86.19 165.29 16.65 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.842 0.353 . . . . 0.0 110.565 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.55 134.94 59.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.17 128.08 53.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.3 m -83.22 108.75 16.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.88 0.372 . . . . 0.0 110.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.78 127.07 62.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.398 0.618 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 312' ' ' LEU . 2.2 pp -86.41 -9.77 55.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.506 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 117.97 6.7 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -76.97 101.4 5.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.728 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -123.01 84.4 50.8 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.45 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 -2.0 12.14 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 114.236 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -108.12 106.87 17.28 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.479 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 93.79 173.12 39.46 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.779 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -68.46 128.87 38.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 109.897 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.416 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -126.3 162.19 26.06 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.537 -176.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -98.69 136.87 38.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.277 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -139.8 171.85 23.63 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.154 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -109.14 128.14 54.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.954 0.407 . . . . 0.0 111.151 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 11.4 tp -124.42 154.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 54.8 t60 71.99 166.27 0.3 Allowed 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.5 0.5 . . . . 0.0 110.417 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.07 154.5 41.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.839 0.352 . . . . 0.0 110.603 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 6.2 p -101.83 108.48 19.98 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.118 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.14 179.74 7.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.685 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -73.09 117.09 14.41 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.102 0.477 . . . . 0.0 111.927 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 102.52 -53.12 0.79 Allowed Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.945 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.23 157.64 46.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.209 0.504 . . . . 0.0 111.516 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -146.23 -170.89 3.6 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -115.1 108.83 17.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.392 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 39.8 mm -106.82 129.69 60.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.547 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -140.0 159.94 26.14 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.025 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -97.2 140.76 31.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.882 0.372 . . . . 0.0 110.243 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.458 ' HE2' HG21 ' A' ' 342' ' ' VAL . 5.9 p90 -148.78 160.56 35.37 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.259 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.484 ' O ' HG12 ' A' ' 341' ' ' ILE . 4.0 Cg_endo -87.11 132.91 3.29 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.763 2.309 . . . . 0.0 112.135 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.81 -14.07 34.34 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.133 2.555 . . . . 0.0 112.472 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.48 -18.84 68.22 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.498 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.485 HG13 HG13 ' A' ' 342' ' ' VAL . 49.2 pt -101.98 -4.49 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.485 HG13 HG13 ' A' ' 341' ' ' ILE . 27.6 m -126.83 150.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.856 0.36 . . . . 0.0 111.52 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -143.18 146.55 33.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.674 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.41 -34.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.727 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.42 -37.05 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.502 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.2 m -109.24 86.41 2.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.094 0.474 . . . . 0.0 110.204 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 347' ' ' LYS . 14.6 tmtt? -85.89 94.58 9.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.217 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.955 177.951 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.084 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.3 m -85.0 107.25 17.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.091 0.472 . . . . 0.0 110.885 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.443 ' HB2' HG23 ' A' ' 311' ' ' VAL . 73.1 mt -105.6 179.86 4.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.174 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 25.4 pttm -153.05 145.01 23.69 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.287 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.9 m -128.88 157.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.832 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -102.42 127.99 49.22 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.906 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -81.61 128.68 34.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.89 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.25 -9.8 26.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.581 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.473 ' HB3' ' HB ' ' A' ' 341' ' ' ILE . 54.6 tptt -133.62 147.3 51.47 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -80.25 122.41 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 302' ' ' ASN . 0.6 OUTLIER -104.94 111.38 24.13 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -162.36 -2.96 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.74 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -56.81 -44.38 81.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.147 0.498 . . . . 0.0 109.689 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 300' ' ' ALA . 26.4 tp -89.44 120.59 30.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -94.87 0.8 55.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.2 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 2.6 m-20 -66.24 139.34 96.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 297' ' ' ASP . 52.1 Cg_exo -56.32 -21.24 35.69 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.127 2.551 . . . . 0.0 113.293 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.4 t -78.03 -12.07 59.96 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.437 ' HB2' HD23 ' A' ' 295' ' ' LEU . . . -87.17 142.11 28.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.819 0.342 . . . . 0.0 110.393 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 309' ' ' ILE . 1.3 tp -82.91 89.33 6.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 292' ' ' PHE . 88.2 m-20 -75.27 111.33 10.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 10.6 p -142.89 154.59 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.839 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -95.16 144.56 25.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.247 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -68.48 118.41 11.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 108.19 -2.37 33.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.62 150.88 20.66 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.6 m -97.63 124.09 50.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.418 0.628 . . . . 0.0 111.441 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.49 HD13 HD21 ' A' ' 301' ' ' LEU . 27.3 mt -88.51 132.38 33.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.479 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 23.2 m -81.32 107.22 13.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 284' ' ' LEU . 17.6 m -106.59 144.66 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.416 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 3.8 pp -93.78 -8.4 40.72 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.335 0.588 . . . . 0.0 110.25 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.72 171.69 13.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -139.57 13.85 2.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.096 0.474 . . . . 0.0 110.296 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -97.31 115.25 65.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.488 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.76 105.22 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.745 2.297 . . . . 0.0 112.152 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.97 8.13 45.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.653 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.27 107.22 0.34 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 41.05 71.4 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.833 0.825 . . . . 0.0 110.554 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -95.43 174.46 7.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -173.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 336' ' ' TYR . 0.4 OUTLIER -96.07 151.29 19.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.53 171.98 23.77 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.884 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.521 ' HB3' ' O ' ' A' ' 310' ' ' THR . 8.1 t60 -109.49 122.54 47.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.692 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.5 146.41 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 69.58 88.0 0.11 Allowed 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 123.509 0.505 . . . . 0.0 110.113 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.96 -26.77 38.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.985 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.8 t -115.36 104.02 11.38 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.577 ' C ' ' HD2' ' A' ' 329' ' ' ARG . 4.5 pp0? -97.3 167.81 10.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.879 0.371 . . . . 0.0 111.854 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ARG . . . . . 0.577 ' HD2' ' C ' ' A' ' 328' ' ' GLN . 3.4 mpt_? -128.95 105.94 8.55 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.424 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 79.58 -52.44 4.14 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.842 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 20.8 m -139.21 146.91 41.09 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.432 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 11.5 p-10 -88.73 -172.47 3.73 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.012 0.434 . . . . 0.0 111.174 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 333' ' ' ARG . 1.5 tpp180 -135.53 107.51 7.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 34.2 mm -107.07 128.15 62.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.129 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.77 155.6 23.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 321' ' ' LYS . 41.1 p90 -96.33 147.74 23.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.492 0.646 . . . . 0.0 111.002 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 338' ' ' PRO . 39.8 p90 -148.61 145.13 19.37 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.855 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 341' ' ' ILE . 9.4 Cg_exo -73.22 130.01 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.384 2.056 . . . . 0.0 110.606 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.19 -16.35 33.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.726 2.284 . . . . 0.0 112.859 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.63 -22.76 76.8 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.238 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 338' ' ' PRO . 38.6 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.325 0.562 . . . . 0.0 111.975 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.38 170.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.544 0.211 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -158.92 168.0 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.02 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.1 -31.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.915 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.3 -22.94 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.5 m -106.98 22.55 15.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 0.0 109.956 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -63.57 111.96 2.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.824 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 . . . . . 0 C--N 1.313 -0.991 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -177.432 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 37.4 p -155.07 138.31 15.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.842 0.353 . . . . 0.0 110.784 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 285' ' ' LYS . 57.0 tp -136.09 166.31 23.66 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.407 ' N ' ' HG ' ' A' ' 284' ' ' LEU . 21.7 pttm -131.9 141.62 49.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.075 0.464 . . . . 0.0 110.95 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.74 146.4 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.994 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -104.47 120.36 41.07 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.666 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 342' ' ' VAL . . . -73.44 124.8 26.5 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.441 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 289' ' ' LEU . 1.4 pt? -89.26 -9.93 48.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.21 0.529 . . . . 0.0 109.709 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -143.53 148.08 35.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.115 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 304' ' ' ARG . 24.0 m-20 -68.74 155.7 39.63 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.428 ' HB2' HG12 ' A' ' 303' ' ' VAL . 94.2 t80 -76.66 113.81 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.328 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -102.78 127.58 49.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -163.79 162.41 23.8 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.27 122.64 10.75 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -43.37 113.55 0.51 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.787 0.679 . . . . 0.0 112.738 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -158.94 135.91 6.79 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.26 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.7 -13.28 39.04 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.126 2.551 . . . . 0.0 114.736 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 34.2 p -95.82 9.12 41.57 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.212 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -75.38 152.54 38.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 tp -79.69 102.43 8.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -80.58 86.32 5.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 0.0 111.904 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 292' ' ' PHE . 7.3 p -107.53 137.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.382 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.478 ' HA ' ' OD1' ' A' ' 291' ' ' ASP . 19.1 ttp180 -98.9 147.96 24.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.55 115.13 3.37 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.25 37.84 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.042 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.2 173.16 8.57 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.81 143.98 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -175.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.403 HG12 HD13 ' A' ' 324' ' ' ILE . 81.4 mt -111.83 124.38 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.495 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 41.5 m -86.32 110.95 20.02 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.169 0.509 . . . . 0.0 110.784 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 33.9 m -107.17 148.53 11.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.996 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 4.5 tt -88.6 -52.88 4.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.12 131.02 53.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' GLN . . . . . 0.566 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 55.9 mt-30 -79.08 130.32 35.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.199 0.524 . . . . 0.0 111.804 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -138.85 70.15 43.18 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.857 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.07 81.92 1.63 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 111.733 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -144.93 -62.27 0.36 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.966 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -130.64 -160.55 10.03 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -69.15 101.65 1.5 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 117.39 0.595 . . . . 0.0 110.362 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.566 ' CZ3' ' HA ' ' A' ' 314' ' ' GLN . 1.0 OUTLIER -102.81 169.04 8.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.348 -177.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 25.5 pttm -93.85 152.13 19.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.528 0.68 . . . . 0.0 112.795 -174.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.51 39.63 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.732 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -108.8 122.64 47.58 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.193 0.497 . . . . 0.0 110.402 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.403 HD13 HG12 ' A' ' 309' ' ' ILE . 10.1 tp -103.02 156.64 5.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.902 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -46.88 142.88 3.17 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.595 0.56 . . . . 0.0 110.188 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.72 108.09 19.6 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.824 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 29.1 m -58.74 143.42 47.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.371 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -74.67 -18.24 60.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.295 0.569 . . . . 0.0 110.26 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -119.46 101.21 7.79 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 84.27 65.41 1.53 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.4 t -49.86 137.24 16.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.337 0.589 . . . . 0.0 111.673 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.17 171.49 8.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.324 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -148.58 -164.37 2.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.57 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.38 125.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.62 -179.8 17.64 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -104.13 147.68 27.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.892 0.377 . . . . 0.0 110.769 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.64 151.69 36.31 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.54 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.52 135.61 5.17 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.862 2.374 . . . . 0.0 111.642 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.485 ' HA ' HG22 ' A' ' 342' ' ' VAL . 30.5 Cg_endo -63.35 -3.5 5.26 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.964 2.443 . . . . 0.0 112.716 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -79.99 -19.6 69.66 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.852 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 37.8 pt -102.61 1.89 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.841 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 288' ' ' ALA . 27.6 m -112.41 150.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.468 0.652 . . . . 0.0 112.665 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.5 133.34 55.95 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.905 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.55 -31.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.807 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.87 -63.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.962 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.8 m -122.52 173.44 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.648 0.261 . . . . 0.0 111.687 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.66 82.58 0.18 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.666 0.786 . . . . 0.0 111.223 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.512 ' H ' ' NE ' ' A' ' 348' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 54.8 m -157.83 107.93 2.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.794 0.33 . . . . 0.0 110.309 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.45 161.09 18.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -126.26 133.99 51.3 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.723 0.297 . . . . 0.0 110.376 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.48 138.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.057 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -106.06 134.62 48.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.425 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.12 131.25 37.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.9 -29.82 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.803 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -127.73 147.56 50.4 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.54 147.0 53.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.762 0.315 . . . . 0.0 110.397 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.542 ' HB2' HG12 ' A' ' 303' ' ' VAL . 69.3 t80 -64.4 133.45 52.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.084 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -77.37 102.39 6.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -66.15 103.49 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.478 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.18 4.64 51.72 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.697 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 66.11 79.56 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.536 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -154.11 135.5 8.87 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.889 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.15 -23.61 66.62 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.044 2.496 . . . . 0.0 113.516 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.6 m -98.05 -1.85 41.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.366 0.603 . . . . 0.0 110.951 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.92 38.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.5 103.66 16.09 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.798 0.332 . . . . 0.0 111.154 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -78.88 123.39 27.19 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 292' ' ' PHE . 11.8 p -141.45 146.36 23.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.032 0.444 . . . . 0.0 111.064 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.497 ' HB3' ' OD2' ' A' ' 307' ' ' ASP . 17.2 ttm-85 -98.53 148.49 23.71 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.519 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.1 127.38 31.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 110.127 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.14 -13.15 48.85 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.682 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 304' ' ' ARG . 81.8 m-20 -87.17 153.97 21.09 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.144 0.472 . . . . 0.0 110.422 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 6.4 t -107.07 128.57 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 111.094 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 303' ' ' VAL . 4.1 mp -102.1 142.37 16.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.315 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 8.2 m -108.36 108.82 19.95 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.22 148.78 5.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.91 0.386 . . . . 0.0 111.17 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.79 -64.42 1.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.519 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.07 134.51 52.09 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -80.37 82.99 6.29 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.497 0.665 . . . . 0.0 110.54 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -70.53 131.78 87.89 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.052 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.79 -41.04 40.65 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.846 2.364 . . . . 0.0 113.483 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -139.66 174.9 10.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 111.116 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.16 -155.7 31.64 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.514 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.409 ' HB3' ' HB2' ' A' ' 336' ' ' TYR . 9.5 mpt_? -110.63 110.47 21.17 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -89.78 157.75 17.8 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.856 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.93 121.89 30.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.772 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -119.09 151.54 17.59 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.129 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.481 ' CE1' ' HB3' ' A' ' 332' ' ' ASP . 0.4 OUTLIER -112.37 121.39 44.73 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.193 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 332' ' ' ASP . 55.6 mt -109.35 137.23 42.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -154.37 112.35 3.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.463 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 329' ' ' ARG . 6.3 pt-20 -91.43 179.29 5.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -177.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 15.7 m -67.71 -59.84 3.01 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -62.36 -74.32 0.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.765 0.317 . . . . 0.0 111.479 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 326' ' ' GLU . 22.8 mmm180 -131.39 -135.39 0.2 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 65.97 66.27 2.49 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.638 -1.268 . . . . 0.0 111.938 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.8 p -56.29 154.78 7.65 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.445 0.164 . . . . 0.0 111.189 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 324' ' ' ILE . 9.9 m-20 -41.81 110.14 0.16 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -116.41 138.84 51.03 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.055 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.56 138.68 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 111.676 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -166.26 174.71 41.81 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 319' ' ' ARG . 22.4 p90 -99.99 149.07 23.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.363 0.582 . . . . 0.0 111.102 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -154.49 162.63 26.56 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.781 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.401 ' O ' HG12 ' A' ' 341' ' ' ILE . 4.0 Cg_endo -87.31 122.59 1.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.119 2.546 . . . . 0.0 112.456 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 342' ' ' VAL . 49.2 Cg_exo -56.2 -18.61 24.33 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.417 2.745 . . . . 0.0 112.82 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -62.84 -23.98 66.1 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.877 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.402 HG13 HG13 ' A' ' 342' ' ' VAL . 42.8 pt -99.06 4.63 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.542 0.671 . . . . 0.0 112.228 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 288' ' ' ALA . 33.2 m -129.22 165.74 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 112.011 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 345' ' ' VAL . 10.5 tp10 -149.79 148.13 28.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.074 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.96 -35.81 61.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.465 ' H ' ' HG3' ' A' ' 343' ' ' GLU . 18.0 t -89.4 146.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.3 t -69.98 95.77 0.97 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.15 0.5 . . . . 0.0 111.645 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt 64.13 30.42 13.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 113.0 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.491 ' C ' ' HD3' ' A' ' 348' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 112.109 -0.396 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 312' ' ' LEU . 50.7 m -148.72 158.99 44.54 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 285' ' ' LYS . 43.1 tp -146.35 166.61 25.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.778 0.323 . . . . 0.0 110.642 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LYS . . . . . 0.425 ' N ' ' HG ' ' A' ' 284' ' ' LEU . 60.1 pttt -123.12 135.88 54.55 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.74 137.78 55.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -102.75 130.54 49.74 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.731 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -86.04 119.58 26.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.874 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.48 -21.12 24.35 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 291' ' ' ASP . 9.7 tmtm? -123.71 146.08 48.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 290' ' ' LYS . 13.7 m-20 -72.83 122.21 21.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.05 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.453 ' HB3' ' H ' ' A' ' 303' ' ' VAL . 6.5 t80 -80.6 111.23 16.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -170.37 18.12 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.12 0.486 . . . . 0.0 109.883 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 -8.87 59.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.04 168.07 10.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -105.45 -24.65 12.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.521 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.37 131.91 23.28 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 111.737 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.3 3.36 5.84 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.04 3.16 . . . . 0.0 114.386 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.7 t -73.38 -12.85 60.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.241 0.543 . . . . 0.0 110.47 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -89.17 153.41 20.97 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.792 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 tt -79.78 114.66 18.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.987 0.422 . . . . 0.0 110.137 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -99.01 154.43 18.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.773 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.453 ' H ' ' HB3' ' A' ' 292' ' ' PHE . 7.5 p -156.05 146.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.432 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.416 HH21 ' CB ' ' A' ' 327' ' ' SER . 13.3 ttm180 -87.12 141.54 28.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.58 127.0 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.7 56.79 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.373 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -89.22 164.81 14.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.19 132.37 70.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.399 0.619 . . . . 0.0 111.589 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.49 128.98 49.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.332 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 26.2 m -85.47 110.26 19.05 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.924 0.392 . . . . 0.0 110.799 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.39 148.33 9.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 283' ' ' SER . 5.8 mp -87.37 -79.13 0.29 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.409 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -174.13 118.46 0.24 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.334 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 178.51 178.21 0.42 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.7 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -83.69 119.91 74.4 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.02 98.7 1.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.247 1.965 . . . . 0.0 111.667 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -140.25 119.22 12.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' A' ' 339' ' ' PRO . . . 76.26 -95.68 1.08 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.909 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -132.74 122.92 25.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.492 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -116.31 156.41 26.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.112 0.482 . . . . 0.0 111.936 -178.199 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 8.4 ttpm? -84.06 127.18 33.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.838 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -137.91 172.54 22.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.715 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -112.08 124.33 52.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.0 151.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.909 0.385 . . . . 0.0 110.82 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -92.21 114.49 27.05 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.429 ' HB3' HG22 ' A' ' 331' ' ' THR . 0.3 OUTLIER -69.06 152.38 45.28 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 327' ' ' SER . . . . . 0.416 ' CB ' HH21 ' A' ' 304' ' ' ARG . 49.4 m -78.41 -37.89 42.82 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.167 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 328' ' ' GLN . 6.7 tp60 -91.9 154.45 18.85 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.25 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -59.48 150.0 28.04 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 90.46 40.09 5.8 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 326' ' ' GLU . 72.4 p -69.41 149.2 48.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.123 -0.539 . . . . 0.0 111.997 -176.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -114.25 173.72 6.31 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -119.47 -12.47 9.34 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.947 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.418 HG23 ' HD2' ' A' ' 321' ' ' LYS . 65.2 mt -126.38 123.89 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -152.93 171.62 31.97 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.845 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -119.96 137.17 54.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.626 0.213 . . . . 0.0 110.674 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.8 159.08 41.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.956 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.458 ' O ' HG12 ' A' ' 341' ' ' ILE . 71.6 Cg_endo -81.61 125.81 5.1 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.712 2.274 . . . . 0.0 112.1 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 318' ' ' GLY . 29.7 Cg_endo -62.97 -12.37 29.23 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.151 2.567 . . . . 0.0 113.134 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.13 -19.72 68.36 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.541 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.463 HG13 HG13 ' A' ' 342' ' ' VAL . 43.7 pt -96.84 -1.5 10.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 117.338 0.569 . . . . 0.0 111.761 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.463 HG13 HG13 ' A' ' 341' ' ' ILE . 31.5 m -123.96 156.58 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.076 0.465 . . . . 0.0 111.823 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.53 153.7 47.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.23 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.14 -20.17 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.094 0.473 . . . . 0.0 110.499 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 346' ' ' SER . 10.7 t -110.17 169.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 345' ' ' VAL . 43.0 m -69.47 156.63 38.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.24 140.56 58.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 111.425 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 . . . . . 0 C--N 1.311 -1.107 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.002 177.381 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.188 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.4 p -155.46 125.24 6.49 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.859 0.362 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.38 -173.07 2.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.382 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -141.99 141.53 32.89 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.108 0.48 . . . . 0.0 111.306 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.25 142.23 40.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.083 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -102.58 128.13 49.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.901 0.382 . . . . 0.0 111.298 -177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.45 130.19 35.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.546 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.13 -11.96 34.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.876 0.37 . . . . 0.0 110.737 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 291' ' ' ASP . 2.0 tmtp? -145.69 146.58 31.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.49 ' N ' ' HD3' ' A' ' 290' ' ' LYS . 0.9 OUTLIER -62.29 122.77 16.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.754 0.312 . . . . 0.0 110.214 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -76.58 115.01 15.93 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.995 0.426 . . . . 0.0 110.968 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -75.06 92.29 2.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -60.15 149.28 33.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.889 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.77 -163.45 1.05 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.844 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' ' 297' ' ' ASP . 41.4 m170 -82.78 -173.65 4.78 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.134 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 296' ' ' HIS . 17.4 m-20 77.34 144.79 0.1 Allowed Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 123.707 0.629 . . . . 0.0 110.834 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.55 2.5 5.72 Favored 'Trans proline' 0 C--O 1.221 -0.338 0 C-N-CA 122.907 2.405 . . . . 0.0 112.566 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 5.0 p -101.52 3.41 40.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.872 0.367 . . . . 0.0 111.412 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -76.85 132.48 39.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.508 HD22 ' CD1' ' A' ' 337' ' ' PHE . 0.8 OUTLIER -82.41 151.7 26.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.323 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.469 ' O ' HG12 ' A' ' 324' ' ' ILE . 33.7 m-80 -128.6 123.57 33.67 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.66 149.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.6 0.238 . . . . 0.0 110.558 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -109.34 165.24 11.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.078 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.85 117.12 5.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.041 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.48 -11.58 39.34 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.663 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -88.47 159.36 18.0 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.346 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 12.1 m -117.14 132.25 67.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.448 0.642 . . . . 0.0 112.663 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.478 HG13 HD13 ' A' ' 324' ' ' ILE . 3.8 mp -97.81 138.68 21.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.527 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 46.9 m -87.31 110.27 20.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.896 0.379 . . . . 0.0 110.53 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 30.4 m -105.77 141.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.301 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.59 -75.97 0.39 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.1 96.46 2.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.52 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -150.62 176.42 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.72 158.06 76.46 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.409 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.567 ' O ' ' HG3' ' A' ' 339' ' ' PRO . 25.0 Cg_exo -64.32 -20.63 66.76 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.825 2.35 . . . . 0.0 113.121 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.02 109.09 2.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.568 0.699 . . . . 0.0 111.183 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 106.55 -99.59 1.5 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 339' ' ' PRO . 0.0 OUTLIER -156.26 147.86 22.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.664 0.269 . . . . 0.0 110.305 178.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.27 153.07 22.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.545 ' HG2' HG22 ' A' ' 334' ' ' ILE . 88.8 tttt -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.09 176.88 21.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.028 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -106.48 122.22 45.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.478 HD13 HG13 ' A' ' 309' ' ' ILE . 9.0 tp -110.31 152.68 12.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.681 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -77.36 103.04 7.06 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.424 ' HG2' HG23 ' A' ' 324' ' ' ILE . 6.9 mm-40 -103.02 148.7 25.37 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.813 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 45.6 m -88.83 -3.28 58.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.235 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -128.17 151.57 49.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.033 0.444 . . . . 0.0 112.043 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 168.49 9.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.389 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 104.77 -40.74 2.36 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 85.4 m -72.4 142.51 48.71 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.48 153.03 42.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.044 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.489 ' HG3' HG12 ' A' ' 334' ' ' ILE . 14.5 ptm180 -64.25 -25.66 68.16 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.439 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.545 HG22 ' HG2' ' A' ' 321' ' ' LYS . 5.7 mm -117.14 140.5 39.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.59 155.51 23.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.398 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.79 144.52 26.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 0.0 111.437 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.508 ' CD1' HD22 ' A' ' 301' ' ' LEU . 24.5 p90 -155.19 148.38 18.32 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 3.0 Cg_exo -75.86 133.74 15.66 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.02 2.48 . . . . 0.0 113.095 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' PRO . . . . . 0.567 ' HG3' ' O ' ' A' ' 316' ' ' PRO . 30.0 Cg_endo -61.7 -19.74 66.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.176 2.584 . . . . 0.0 112.641 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -61.2 -19.55 57.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.584 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 36.8 pt -111.66 4.49 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.354 0.577 . . . . 0.0 112.355 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 339' ' ' PRO . 27.5 m -129.41 153.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 112.003 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 345' ' ' VAL . 10.0 tp10 -148.33 150.94 34.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.16 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.57 -40.8 71.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.43 ' H ' ' HG3' ' A' ' 343' ' ' GLU . 26.0 t -96.05 -84.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.546 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 14.7 m -154.32 -179.92 8.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -73.23 -26.74 61.25 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.108 0.48 . . . . 0.0 110.579 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ARG . . . . . 0.599 ' HD3' ' O ' ' A' ' 348' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.335 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.376 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 48.2 m -102.33 115.46 30.62 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.028 0.442 . . . . 0.0 110.295 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.59 161.74 27.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.699 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -122.69 136.26 54.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 308' ' ' VAL . 19.3 m -115.16 148.83 17.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 345' ' ' VAL . 13.1 mmm180 -102.42 128.48 49.01 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.318 -176.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.57 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -89.63 120.77 31.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.68 -14.74 27.65 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.981 0.42 . . . . 0.0 110.107 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -134.12 157.57 45.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 142.97 33.01 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.995 0.426 . . . . 0.0 111.351 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 303' ' ' VAL . 41.5 t80 -121.76 113.26 19.44 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -161.3 136.31 7.47 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.16 131.79 56.81 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.115 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.09 8.47 4.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.278 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -133.95 133.12 41.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.134 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 8.6 t70 69.52 120.84 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.56 0.744 . . . . 0.0 111.448 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.73 1.94 8.0 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.119 2.546 . . . . 0.0 114.172 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -88.26 23.07 2.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.317 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.08 150.31 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.214 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.7 tp -83.04 114.36 21.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -88.32 109.8 20.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.809 0.337 . . . . 0.0 111.332 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' VAL . . . . . 0.594 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.8 p -142.64 134.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.085 0.469 . . . . 0.0 110.274 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -103.5 151.64 22.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.766 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.41 119.67 8.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.392 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.13 -11.49 31.55 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.971 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -95.06 171.32 8.82 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.641 0.257 . . . . 0.0 110.625 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 286' ' ' VAL . 15.4 m -122.03 135.77 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.7 mt -101.64 143.08 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 2.9 m -91.7 107.18 19.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.096 0.474 . . . . 0.0 110.293 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.9 m -108.53 149.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.574 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.627 ' HG ' ' H ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -89.44 -72.82 0.54 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.627 ' H ' ' HG ' ' A' ' 312' ' ' LEU . 13.3 pt-20 170.74 156.4 0.07 Allowed 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.095 0.958 . . . . 0.0 108.977 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' GLN . . . . . 0.505 ' OE1' ' HB3' ' A' ' 316' ' ' PRO . 35.5 tt0 -173.76 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.281 0.363 . . . . 0.0 111.265 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 48.4 m80 58.69 65.95 2.7 Favored Pre-proline 0 N--CA 1.469 0.512 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.532 ' HG3' ' CG ' ' A' ' 320' ' ' TRP . 64.9 Cg_endo -82.65 168.68 14.14 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.953 2.435 . . . . 0.0 114.088 -172.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.24 -7.88 31.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.943 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -164.71 -138.48 2.42 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.588 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 135.07 56.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.65 0.262 . . . . 0.0 111.046 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' TRP . . . . . 0.542 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 0.3 OUTLIER -132.72 179.07 6.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 33.5 mmtp -86.38 154.1 21.43 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.507 0.67 . . . . 0.0 112.488 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 334' ' ' ILE . . . -161.1 151.43 21.79 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.414 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -108.8 122.69 47.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 10.4 tp -118.97 142.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -101.05 75.88 1.7 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' GLU . . . . . 0.416 ' CD ' ' HG3' ' A' ' 333' ' ' ARG . 8.9 pt-20 -85.91 171.36 11.54 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.645 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 6.2 m -83.47 80.69 9.02 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.674 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 329' ' ' ARG . 4.4 tp60 -136.85 -170.3 2.66 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ARG . . . . . 0.419 ' H ' ' HG3' ' A' ' 328' ' ' GLN . 68.3 ttt180 -82.11 58.43 3.97 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 60.53 30.2 71.29 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 121.318 -0.468 . . . . 0.0 112.854 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 3.6 p -74.15 149.87 40.74 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.713 0.292 . . . . 0.0 111.205 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -61.06 -56.88 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.036 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.416 ' HG3' ' CD ' ' A' ' 326' ' ' GLU . 13.6 mmt180 63.01 89.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 322' ' ' GLY . 7.8 tt -133.77 117.44 26.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.095 173.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.66 -169.36 11.55 Favored Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.009 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 23.7 p90 -108.45 142.95 38.08 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.477 ' CE2' HG21 ' A' ' 342' ' ' VAL . 21.4 p90 -151.49 146.64 19.11 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.048 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 340' ' ' GLY . 93.8 Cg_endo -84.1 128.19 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.498 2.132 . . . . 0.0 112.725 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.65 18.99 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.426 2.751 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 338' ' ' PRO . . . -93.96 -19.33 34.22 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' ILE . . . . . 0.494 HG13 HG13 ' A' ' 342' ' ' VAL . 44.5 pt -108.87 -8.73 11.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.061 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 288' ' ' ALA . 25.0 m -131.81 150.02 33.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.175 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -161.54 167.7 24.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.67 100.95 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 109.941 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.648 ' O ' ' HG3' ' A' ' 287' ' ' ARG . 10.3 p -156.93 152.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.429 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.0 m -67.06 -56.07 11.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.927 0.394 . . . . 0.0 110.031 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -157.34 154.95 29.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.318 -0.783 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.77 176.62 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 285' ' ' LYS . 2.7 tm? -94.89 141.64 28.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -116.57 136.8 52.67 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.93 0.395 . . . . 0.0 110.964 -177.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 342' ' ' VAL . 16.9 m -132.4 154.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.463 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -102.55 141.78 34.8 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.419 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -82.73 110.94 18.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.87 -32.23 31.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.34 164.96 16.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.768 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.11 157.52 18.82 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.473 ' HB3' HG12 ' A' ' 303' ' ' VAL . 23.4 t80 -141.15 112.73 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -141.67 119.48 11.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.916 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.404 ' HB3' ' HB1' ' A' ' 300' ' ' ALA . 55.4 t30 -150.44 126.88 10.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.433 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.79 166.85 10.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 71.94 7.59 5.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.575 0.75 . . . . 0.0 111.042 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -127.71 114.98 20.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.82 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.89 -9.97 26.75 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.966 2.444 . . . . 0.0 113.624 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 22.0 p -107.16 8.04 29.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.179 0.514 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 294' ' ' ASN . . . -82.32 150.09 27.41 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.158 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 337' ' ' PHE . 20.7 tp -105.29 152.73 22.54 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.871 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -119.84 105.26 10.94 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' A' ' 292' ' ' PHE . 8.2 p -148.78 144.39 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.041 0.448 . . . . 0.0 111.255 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.467 ' HD3' ' N ' ' A' ' 305' ' ' ALA . 4.7 tmt_? -112.74 146.51 38.64 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.467 ' N ' ' HD3' ' A' ' 304' ' ' ARG . . . -52.09 125.6 16.08 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.84 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.82 -22.76 20.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.225 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -76.85 165.23 24.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 13.6 m -116.36 137.86 48.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.313 0.578 . . . . 0.0 111.6 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 303' ' ' VAL . 3.6 mp -116.7 132.95 64.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.831 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 6.5 m -98.32 107.25 19.67 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 284' ' ' LEU . 35.9 m -93.5 142.81 12.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.475 0.655 . . . . 0.0 112.071 -176.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 60.1 tp -87.88 -14.67 38.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.024 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -91.31 164.7 13.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.149 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -155.3 121.92 5.33 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.5 m80 58.42 75.52 0.52 Allowed Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.408 0.443 . . . . 0.0 110.129 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -95.03 -170.26 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.115 2.543 . . . . 0.0 112.767 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.19 104.98 5.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 92.85 -69.03 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.24 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -148.85 158.19 43.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.652 0.263 . . . . 0.0 110.493 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -137.03 167.98 20.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.505 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -104.73 137.94 41.77 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.93 26.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.957 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -114.79 130.89 56.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 41.6 mm -72.78 135.45 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.877 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 333' ' ' ARG . 53.2 mtt180 . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 120.621 0.248 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 47.6 mm -124.08 124.42 68.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.827 0.346 . . . . 0.0 110.815 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.1 21.05 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -102.27 136.83 41.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.863 0.363 . . . . 0.0 110.443 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.527 ' CD1' HD22 ' A' ' 301' ' ' LEU . 4.8 p90 -154.87 154.78 29.55 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.267 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.448 ' O ' HG12 ' A' ' 341' ' ' ILE . 73.8 Cg_endo -77.44 134.33 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.39 2.06 . . . . 0.0 112.176 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.85 -6.88 13.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.867 2.378 . . . . 0.0 112.311 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -74.52 -19.59 79.82 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.157 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.491 HG13 HG13 ' A' ' 342' ' ' VAL . 39.0 pt -99.58 2.91 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 117.254 0.527 . . . . 0.0 111.733 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.491 HG13 HG13 ' A' ' 341' ' ' ILE . 29.1 m -133.8 155.32 39.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 345' ' ' VAL . 11.5 tp10 -160.68 150.13 17.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.048 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.15 -28.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' A' ' 343' ' ' GLU . 20.4 m -77.05 168.41 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.853 0.359 . . . . 0.0 111.665 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 162.87 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.54 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -179.23 6.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? . . . . . 0 C--O 1.244 0.816 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.259 177.271 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 121.134 0.493 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.17 -176.88 3.06 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 7.4 ptpp? -143.7 134.22 24.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 111.36 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 31.3 m -118.55 156.67 20.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.112 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -102.74 134.87 45.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.6 115.52 18.36 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.169 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.403 ' HG ' ' OE2' ' A' ' 343' ' ' GLU . 4.2 mm? -87.77 -17.11 32.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.235 0.54 . . . . 0.0 110.137 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -140.75 147.26 38.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.42 134.44 39.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.499 ' HD2' ' O ' ' A' ' 301' ' ' LEU . 3.8 t80 -78.74 112.58 16.01 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -71.35 -31.96 67.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.54 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -79.83 78.76 6.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.06 -9.85 10.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.13 68.75 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.258 0.551 . . . . 0.0 110.223 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -179.76 126.15 0.24 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.16 -27.69 81.15 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.449 . . . . 0.0 113.531 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.89 -1.79 57.62 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.191 0.52 . . . . 0.0 111.105 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -102.28 150.78 22.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.539 HD22 ' CG ' ' A' ' 337' ' ' PHE . 3.9 tp -90.01 104.49 17.06 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.375 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -79.42 102.24 8.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.07 144.79 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.266 0.555 . . . . 0.0 111.592 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -104.4 147.29 27.72 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.279 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.51 124.44 20.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.385 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.03 40.89 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.928 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.54 158.07 19.61 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.22 139.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.171 0.51 . . . . 0.0 111.632 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 285' ' ' LYS . 20.5 mt -110.94 132.58 59.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.438 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 27.5 m -80.86 108.54 14.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.63 143.44 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 6.2 mp -81.89 -49.73 9.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.19 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -162.47 162.78 27.67 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.608 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.7 132.36 40.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 320' ' ' TRP . 9.8 m-70 -145.23 81.02 10.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.426 177.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.87 -0.8 10.91 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.897 2.398 . . . . 0.0 112.398 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -70.3 -21.97 62.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.225 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -180.0 -156.92 19.16 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 319' ' ' ARG . 6.2 ptt180 -65.34 110.72 2.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.088 0.471 . . . . 0.0 110.773 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.468 ' HD1' ' O ' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -85.13 175.5 8.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.477 ' HB2' HD11 ' A' ' 334' ' ' ILE . 12.2 ptmm? -119.03 142.1 48.13 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.107 0.48 . . . . 0.0 112.171 -175.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -159.72 171.25 36.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.778 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -109.14 129.52 55.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.915 0.388 . . . . 0.0 110.141 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.438 HG23 ' CE1' ' A' ' 325' ' ' HIS . 8.2 tp -119.61 149.42 22.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.355 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . 0.438 ' CE1' HG23 ' A' ' 324' ' ' ILE . 8.3 p-80 . . . . . 0 N--CA 1.486 1.339 0 C-N-CA 124.887 1.275 . . . . 0.0 114.144 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 334' ' ' ILE . 32.7 ptt180 . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 335' ' ' GLY . 0.0 OUTLIER -179.51 145.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.489 ' N ' HD13 ' A' ' 334' ' ' ILE . . . -138.21 175.79 21.15 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.634 -1.27 . . . . 0.0 113.197 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -111.07 146.12 37.32 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.539 ' CG ' HD22 ' A' ' 301' ' ' LEU . 4.4 p90 -154.01 151.07 23.87 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.003 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.454 ' O ' HG12 ' A' ' 341' ' ' ILE . 70.4 Cg_endo -77.32 127.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.49 2.127 . . . . 0.0 112.109 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.448 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.6 Cg_endo -61.86 -13.28 29.89 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.996 2.464 . . . . 0.0 112.636 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -70.62 -18.9 76.06 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.324 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 338' ' ' PRO . 42.4 pt -103.13 4.3 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 117.4 0.6 . . . . 0.0 111.714 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 288' ' ' ALA . 35.3 m -131.2 150.86 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.87 0.367 . . . . 0.0 111.099 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.403 ' OE2' ' HG ' ' A' ' 289' ' ' LEU . 46.7 mt-10 -137.91 145.38 42.03 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.95 -30.47 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.7 p -83.37 143.31 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 63.7 m -76.94 146.43 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.643 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.68 129.28 34.65 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 . . . . . 0 C--N 1.315 -0.919 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.382 179.302 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 285' ' ' LYS . 2.2 tm? -124.14 141.12 52.32 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.698 -0.401 . . . . 0.0 109.98 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 284' ' ' LEU . 58.9 mtpt -124.69 134.4 52.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.53 142.3 29.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 308' ' ' VAL . 58.4 mtp180 -103.8 132.9 49.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -84.87 125.7 32.85 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.806 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.0 -13.76 30.49 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.052 0.453 . . . . 0.0 110.836 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 291' ' ' ASP . 14.2 tmtt? -132.55 146.47 51.94 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.464 ' N ' ' HD3' ' A' ' 290' ' ' LYS . 11.4 m-20 -73.74 120.55 19.49 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.379 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.451 ' HB3' HG12 ' A' ' 303' ' ' VAL . 3.1 t80 -103.06 113.89 27.74 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -141.53 149.64 41.11 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.511 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -139.62 147.07 40.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.602 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 37.7 tp -75.88 -44.65 39.56 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -161.37 90.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.614 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 15.3 t70 -138.46 126.68 13.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 297' ' ' ASP . 15.9 Cg_exo -68.08 -15.82 43.77 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.047 2.498 . . . . 0.0 114.234 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 20.9 p -113.81 -32.38 6.13 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.52 131.23 48.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.367 0.603 . . . . 0.0 112.53 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.402 HD11 ' HB ' ' A' ' 324' ' ' ILE . 24.0 tp -83.05 153.99 24.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.092 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -110.2 108.13 18.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.451 HG12 ' HB3' ' A' ' 292' ' ' PHE . 8.2 p -146.02 136.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 111.42 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.448 ' HG3' ' HB2' ' A' ' 307' ' ' ASP . 32.9 ptt180 -88.86 152.84 21.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.87 25.61 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.805 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 100.42 -9.17 58.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.023 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.448 ' HB2' ' HG3' ' A' ' 304' ' ' ARG . 1.2 t70 -84.46 164.0 19.1 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.684 0.278 . . . . 0.0 110.528 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.468 HG12 ' HG2' ' A' ' 287' ' ' ARG . 15.8 m -111.2 128.38 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.574 0.702 . . . . 0.0 112.301 -177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 337' ' ' PHE . 49.0 mt -97.82 130.4 46.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 7.0 m -93.63 108.08 19.85 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 18.0 m -105.46 148.31 10.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 312' ' ' LEU . 5.6 mp -64.35 -77.81 0.05 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 312' ' ' LEU . 0.1 OUTLIER 167.49 134.99 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.486 1.114 . . . . 0.0 108.321 175.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 178.79 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.771 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 16.3 m80 52.85 71.49 1.43 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.253 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.64 173.98 9.05 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.729 2.286 . . . . 0.0 111.316 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.57 125.14 45.1 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 100.69 -32.68 7.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.367 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -151.65 137.52 18.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.875 0.369 . . . . 0.0 111.073 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 56.1 m95 -110.52 159.03 17.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.406 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -136.48 122.23 19.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.89 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -152.86 175.02 31.55 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.472 -1.346 . . . . 0.0 113.898 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 333' ' ' ARG . 53.5 m80 -107.12 128.27 54.25 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.402 ' HB ' HD11 ' A' ' 301' ' ' LEU . 10.2 tp -111.91 155.54 13.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.563 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 . . . . . 0 CA--C 1.533 0.312 0 O-C-N 123.455 0.472 . . . . 0.0 110.758 177.585 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 65.4 mtt180 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 120.775 0.321 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 31.3 mm -113.26 121.35 65.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.055 0.455 . . . . 0.0 110.772 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.89 149.69 20.77 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.551 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 67.5 m-85 -107.64 139.15 42.62 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.461 ' CD2' HG11 ' A' ' 342' ' ' VAL . 17.0 p90 -140.93 147.19 47.02 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.632 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 4.8 Cg_exo -75.79 130.85 12.83 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.893 2.395 . . . . 0.0 111.979 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.2 Cg_endo -59.59 -16.57 37.1 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.366 2.711 . . . . 0.0 112.921 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.57 76.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.541 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 41.2 pt -107.99 1.18 9.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 117.386 0.593 . . . . 0.0 112.048 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 339' ' ' PRO . 35.4 m -124.11 150.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.421 . . . . 0.0 111.362 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -146.98 170.27 17.45 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.326 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.83 -167.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.22 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 37.2 t -67.78 -34.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 54.7 m -70.0 95.07 0.91 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 110.907 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -100.27 136.96 39.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.694 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--O 1.24 0.559 0 CA-C-O 118.651 -0.69 . . . . 0.0 109.801 177.827 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 120.914 0.388 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -122.71 175.4 6.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.651 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -144.36 133.81 23.29 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.81 168.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.531 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -124.34 134.48 53.15 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.05 137.04 38.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.242 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 343' ' ' GLU . 4.6 mm? -87.06 -28.8 22.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.517 176.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -129.16 146.76 51.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.929 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 304' ' ' ARG . 0.1 OUTLIER -71.87 138.06 47.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.851 178.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -101.92 110.5 22.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -151.32 119.62 6.37 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -151.4 -43.57 0.11 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.325 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 14.6 mt -150.83 134.03 16.12 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.519 ' HA ' ' OD1' ' A' ' 302' ' ' ASN . 38.7 m80 -84.19 84.44 7.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.81 146.89 28.01 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.245 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.88 -8.32 4.4 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.073 2.515 . . . . 0.0 113.668 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 8.1 t -87.59 -11.82 47.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.013 0.435 . . . . 0.0 110.369 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -121.76 150.56 41.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 337' ' ' PHE . 31.3 tp -88.51 104.03 16.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.576 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 296' ' ' HIS . 29.1 m-80 -84.05 94.09 8.24 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.303 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.46 146.1 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.753 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 291' ' ' ASP . 77.5 mtm180 -108.73 161.29 15.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.77 128.03 34.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.675 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 98.28 -13.3 63.2 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.827 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -80.89 161.17 24.49 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 120.688 0.28 . . . . 0.0 110.659 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 26.5 m -98.03 144.71 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.202 0.525 . . . . 0.0 111.678 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.407 HD13 HD21 ' A' ' 301' ' ' LEU . 42.9 mt -128.99 129.49 68.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.752 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 23.5 m -86.69 108.82 18.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 10.6 t -90.79 148.15 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.92 -56.05 13.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.804 0.335 . . . . 0.0 110.222 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -176.68 144.63 0.5 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.431 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . 0.508 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 23.9 pt20 -92.29 79.27 5.05 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.743 0.782 . . . . 0.0 110.626 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 316' ' ' PRO . 1.4 t-80 -136.74 -53.73 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.217 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 315' ' ' HIS . 2.0 Cg_endo -83.48 101.03 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.18 1.92 . . . . 0.0 110.501 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.53 146.57 48.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.824 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 126.8 -158.65 20.88 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 319' ' ' ARG . 33.2 ptt180 -80.65 98.62 7.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 0.0 109.575 177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.511 ' CZ2' ' HB3' ' A' ' 339' ' ' PRO . 0.2 OUTLIER -89.4 158.91 17.57 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.908 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -85.91 127.8 34.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.255 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -126.05 154.16 18.74 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.971 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -119.72 139.43 52.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 37.2 mt -106.94 139.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.155 0.502 . . . . 0.0 110.97 -177.858 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.211 0.529 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 19.5 mm -128.06 111.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.304 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -144.35 159.09 27.68 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.555 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 5.4 p90 -104.03 137.71 41.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 301' ' ' LEU . 20.2 p90 -147.81 155.08 44.58 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.278 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.405 ' O ' HG12 ' A' ' 341' ' ' ILE . 98.3 Cg_endo -84.01 134.59 6.18 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.544 2.162 . . . . 0.0 111.379 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.511 ' HB3' ' CZ2' ' A' ' 320' ' ' TRP . 11.1 Cg_endo -54.94 -19.96 21.32 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.2 2.6 . . . . 0.0 113.202 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -60.92 -20.27 57.3 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 114.258 0.463 . . . . 0.0 114.258 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.469 HG13 HG13 ' A' ' 342' ' ' VAL . 43.1 pt -100.55 4.84 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.605 0.703 . . . . 0.0 112.259 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 341' ' ' ILE . 31.9 m -132.77 164.19 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.096 0.474 . . . . 0.0 111.596 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.485 ' HB2' HD21 ' A' ' 289' ' ' LEU . 0.4 OUTLIER -135.06 149.57 50.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.07 -33.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.1 p -158.25 -20.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 74.0 m -80.24 14.93 1.72 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.981 -0.449 . . . . 0.0 111.981 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 348' ' ' ARG . 8.6 tmtt? -88.67 127.36 35.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . 0.539 ' N ' ' HD3' ' A' ' 347' ' ' LYS . 40.5 ttm180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.683 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.444 -0.742 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 60.0 tp -128.64 148.64 50.82 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -124.82 135.48 52.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.016 0.436 . . . . 0.0 111.266 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.465 HG11 ' CH2' ' A' ' 320' ' ' TRP . 16.0 m -125.11 146.68 30.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.898 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -103.07 139.5 38.52 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.86 119.67 23.06 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.076 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.93 -26.87 17.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.413 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -127.31 146.89 50.29 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.83 122.31 25.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -103.49 113.02 26.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.417 ' HE1' HD23 ' A' ' 295' ' ' LEU . 19.8 t-105 -115.55 104.72 12.01 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.956 0.408 . . . . 0.0 111.469 -173.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -130.69 106.25 8.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.417 HD23 ' HE1' ' A' ' 293' ' ' TRP . 2.1 pp -107.24 -1.01 22.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.178 0.513 . . . . 0.0 110.703 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.57 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.25 113.6 23.67 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.685 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.13 -0.48 9.17 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.621 2.214 . . . . 0.0 111.978 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 3.4 m -85.26 -16.84 38.83 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.48 0.657 . . . . 0.0 109.564 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -91.94 144.7 25.2 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.379 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.71 110.9 18.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.051 0.453 . . . . 0.0 111.166 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -101.06 121.62 42.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.96 152.34 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.939 0.4 . . . . 0.0 111.253 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.554 ' HB2' ' OD2' ' A' ' 307' ' ' ASP . 61.2 mtm180 -101.74 146.58 27.57 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.28 125.51 23.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.758 0.313 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.33 -16.06 29.79 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.699 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.554 ' OD2' ' HB2' ' A' ' 304' ' ' ARG . 33.4 m-20 -84.29 156.55 21.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.53 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 8.9 t -112.14 135.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.353 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 20.8 mt -114.7 134.05 58.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.952 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 39.7 m -104.19 120.09 40.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.043 0.449 . . . . 0.0 110.711 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 31.3 m -105.24 146.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.133 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 80.0 mt -83.27 -60.12 2.25 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.312 0.577 . . . . 0.0 109.795 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -114.09 114.21 25.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.065 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 141.93 43.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 320' ' ' TRP . 66.8 m-70 -139.95 89.47 11.3 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.22 -9.21 25.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.874 2.382 . . . . 0.0 113.318 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -123.41 117.8 26.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.3 -102.41 1.82 Allowed Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.964 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -153.62 158.0 40.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.465 ' CH2' HG11 ' A' ' 286' ' ' VAL . 0.1 OUTLIER -148.76 170.69 17.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 178.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 24.9 pttm -128.25 144.56 51.14 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.439 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.1 34.51 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.997 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 333' ' ' ARG . 3.9 p-80 -114.26 133.83 55.36 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 47.2 mt -80.93 150.96 4.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.407 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 . . . . . 0 CA--C 1.508 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.44 177.628 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 30.3 tpt180 . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 14.1 mm -153.77 116.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -137.35 151.49 21.15 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.439 -1.363 . . . . 0.0 112.563 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -89.14 146.33 24.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -158.38 158.48 29.7 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.896 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 341' ' ' ILE . 78.2 Cg_endo -82.39 132.97 7.15 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.334 2.023 . . . . 0.0 111.942 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.8 -14.83 19.12 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.249 2.633 . . . . 0.0 113.116 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -67.9 -19.86 71.99 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.861 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.492 HG13 HG13 ' A' ' 342' ' ' VAL . 39.5 pt -94.28 -8.15 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 117.599 0.699 . . . . 0.0 111.835 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 341' ' ' ILE . 28.8 m -123.05 170.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.974 0.416 . . . . 0.0 111.083 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 346' ' ' SER . 6.9 tp10 -157.12 151.19 24.8 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.3 -67.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 73.7 t -104.03 -41.19 6.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.488 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 35.2 m -60.05 133.96 56.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -177.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -99.15 158.23 15.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.794 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.908 179.308 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.433 0.635 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.59 173.09 7.39 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.147 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -146.31 143.16 28.95 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.266 0.555 . . . . 0.0 112.181 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.19 164.04 34.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.86 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . 0.484 ' HG2' HG12 ' A' ' 308' ' ' VAL . 74.9 mtp180 -113.64 144.58 42.67 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.131 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.5 118.28 23.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.751 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 -5.96 48.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.29 0.567 . . . . 0.0 110.426 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -138.85 146.49 41.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -80.12 121.92 26.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.663 0.268 . . . . 0.0 110.634 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.55 ' CE1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.83 53.69 1.76 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.511 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.55 ' HB2' ' CE1' ' A' ' 292' ' ' PHE . 50.4 t-20 -66.82 -61.35 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.497 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 13.9 tp -160.48 165.06 31.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -97.38 20.46 11.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.905 0.383 . . . . 0.0 111.936 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.47 153.54 41.36 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.017 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.86 -19.42 65.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.887 2.392 . . . . 0.0 112.829 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.4 m -81.25 -14.99 56.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 110.698 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -109.55 137.65 47.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.963 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.476 HD11 ' CG1' ' A' ' 324' ' ' ILE . 31.4 tp -86.59 111.24 20.44 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.082 0.467 . . . . 0.0 110.978 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.14 102.68 12.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.17 148.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.416 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -96.05 149.25 21.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.78 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.43 27.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.743 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.42 -19.36 26.75 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.382 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -76.98 155.88 32.31 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 116.904 0.352 . . . . 0.0 111.146 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.484 HG12 ' HG2' ' A' ' 287' ' ' ARG . 34.4 m -101.77 134.13 43.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.344 0.592 . . . . 0.0 111.429 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.453 HG12 ' CD1' ' A' ' 324' ' ' ILE . 56.3 mt -109.24 116.85 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 22.4 m -91.2 114.84 27.47 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.2 142.09 17.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.67 -66.73 0.57 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 313' ' ' GLU . 11.0 pt-20 -178.71 113.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.439 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -158.64 132.49 7.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -64.0 116.94 31.2 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 97.32 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.537 2.158 . . . . 0.0 113.035 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -150.57 129.2 12.28 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.503 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.24 -87.5 0.49 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -151.03 132.03 14.27 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.403 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -125.59 166.3 16.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.663 -175.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -89.16 140.07 29.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 111.886 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.96 156.23 26.33 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.371 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -111.2 121.08 44.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.933 0.397 . . . . 0.0 110.148 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.476 ' CG1' HD11 ' A' ' 301' ' ' LEU . 35.3 mm -85.9 121.75 37.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.438 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 C--N 1.311 -1.086 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.457 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 . . . . . 0 C--O 1.224 -0.271 0 CA-C-O 120.543 0.211 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 15.8 tt -101.44 140.25 20.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.847 0.356 . . . . 0.0 110.337 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.05 179.26 35.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -110.9 143.98 40.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.693 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 301' ' ' LEU . 9.5 p90 -149.14 156.51 40.17 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.115 -177.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.438 ' O ' HG12 ' A' ' 341' ' ' ILE . 3.5 Cg_exo -81.72 131.04 7.03 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.822 2.348 . . . . 0.0 111.363 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.0 Cg_endo -60.17 -15.79 36.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.862 2.375 . . . . 0.0 112.789 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.38 -19.55 74.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.594 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.463 HG13 HG13 ' A' ' 342' ' ' VAL . 41.1 pt -100.25 1.7 10.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.539 0.669 . . . . 0.0 111.803 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.463 HG13 HG13 ' A' ' 341' ' ' ILE . 33.5 m -128.18 164.5 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.182 0.515 . . . . 0.0 111.581 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.428 ' HG2' ' OG ' ' A' ' 346' ' ' SER . 8.6 tp10 -160.35 151.83 19.59 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.465 HG13 HG12 ' A' ' 345' ' ' VAL . 7.2 p -66.54 -40.92 87.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.465 HG12 HG13 ' A' ' 344' ' ' VAL . 7.9 p -157.09 122.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.411 . . . . 0.0 110.752 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 343' ' ' GLU . 49.6 m -163.96 -23.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.22 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -64.56 121.09 13.62 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.653 -0.689 . . . . 0.0 109.657 179.489 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 311' ' ' VAL . 30.5 p . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 120.886 0.374 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 311' ' ' VAL . 24.6 tp -144.39 157.48 44.23 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.24 133.44 56.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.789 0.328 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.98 152.08 36.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -105.41 137.43 43.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.696 0.284 . . . . 0.0 110.518 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -82.1 110.89 17.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.028 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 47.0 mt -78.66 -26.31 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.198 0.523 . . . . 0.0 110.089 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -132.67 162.79 30.48 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.42 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.568 ' OD2' ' HD2' ' A' ' 304' ' ' ARG . 10.0 m-20 -78.44 151.97 32.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.725 0.298 . . . . 0.0 110.206 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.558 ' HB3' HG12 ' A' ' 303' ' ' VAL . 32.4 t80 -140.69 113.48 8.24 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -144.72 102.32 3.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -108.95 129.04 55.43 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 295' ' ' LEU . 1.8 pt? -111.58 7.78 20.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.836 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -92.2 -41.04 10.66 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.049 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 300' ' ' ALA . 29.5 m-20 -101.97 122.05 48.55 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.085 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.8 -28.55 59.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.318 2.012 . . . . 0.0 111.612 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 7.3 t -83.95 -3.04 57.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.737 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 297' ' ' ASP . . . -70.28 150.21 46.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.618 0.247 . . . . 0.0 110.501 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.563 HD22 ' CD1' ' A' ' 337' ' ' PHE . 15.7 tp -82.51 153.67 25.45 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.059 0.457 . . . . 0.0 110.77 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.434 ' N ' ' HG ' ' A' ' 301' ' ' LEU . 23.4 p-10 -128.15 119.64 25.7 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.558 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.7 p -144.4 146.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.048 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.568 ' HD2' ' OD2' ' A' ' 291' ' ' ASP . 10.3 tpt180 -96.55 142.3 28.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.1 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.37 122.11 12.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.733 0.301 . . . . 0.0 110.335 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.17 40.16 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.72 -0.753 . . . . 0.0 113.028 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.2 169.56 12.95 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.151 0.475 . . . . 0.0 110.151 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.13 128.72 72.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.353 0.597 . . . . 0.0 111.583 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.529 HG12 HD13 ' A' ' 324' ' ' ILE . 68.2 mt -99.3 129.05 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.993 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.8 m -98.0 108.6 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 283' ' ' SER . 19.5 m -93.06 140.13 16.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 120.842 0.353 . . . . 0.0 110.603 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 312' ' ' LEU . 2.6 pt? -82.18 -12.72 57.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.574 0.702 . . . . 0.0 109.46 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -159.33 143.99 15.44 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.582 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.28 -33.09 69.44 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.011 0.195 . . . . 0.0 110.98 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.4 m80 67.77 157.38 0.14 Allowed Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.814 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.35 137.92 63.19 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.001 1.8 . . . . 0.0 110.216 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.24 118.77 7.86 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.768 0.794 . . . . 0.0 111.035 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 161.51 -43.9 0.39 Allowed Glycine 0 C--N 1.31 -0.908 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.608 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -157.57 123.91 4.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 110.043 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 339' ' ' PRO . 45.0 m95 -94.67 174.34 7.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.566 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.505 ' HG2' HD11 ' A' ' 334' ' ' ILE . 86.4 tttt -156.61 114.13 3.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -145.33 176.68 24.21 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.453 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 333' ' ' ARG . 46.8 m80 -107.17 136.94 46.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.529 HD13 HG12 ' A' ' 309' ' ' ILE . 11.0 tp -130.67 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.643 0.259 . . . . 0.0 110.629 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--O 1.236 0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.335 178.281 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 57.2 ttp85 . . . . . 0 N--CA 1.444 -0.742 0 CA-C-O 120.901 0.381 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.505 HD11 ' HG2' ' A' ' 321' ' ' LYS . 9.1 tp -94.82 140.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.52 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.41 159.1 30.54 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.602 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 321' ' ' LYS . 36.3 p90 -101.75 151.78 21.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.818 0.309 . . . . 0.0 110.314 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.563 ' CD1' HD22 ' A' ' 301' ' ' LEU . 16.7 p90 -153.71 151.08 24.38 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 341' ' ' ILE . 62.3 Cg_endo -75.29 133.43 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.714 2.276 . . . . 0.0 112.131 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 320' ' ' TRP . 20.7 Cg_endo -61.4 -17.57 54.18 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.218 2.612 . . . . 0.0 113.023 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -63.89 -19.18 62.99 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.655 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 338' ' ' PRO . 45.6 pt -107.96 6.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 339' ' ' PRO . 28.3 m -132.26 161.45 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 111.78 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -160.46 161.97 33.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 -24.53 35.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.58 -178.59 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.095 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.2 m -71.54 161.01 31.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -64.24 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.011 0.434 . . . . 0.0 110.736 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.485 178.867 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.07 167.93 10.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.432 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -129.89 141.49 50.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.02 144.67 31.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.636 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . 0.428 ' HG2' HG12 ' A' ' 308' ' ' VAL . 58.2 mtt85 -102.34 129.46 48.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.05 117.78 24.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.817 0.341 . . . . 0.0 111.159 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.97 -23.32 20.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.237 0.542 . . . . 0.0 109.563 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 341' ' ' ILE . 57.9 tptt -117.81 146.35 43.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.54 135.57 36.12 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.328 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.478 ' HD2' ' O ' ' A' ' 301' ' ' LEU . 35.6 t80 -99.25 112.62 24.75 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.36 167.29 21.94 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.453 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -74.82 133.63 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.255 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.42 177.6 4.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.822 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.53 45.09 0.94 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.71 138.21 6.15 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.67 -18.75 42.23 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.268 2.645 . . . . 0.0 113.85 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 2.7 m -80.45 1.14 30.47 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.169 0.509 . . . . 0.0 110.861 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.11 124.5 23.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.478 ' O ' ' HD2' ' A' ' 292' ' ' PHE . 21.2 tp -88.84 87.45 7.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.561 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -74.63 97.58 3.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.674 . . . . 0.0 111.116 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.45 HG21 HD11 ' A' ' 309' ' ' ILE . 13.0 p -123.55 139.83 48.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.868 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 307' ' ' ASP . 51.4 mtm180 -99.61 157.05 16.73 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -178.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.96 121.67 13.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.746 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.87 26.87 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.297 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 304' ' ' ARG . 26.7 m-20 -85.63 162.75 18.68 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 122.503 -0.41 . . . . 0.0 110.52 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.428 HG12 ' HG2' ' A' ' 287' ' ' ARG . 30.2 m -114.57 145.2 20.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.292 0.568 . . . . 0.0 112.208 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 303' ' ' VAL . 4.4 mp -118.02 130.75 72.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.84 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 85.7 m -96.99 120.55 37.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.061 0.458 . . . . 0.0 110.761 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.18 146.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.559 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.38 -78.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.702 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -164.62 98.91 0.79 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.438 0.637 . . . . 0.0 110.792 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -164.62 153.73 13.13 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.335 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 316' ' ' PRO . 9.3 m170 -90.63 144.19 30.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 315' ' ' HIS . 6.4 Cg_exo -75.1 49.45 2.29 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.162 2.575 . . . . 0.0 112.661 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -101.9 45.12 0.98 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.112 0.482 . . . . 0.0 110.726 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 149.43 170.01 16.5 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.437 ' H ' ' HD3' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -62.8 134.79 56.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.588 0.694 . . . . 0.0 109.606 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.41 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -139.63 -179.64 6.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 -176.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -123.1 145.06 48.9 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -133.47 166.21 23.9 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.358 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -109.94 122.39 47.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.24 137.39 31.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.379 0.609 . . . . 0.0 112.138 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.0 p80 . . . . . 0 C--N 1.317 -0.806 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.981 175.41 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.763 0.316 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 13.7 tt -124.83 130.93 73.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.61 33.75 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.546 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -88.88 146.69 24.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.664 0.269 . . . . 0.0 111.279 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.69 152.66 18.18 Favored Pre-proline 0 C--O 1.242 0.679 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.489 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.584 ' O ' HG12 ' A' ' 341' ' ' ILE . 72.3 Cg_endo -79.46 133.64 10.74 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.53 2.153 . . . . 0.0 111.72 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.81 -14.92 45.92 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.821 2.347 . . . . 0.0 112.734 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -72.34 -18.8 78.44 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 116.099 -0.5 . . . . 0.0 113.574 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 338' ' ' PRO . 46.9 pt -93.51 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.471 0.635 . . . . 0.0 111.501 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.418 HG13 HG13 ' A' ' 341' ' ' ILE . 35.6 m -120.87 163.45 18.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -146.55 146.24 30.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.725 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.39 -35.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.426 HG11 ' NE ' ' A' ' 348' ' ' ARG . 17.5 t -72.65 158.55 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 30.7 m -72.75 102.77 3.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.656 0.265 . . . . 0.0 111.447 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt 45.39 37.96 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.443 1.097 . . . . 0.0 113.8 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . 0.426 ' NE ' HG11 ' A' ' 345' ' ' VAL . 38.6 ttm180 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.375 -0.822 . . . . 0.0 109.916 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.87 159.2 21.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -131.61 136.2 47.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 25.0 m -115.54 142.41 28.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -101.6 132.71 47.11 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.344 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -80.34 117.53 21.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.56 -21.91 22.64 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -126.32 147.7 49.68 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.679 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.84 153.78 28.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.111 0.482 . . . . 0.0 111.38 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.555 ' HB3' HG12 ' A' ' 303' ' ' VAL . 40.3 t80 -135.65 110.72 8.89 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -174.52 133.85 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -124.13 161.74 25.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 295' ' ' LEU . 2.5 pt? -77.26 -8.74 58.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.64 0.734 . . . . 0.0 109.229 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -126.71 -156.75 0.76 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.538 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 6.4 m-20 66.44 91.61 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 123.327 0.392 . . . . 0.0 111.287 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.86 -15.74 26.4 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.445 2.097 . . . . 0.0 112.842 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.6 m -105.67 7.48 32.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 110.886 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 297' ' ' ASP . . . -72.38 139.89 48.11 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.451 ' O ' ' HD2' ' A' ' 292' ' ' PHE . 21.0 tp -84.36 91.21 7.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.49 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.97 106.17 1.51 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.249 0.547 . . . . 0.0 111.344 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 292' ' ' PHE . 12.8 p -134.84 135.16 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.563 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.431 ' HB3' ' OD2' ' A' ' 307' ' ' ASP . 37.6 ttp180 -97.01 147.4 24.04 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.959 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.58 125.79 25.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.086 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.41 -18.15 25.56 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.611 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 304' ' ' ARG . 18.0 m-20 -86.19 165.29 16.65 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.842 0.353 . . . . 0.0 110.565 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.55 134.94 59.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.17 128.08 53.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.3 m -83.22 108.75 16.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.88 0.372 . . . . 0.0 110.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.78 127.07 62.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.398 0.618 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 312' ' ' LEU . 2.2 pp -86.41 -9.77 55.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.506 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 117.97 6.7 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -76.97 101.4 5.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.728 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -123.01 84.4 50.8 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.45 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 -2.0 12.14 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 114.236 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -108.12 106.87 17.28 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.479 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 93.79 173.12 39.46 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.779 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -68.46 128.87 38.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 109.897 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.416 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -126.3 162.19 26.06 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.537 -176.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -98.69 136.87 38.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.277 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -139.8 171.85 23.63 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.154 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -109.14 128.14 54.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.954 0.407 . . . . 0.0 111.151 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 11.4 tp -124.42 154.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 54.8 t60 . . . . . 0 CA--C 1.54 0.581 0 O-C-N 123.5 0.5 . . . . 0.0 110.417 178.758 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 . . . . . 0 N--CA 1.445 -0.681 0 CA-C-O 121.299 0.571 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 39.8 mm -106.82 129.69 60.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.547 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -140.0 159.94 26.14 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.025 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -97.2 140.76 31.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.882 0.372 . . . . 0.0 110.243 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.458 ' HE2' HG21 ' A' ' 342' ' ' VAL . 5.9 p90 -148.78 160.56 35.37 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.259 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.484 ' O ' HG12 ' A' ' 341' ' ' ILE . 4.0 Cg_endo -87.11 132.91 3.29 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.763 2.309 . . . . 0.0 112.135 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.81 -14.07 34.34 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.133 2.555 . . . . 0.0 112.472 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.48 -18.84 68.22 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.498 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.485 HG13 HG13 ' A' ' 342' ' ' VAL . 49.2 pt -101.98 -4.49 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.485 HG13 HG13 ' A' ' 341' ' ' ILE . 27.6 m -126.83 150.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.856 0.36 . . . . 0.0 111.52 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -143.18 146.55 33.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.674 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.41 -34.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.727 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.42 -37.05 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.502 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.2 m -109.24 86.41 2.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.094 0.474 . . . . 0.0 110.204 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 347' ' ' LYS . 14.6 tmtt? -85.89 94.58 9.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.217 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.955 177.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 121.091 0.472 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.443 ' HB2' HG23 ' A' ' 311' ' ' VAL . 73.1 mt -105.6 179.86 4.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.174 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 25.4 pttm -153.05 145.01 23.69 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.287 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.9 m -128.88 157.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.832 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -102.42 127.99 49.22 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.906 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -81.61 128.68 34.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.89 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.25 -9.8 26.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.581 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . 0.473 ' HB3' ' HB ' ' A' ' 341' ' ' ILE . 54.6 tptt -133.62 147.3 51.47 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -80.25 122.41 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 302' ' ' ASN . 0.6 OUTLIER -104.94 111.38 24.13 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -162.36 -2.96 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.74 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -56.81 -44.38 81.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.147 0.498 . . . . 0.0 109.689 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 300' ' ' ALA . 26.4 tp -89.44 120.59 30.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -94.87 0.8 55.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.2 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 2.6 m-20 -66.24 139.34 96.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 297' ' ' ASP . 52.1 Cg_exo -56.32 -21.24 35.69 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.127 2.551 . . . . 0.0 113.293 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.4 t -78.03 -12.07 59.96 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.437 ' HB2' HD23 ' A' ' 295' ' ' LEU . . . -87.17 142.11 28.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.819 0.342 . . . . 0.0 110.393 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 309' ' ' ILE . 1.3 tp -82.91 89.33 6.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 292' ' ' PHE . 14.5 m120 -75.27 111.33 10.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 10.6 p -142.89 154.59 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.839 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -95.16 144.56 25.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.247 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -68.48 118.41 11.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 108.19 -2.37 33.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.62 150.88 20.66 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.6 m -97.63 124.09 50.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.418 0.628 . . . . 0.0 111.441 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.49 HD13 HD21 ' A' ' 301' ' ' LEU . 27.3 mt -88.51 132.38 33.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.479 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 23.2 m -81.32 107.22 13.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 284' ' ' LEU . 17.6 m -106.59 144.66 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.416 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 3.8 pp -93.78 -8.4 40.72 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.335 0.588 . . . . 0.0 110.25 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.72 171.69 13.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -139.57 13.85 2.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.096 0.474 . . . . 0.0 110.296 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -97.31 115.25 65.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.488 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.76 105.22 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.745 2.297 . . . . 0.0 112.152 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.97 8.13 45.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.653 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.27 107.22 0.34 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 41.05 71.4 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.833 0.825 . . . . 0.0 110.554 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -95.43 174.46 7.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -173.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 336' ' ' TYR . 0.4 OUTLIER -96.07 151.29 19.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.53 171.98 23.77 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.884 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.521 ' HB3' ' O ' ' A' ' 310' ' ' THR . 8.1 t60 -109.49 122.54 47.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.692 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.5 146.41 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 CA--C 1.513 -0.446 0 O-C-N 123.509 0.505 . . . . 0.0 110.113 -177.037 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 333' ' ' ARG . 1.5 tpp180 . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 120.92 0.39 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 34.2 mm -107.07 128.15 62.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.129 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.77 155.6 23.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 321' ' ' LYS . 41.1 p90 -96.33 147.74 23.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.492 0.646 . . . . 0.0 111.002 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 338' ' ' PRO . 39.8 p90 -148.61 145.13 19.37 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.855 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 341' ' ' ILE . 9.4 Cg_exo -73.22 130.01 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.384 2.056 . . . . 0.0 110.606 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.19 -16.35 33.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.726 2.284 . . . . 0.0 112.859 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.63 -22.76 76.8 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.238 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 338' ' ' PRO . 38.6 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.325 0.562 . . . . 0.0 111.975 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.38 170.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.544 0.211 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -158.92 168.0 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.02 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.1 -31.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.915 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.3 -22.94 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.5 m -106.98 22.55 15.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 0.0 109.956 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -63.57 111.96 2.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.824 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 . . . . . 0 C--N 1.313 -0.991 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -177.432 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 120.842 0.353 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 285' ' ' LYS . 57.0 tp -136.09 166.31 23.66 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.407 ' N ' ' HG ' ' A' ' 284' ' ' LEU . 21.7 pttm -131.9 141.62 49.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.075 0.464 . . . . 0.0 110.95 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.74 146.4 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.994 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -104.47 120.36 41.07 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.666 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 342' ' ' VAL . . . -73.44 124.8 26.5 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.441 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 289' ' ' LEU . 1.4 pt? -89.26 -9.93 48.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.21 0.529 . . . . 0.0 109.709 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -143.53 148.08 35.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.115 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 304' ' ' ARG . 24.0 m-20 -68.74 155.7 39.63 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.428 ' HB2' HG12 ' A' ' 303' ' ' VAL . 94.2 t80 -76.66 113.81 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.328 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -102.78 127.58 49.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -163.79 162.41 23.8 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.27 122.64 10.75 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -43.37 113.55 0.51 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.787 0.679 . . . . 0.0 112.738 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -158.94 135.91 6.79 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.26 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.7 -13.28 39.04 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.126 2.551 . . . . 0.0 114.736 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 34.2 p -95.82 9.12 41.57 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.212 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -75.38 152.54 38.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 tp -79.69 102.43 8.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -80.58 86.32 5.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 0.0 111.904 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 292' ' ' PHE . 7.3 p -107.53 137.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.382 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.478 ' HA ' ' OD1' ' A' ' 291' ' ' ASP . 19.1 ttp180 -98.9 147.96 24.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.55 115.13 3.37 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.25 37.84 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.042 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.2 173.16 8.57 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.81 143.98 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -175.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.403 HG12 HD13 ' A' ' 324' ' ' ILE . 81.4 mt -111.83 124.38 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.495 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 41.5 m -86.32 110.95 20.02 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.169 0.509 . . . . 0.0 110.784 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 33.9 m -107.17 148.53 11.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.996 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 4.5 tt -88.6 -52.88 4.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.12 131.02 53.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . 0.566 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 55.9 mt-30 -79.08 130.32 35.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.199 0.524 . . . . 0.0 111.804 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -138.85 70.15 43.18 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.857 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.07 81.92 1.63 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 111.733 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -144.93 -62.27 0.36 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.966 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -130.64 -160.55 10.03 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -69.15 101.65 1.5 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 117.39 0.595 . . . . 0.0 110.362 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.566 ' CZ3' ' HA ' ' A' ' 314' ' ' GLN . 1.0 OUTLIER -102.81 169.04 8.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.348 -177.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 25.5 pttm -93.85 152.13 19.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.528 0.68 . . . . 0.0 112.795 -174.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.51 39.63 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.732 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -108.8 122.64 47.58 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.193 0.497 . . . . 0.0 110.402 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.403 HD13 HG12 ' A' ' 309' ' ' ILE . 10.1 tp -103.02 156.64 5.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.902 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 . . . . . 0 CA--C 1.531 0.229 0 O-C-N 123.595 0.56 . . . . 0.0 110.188 176.157 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.38 125.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.62 -179.8 17.64 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -104.13 147.68 27.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.892 0.377 . . . . 0.0 110.769 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.64 151.69 36.31 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.54 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.52 135.61 5.17 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.862 2.374 . . . . 0.0 111.642 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.485 ' HA ' HG22 ' A' ' 342' ' ' VAL . 30.5 Cg_endo -63.35 -3.5 5.26 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.964 2.443 . . . . 0.0 112.716 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -79.99 -19.6 69.66 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.852 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 37.8 pt -102.61 1.89 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.841 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 288' ' ' ALA . 27.6 m -112.41 150.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.468 0.652 . . . . 0.0 112.665 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.5 133.34 55.95 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.905 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.55 -31.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.807 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.87 -63.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.962 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.8 m -122.52 173.44 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.648 0.261 . . . . 0.0 111.687 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.66 82.58 0.18 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.666 0.786 . . . . 0.0 111.223 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . 0.512 ' H ' ' NE ' ' A' ' 348' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 54.8 m . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.794 0.33 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.45 161.09 18.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -126.26 133.99 51.3 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.723 0.297 . . . . 0.0 110.376 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.48 138.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.057 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -106.06 134.62 48.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.425 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.12 131.25 37.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.9 -29.82 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.803 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -127.73 147.56 50.4 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.54 147.0 53.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.762 0.315 . . . . 0.0 110.397 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.542 ' HB2' HG12 ' A' ' 303' ' ' VAL . 69.3 t80 -64.4 133.45 52.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.084 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -77.37 102.39 6.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -66.15 103.49 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.478 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.18 4.64 51.72 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.697 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 66.11 79.56 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.536 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -154.11 135.5 8.87 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.889 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.15 -23.61 66.62 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.044 2.496 . . . . 0.0 113.516 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.6 m -98.05 -1.85 41.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.366 0.603 . . . . 0.0 110.951 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.92 38.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.5 103.66 16.09 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.798 0.332 . . . . 0.0 111.154 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -78.88 123.39 27.19 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 292' ' ' PHE . 11.8 p -141.45 146.36 23.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.032 0.444 . . . . 0.0 111.064 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.497 ' HB3' ' OD2' ' A' ' 307' ' ' ASP . 17.2 ttm-85 -98.53 148.49 23.71 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.519 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.1 127.38 31.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 110.127 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.14 -13.15 48.85 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.682 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 304' ' ' ARG . 81.8 m-20 -87.17 153.97 21.09 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.144 0.472 . . . . 0.0 110.422 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 6.4 t -107.07 128.57 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 111.094 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 303' ' ' VAL . 4.1 mp -102.1 142.37 16.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.315 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 8.2 m -108.36 108.82 19.95 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.22 148.78 5.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.91 0.386 . . . . 0.0 111.17 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.79 -64.42 1.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.519 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.07 134.51 52.09 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -80.37 82.99 6.29 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.497 0.665 . . . . 0.0 110.54 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -70.53 131.78 87.89 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.052 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.79 -41.04 40.65 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.846 2.364 . . . . 0.0 113.483 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -139.66 174.9 10.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 111.116 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.16 -155.7 31.64 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.514 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.409 ' HB3' ' HB2' ' A' ' 336' ' ' TYR . 9.5 mpt_? -110.63 110.47 21.17 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -89.78 157.75 17.8 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.856 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.93 121.89 30.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.772 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -119.09 151.54 17.59 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.129 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.37 121.39 44.73 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 55.6 mt -109.35 137.23 42.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.3 p80 . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.463 176.408 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.56 138.68 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 111.676 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -166.26 174.71 41.81 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 319' ' ' ARG . 22.4 p90 -99.99 149.07 23.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.363 0.582 . . . . 0.0 111.102 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -154.49 162.63 26.56 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.781 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.401 ' O ' HG12 ' A' ' 341' ' ' ILE . 4.0 Cg_endo -87.31 122.59 1.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.119 2.546 . . . . 0.0 112.456 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 342' ' ' VAL . 49.2 Cg_exo -56.2 -18.61 24.33 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.417 2.745 . . . . 0.0 112.82 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -62.84 -23.98 66.1 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.877 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.402 HG13 HG13 ' A' ' 342' ' ' VAL . 42.8 pt -99.06 4.63 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.542 0.671 . . . . 0.0 112.228 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 288' ' ' ALA . 33.2 m -129.22 165.74 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 112.011 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 345' ' ' VAL . 10.5 tp10 -149.79 148.13 28.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.074 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.96 -35.81 61.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.465 ' H ' ' HG3' ' A' ' 343' ' ' GLU . 18.0 t -89.4 146.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.3 t -69.98 95.77 0.97 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.15 0.5 . . . . 0.0 111.645 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt 64.13 30.42 13.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 113.0 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . 0.491 ' C ' ' HD3' ' A' ' 348' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 312' ' ' LEU . 50.7 m . . . . . 0 C--O 1.235 0.333 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 285' ' ' LYS . 43.1 tp -146.35 166.61 25.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.778 0.323 . . . . 0.0 110.642 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . 0.425 ' N ' ' HG ' ' A' ' 284' ' ' LEU . 60.1 pttt -123.12 135.88 54.55 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.74 137.78 55.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -102.75 130.54 49.74 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.731 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -86.04 119.58 26.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.874 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.48 -21.12 24.35 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 291' ' ' ASP . 9.7 tmtm? -123.71 146.08 48.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 290' ' ' LYS . 13.7 m-20 -72.83 122.21 21.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.05 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.453 ' HB3' ' H ' ' A' ' 303' ' ' VAL . 6.5 t80 -80.6 111.23 16.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -170.37 18.12 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.12 0.486 . . . . 0.0 109.883 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 -8.87 59.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.04 168.07 10.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -105.45 -24.65 12.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.521 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.37 131.91 23.28 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 111.737 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.3 3.36 5.84 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.04 3.16 . . . . 0.0 114.386 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.7 t -73.38 -12.85 60.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.241 0.543 . . . . 0.0 110.47 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -89.17 153.41 20.97 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.792 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 tt -79.78 114.66 18.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.987 0.422 . . . . 0.0 110.137 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -99.01 154.43 18.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.773 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.453 ' H ' ' HB3' ' A' ' 292' ' ' PHE . 7.5 p -156.05 146.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.432 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -87.12 141.54 28.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.58 127.0 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.7 56.79 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.373 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -89.22 164.81 14.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.19 132.37 70.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.399 0.619 . . . . 0.0 111.589 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.49 128.98 49.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.332 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 26.2 m -85.47 110.26 19.05 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.924 0.392 . . . . 0.0 110.799 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.39 148.33 9.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 283' ' ' SER . 5.8 mp -87.37 -79.13 0.29 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.409 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -174.13 118.46 0.24 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.334 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . 0.513 HE21 ' HB2' ' A' ' 320' ' ' TRP . 13.6 pt20 178.51 178.21 0.42 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.7 177.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -83.69 119.91 74.4 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.02 98.7 1.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.247 1.965 . . . . 0.0 111.667 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -140.25 119.22 12.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' A' ' 339' ' ' PRO . . . 76.26 -95.68 1.08 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.909 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -132.74 122.92 25.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.513 ' HB2' HE21 ' A' ' 314' ' ' GLN . 0.2 OUTLIER -116.31 156.41 26.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.112 0.482 . . . . 0.0 111.936 -178.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 8.4 ttpm? -84.06 127.18 33.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.838 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -137.91 172.54 22.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.715 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.49 ' CE1' HD11 ' A' ' 312' ' ' LEU . 48.5 m170 -112.08 124.33 52.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.0 151.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.909 0.385 . . . . 0.0 110.82 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.124 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.418 HG23 ' HD2' ' A' ' 321' ' ' LYS . 65.2 mt -126.38 123.89 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -152.93 171.62 31.97 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.845 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -119.96 137.17 54.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.626 0.213 . . . . 0.0 110.674 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.8 159.08 41.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.956 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.458 ' O ' HG12 ' A' ' 341' ' ' ILE . 71.6 Cg_endo -81.61 125.81 5.1 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.712 2.274 . . . . 0.0 112.1 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 318' ' ' GLY . 29.7 Cg_endo -62.97 -12.37 29.23 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.151 2.567 . . . . 0.0 113.134 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.13 -19.72 68.36 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.541 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.463 HG13 HG13 ' A' ' 342' ' ' VAL . 43.7 pt -96.84 -1.5 10.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 117.338 0.569 . . . . 0.0 111.761 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.463 HG13 HG13 ' A' ' 341' ' ' ILE . 31.5 m -123.96 156.58 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.076 0.465 . . . . 0.0 111.823 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.53 153.7 47.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.23 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.14 -20.17 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.094 0.473 . . . . 0.0 110.499 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 346' ' ' SER . 10.7 t -110.17 169.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 345' ' ' VAL . 43.0 m -69.47 156.63 38.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.24 140.56 58.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 111.425 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 . . . . . 0 C--N 1.311 -1.107 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.002 177.381 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 120.859 0.362 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.38 -173.07 2.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.382 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -141.99 141.53 32.89 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.108 0.48 . . . . 0.0 111.306 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.25 142.23 40.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.083 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -102.58 128.13 49.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.901 0.382 . . . . 0.0 111.298 -177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.45 130.19 35.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.546 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.13 -11.96 34.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.876 0.37 . . . . 0.0 110.737 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 291' ' ' ASP . 2.0 tmtp? -145.69 146.58 31.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.49 ' N ' ' HD3' ' A' ' 290' ' ' LYS . 0.9 OUTLIER -62.29 122.77 16.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.754 0.312 . . . . 0.0 110.214 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -76.58 115.01 15.93 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.995 0.426 . . . . 0.0 110.968 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -75.06 92.29 2.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -60.15 149.28 33.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.889 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.77 -163.45 1.05 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.844 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' ' 297' ' ' ASP . 41.4 m170 -82.78 -173.65 4.78 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.134 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 296' ' ' HIS . 17.4 m-20 77.34 144.79 0.1 Allowed Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 123.707 0.629 . . . . 0.0 110.834 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.55 2.5 5.72 Favored 'Trans proline' 0 C--O 1.221 -0.338 0 C-N-CA 122.907 2.405 . . . . 0.0 112.566 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 5.0 p -101.52 3.41 40.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.872 0.367 . . . . 0.0 111.412 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -76.85 132.48 39.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.508 HD22 ' CD1' ' A' ' 337' ' ' PHE . 0.8 OUTLIER -82.41 151.7 26.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.323 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.469 ' O ' HG12 ' A' ' 324' ' ' ILE . 33.7 m-80 -128.6 123.57 33.67 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.66 149.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.6 0.238 . . . . 0.0 110.558 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -109.34 165.24 11.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.078 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.85 117.12 5.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.041 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.48 -11.58 39.34 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.663 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -88.47 159.36 18.0 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.346 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 12.1 m -117.14 132.25 67.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.448 0.642 . . . . 0.0 112.663 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.478 HG13 HD13 ' A' ' 324' ' ' ILE . 3.8 mp -97.81 138.68 21.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.527 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 46.9 m -87.31 110.27 20.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.896 0.379 . . . . 0.0 110.53 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.452 ' HB ' HE22 ' A' ' 314' ' ' GLN . 30.4 m -105.77 141.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.301 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.59 -75.97 0.39 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.1 96.46 2.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.52 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . 0.452 HE22 ' HB ' ' A' ' 311' ' ' VAL . 0.7 OUTLIER -150.62 176.42 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.72 158.06 76.46 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.409 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.567 ' O ' ' HG3' ' A' ' 339' ' ' PRO . 25.0 Cg_exo -64.32 -20.63 66.76 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.825 2.35 . . . . 0.0 113.121 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.02 109.09 2.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.568 0.699 . . . . 0.0 111.183 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 106.55 -99.59 1.5 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 339' ' ' PRO . 0.0 OUTLIER -156.26 147.86 22.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.664 0.269 . . . . 0.0 110.305 178.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.27 153.07 22.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.545 ' HG2' HG22 ' A' ' 334' ' ' ILE . 88.8 tttt -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.09 176.88 21.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.028 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -106.48 122.22 45.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.478 HD13 HG13 ' A' ' 309' ' ' ILE . 9.0 tp -110.31 152.68 12.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.681 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--N 1.317 -0.831 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.857 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.489 ' HG3' HG12 ' A' ' 334' ' ' ILE . 14.5 ptm180 . . . . . 0 N--CA 1.443 -0.777 0 CA-C-O 120.551 0.215 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.545 HG22 ' HG2' ' A' ' 321' ' ' LYS . 5.7 mm -117.14 140.5 39.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.59 155.51 23.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.398 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.79 144.52 26.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 0.0 111.437 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.508 ' CD1' HD22 ' A' ' 301' ' ' LEU . 24.5 p90 -155.19 148.38 18.32 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 3.0 Cg_exo -75.86 133.74 15.66 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.02 2.48 . . . . 0.0 113.095 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . 0.567 ' HG3' ' O ' ' A' ' 316' ' ' PRO . 30.0 Cg_endo -61.7 -19.74 66.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.176 2.584 . . . . 0.0 112.641 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -61.2 -19.55 57.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.584 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 36.8 pt -111.66 4.49 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.354 0.577 . . . . 0.0 112.355 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 339' ' ' PRO . 27.5 m -129.41 153.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 112.003 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 345' ' ' VAL . 10.0 tp10 -148.33 150.94 34.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.16 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.57 -40.8 71.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.43 ' H ' ' HG3' ' A' ' 343' ' ' GLU . 26.0 t -96.05 -84.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.546 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 14.7 m -154.32 -179.92 8.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -73.23 -26.74 61.25 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.108 0.48 . . . . 0.0 110.579 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . 0.599 ' HD3' ' O ' ' A' ' 348' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.335 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 121.028 0.442 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.59 161.74 27.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.699 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -122.69 136.26 54.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 308' ' ' VAL . 19.3 m -115.16 148.83 17.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 345' ' ' VAL . 13.1 mmm180 -102.42 128.48 49.01 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.318 -176.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.57 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -89.63 120.77 31.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.68 -14.74 27.65 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.981 0.42 . . . . 0.0 110.107 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -134.12 157.57 45.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 142.97 33.01 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.995 0.426 . . . . 0.0 111.351 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 303' ' ' VAL . 41.5 t80 -121.76 113.26 19.44 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -161.3 136.31 7.47 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.16 131.79 56.81 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.115 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.09 8.47 4.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.278 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -133.95 133.12 41.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.134 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 8.6 t70 69.52 120.84 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.56 0.744 . . . . 0.0 111.448 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.73 1.94 8.0 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.119 2.546 . . . . 0.0 114.172 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -88.26 23.07 2.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.317 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.08 150.31 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.214 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.7 tp -83.04 114.36 21.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -88.32 109.8 20.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.809 0.337 . . . . 0.0 111.332 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' VAL . . . . . 0.594 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.8 p -142.64 134.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.085 0.469 . . . . 0.0 110.274 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -103.5 151.64 22.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.766 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.41 119.67 8.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.392 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.13 -11.49 31.55 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.971 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -95.06 171.32 8.82 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.641 0.257 . . . . 0.0 110.625 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 286' ' ' VAL . 15.4 m -122.03 135.77 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.7 mt -101.64 143.08 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 2.9 m -91.7 107.18 19.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.096 0.474 . . . . 0.0 110.293 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.9 m -108.53 149.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.574 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.627 ' HG ' ' H ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -89.44 -72.82 0.54 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.627 ' H ' ' HG ' ' A' ' 312' ' ' LEU . 13.3 pt-20 170.74 156.4 0.07 Allowed 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.095 0.958 . . . . 0.0 108.977 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' GLN . . . . . 0.505 ' OE1' ' HB3' ' A' ' 316' ' ' PRO . 35.5 tt0 -173.76 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.281 0.363 . . . . 0.0 111.265 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 48.4 m80 58.69 65.95 2.7 Favored Pre-proline 0 N--CA 1.469 0.512 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.532 ' HG3' ' CG ' ' A' ' 320' ' ' TRP . 64.9 Cg_endo -82.65 168.68 14.14 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.953 2.435 . . . . 0.0 114.088 -172.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.24 -7.88 31.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.943 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -164.71 -138.48 2.42 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.588 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 135.07 56.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.65 0.262 . . . . 0.0 111.046 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' TRP . . . . . 0.542 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 0.3 OUTLIER -132.72 179.07 6.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 33.5 mmtp -86.38 154.1 21.43 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.507 0.67 . . . . 0.0 112.488 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 334' ' ' ILE . . . -161.1 151.43 21.79 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.414 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -108.8 122.69 47.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 10.4 tp -118.97 142.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 . . . . . 0 N--CA 1.441 -0.903 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.352 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 C--O 1.238 0.484 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 322' ' ' GLY . 7.8 tt -133.77 117.44 26.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.095 173.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.66 -169.36 11.55 Favored Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.009 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 23.7 p90 -108.45 142.95 38.08 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.477 ' CE2' HG21 ' A' ' 342' ' ' VAL . 21.4 p90 -151.49 146.64 19.11 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.048 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 340' ' ' GLY . 93.8 Cg_endo -84.1 128.19 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.498 2.132 . . . . 0.0 112.725 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.65 18.99 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.426 2.751 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 338' ' ' PRO . . . -93.96 -19.33 34.22 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' ILE . . . . . 0.494 HG13 HG13 ' A' ' 342' ' ' VAL . 44.5 pt -108.87 -8.73 11.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.061 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 288' ' ' ALA . 25.0 m -131.81 150.02 33.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.175 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -161.54 167.7 24.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.67 100.95 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 109.941 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.648 ' O ' ' HG3' ' A' ' 287' ' ' ARG . 10.3 p -156.93 152.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.429 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.0 m -67.06 -56.07 11.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.927 0.394 . . . . 0.0 110.031 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -157.34 154.95 29.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.318 -0.783 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.77 176.62 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.261 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 20.4 m 63.92 29.02 14.59 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.034 0.534 . . . . 0.0 111.38 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 285' ' ' LYS . 2.7 tm? -94.89 141.64 28.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -116.57 136.8 52.67 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.93 0.395 . . . . 0.0 110.964 -177.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 342' ' ' VAL . 16.9 m -132.4 154.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.463 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -102.55 141.78 34.8 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.419 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -82.73 110.94 18.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.87 -32.23 31.14 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -121.34 164.96 16.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.768 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -88.11 157.52 18.82 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.473 ' HB3' HG12 ' A' ' 303' ' ' VAL . 23.4 t80 -141.15 112.73 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 86.3 t90 -141.67 119.48 11.85 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.916 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.404 ' HB3' ' HB1' ' A' ' 300' ' ' ALA . 55.4 t30 -150.44 126.88 10.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.433 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.79 166.85 10.6 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 71.94 7.59 5.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.575 0.75 . . . . 0.0 111.042 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -127.71 114.98 20.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.82 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.89 -9.97 26.75 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.966 2.444 . . . . 0.0 113.624 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 22.0 p -107.16 8.04 29.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.179 0.514 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 294' ' ' ASN . . . -82.32 150.09 27.41 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.158 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 337' ' ' PHE . 20.7 tp -105.29 152.73 22.54 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.871 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -119.84 105.26 10.94 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' A' ' 292' ' ' PHE . 8.2 p -148.78 144.39 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.041 0.448 . . . . 0.0 111.255 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.467 ' HD3' ' N ' ' A' ' 305' ' ' ALA . 4.7 tmt_? -112.74 146.51 38.64 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.467 ' N ' ' HD3' ' A' ' 304' ' ' ARG . . . -52.09 125.6 16.08 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.84 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.82 -22.76 20.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.225 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -76.85 165.23 24.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 13.6 m -116.36 137.86 48.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.313 0.578 . . . . 0.0 111.6 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 303' ' ' VAL . 3.6 mp -116.7 132.95 64.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.831 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 6.5 m -98.32 107.25 19.67 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 284' ' ' LEU . 35.9 m -93.5 142.81 12.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.475 0.655 . . . . 0.0 112.071 -176.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 60.1 tp -87.88 -14.67 38.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.024 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -91.31 164.7 13.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.149 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -155.3 121.92 5.33 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 44.5 m80 58.42 75.52 0.52 Allowed Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.408 0.443 . . . . 0.0 110.129 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -95.03 -170.26 0.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.115 2.543 . . . . 0.0 112.767 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -138.19 104.98 5.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.87 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 92.85 -69.03 1.69 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.24 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -148.85 158.19 43.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.652 0.263 . . . . 0.0 110.493 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -137.03 167.98 20.47 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.505 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -104.73 137.94 41.77 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.633 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.52 167.93 26.02 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.957 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -114.79 130.89 56.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 326' ' ' GLU . 41.6 mm -72.78 135.45 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -73.55 101.53 3.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 324' ' ' ILE . 0.0 OUTLIER -113.33 161.87 16.74 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.373 0.606 . . . . 0.0 112.329 -176.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 14.2 m -101.71 -25.59 13.79 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.024 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -104.83 116.04 31.32 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.606 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -59.69 134.49 57.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.138 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.51 -10.56 46.2 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.847 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 86.6 m -81.03 136.01 35.92 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 23.73 96.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.262 1.425 . . . . 0.0 114.363 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 333' ' ' ARG . 53.2 mtt180 -80.01 -81.05 0.12 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.538 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 47.6 mm -124.08 124.42 68.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.827 0.346 . . . . 0.0 110.815 -177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.5 151.1 21.05 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -102.27 136.83 41.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.863 0.363 . . . . 0.0 110.443 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.527 ' CD1' HD22 ' A' ' 301' ' ' LEU . 4.8 p90 -154.87 154.78 29.55 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.267 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.448 ' O ' HG12 ' A' ' 341' ' ' ILE . 73.8 Cg_endo -77.44 134.33 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.39 2.06 . . . . 0.0 112.176 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.85 -6.88 13.48 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.867 2.378 . . . . 0.0 112.311 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -74.52 -19.59 79.82 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.157 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.491 HG13 HG13 ' A' ' 342' ' ' VAL . 39.0 pt -99.58 2.91 10.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 117.254 0.527 . . . . 0.0 111.733 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.491 HG13 HG13 ' A' ' 341' ' ' ILE . 29.1 m -133.8 155.32 39.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.55 ' HG3' HG22 ' A' ' 345' ' ' VAL . 11.5 tp10 -160.68 150.13 17.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.048 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.15 -28.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' A' ' 343' ' ' GLU . 20.4 m -77.05 168.41 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.853 0.359 . . . . 0.0 111.665 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 17.7 t -72.23 162.87 28.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.54 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.29 -179.23 6.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? . . . . . 0 C--O 1.244 0.816 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.259 177.271 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 112.173 -0.371 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 11.0 p -147.76 99.8 3.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.134 0.493 . . . . 0.0 111.427 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.17 -176.88 3.06 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 7.4 ptpp? -143.7 134.22 24.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 111.36 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 31.3 m -118.55 156.67 20.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.112 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -102.74 134.87 45.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.6 115.52 18.36 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.169 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.403 ' HG ' ' OE2' ' A' ' 343' ' ' GLU . 4.2 mm? -87.77 -17.11 32.37 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.235 0.54 . . . . 0.0 110.137 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -140.75 147.26 38.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.42 134.44 39.6 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.499 ' HD2' ' O ' ' A' ' 301' ' ' LEU . 3.8 t80 -78.74 112.58 16.01 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.9 t-105 -71.35 -31.96 67.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.54 -174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -79.83 78.76 6.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.06 -9.85 10.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.096 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.13 68.75 10.04 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.258 0.551 . . . . 0.0 110.223 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -179.76 126.15 0.24 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.16 -27.69 81.15 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.973 2.449 . . . . 0.0 113.531 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.89 -1.79 57.62 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.191 0.52 . . . . 0.0 111.105 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -102.28 150.78 22.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.517 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.539 HD22 ' CG ' ' A' ' 337' ' ' PHE . 3.9 tp -90.01 104.49 17.06 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.375 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -79.42 102.24 8.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.07 144.79 32.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.266 0.555 . . . . 0.0 111.592 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -104.4 147.29 27.72 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.279 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.51 124.44 20.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.385 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 106.65 -16.03 40.89 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.928 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.54 158.07 19.61 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.22 139.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.171 0.51 . . . . 0.0 111.632 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 285' ' ' LYS . 20.5 mt -110.94 132.58 59.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.438 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 27.5 m -80.86 108.54 14.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 6.9 t -97.63 143.44 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.505 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 6.2 mp -81.89 -49.73 9.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.19 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -162.47 162.78 27.67 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.608 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -75.7 132.36 40.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 320' ' ' TRP . 9.8 m-70 -145.23 81.02 10.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.426 177.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.87 -0.8 10.91 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.897 2.398 . . . . 0.0 112.398 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -70.3 -21.97 62.88 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.225 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -180.0 -156.92 19.16 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 319' ' ' ARG . 6.2 ptt180 -65.34 110.72 2.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.088 0.471 . . . . 0.0 110.773 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.468 ' HD1' ' O ' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -85.13 175.5 8.95 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.85 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.477 ' HB2' HD11 ' A' ' 334' ' ' ILE . 12.2 ptmm? -119.03 142.1 48.13 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.107 0.48 . . . . 0.0 112.171 -175.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -159.72 171.25 36.07 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.778 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -109.14 129.52 55.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.915 0.388 . . . . 0.0 110.141 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.438 HG23 ' CE1' ' A' ' 325' ' ' HIS . 8.2 tp -119.61 149.42 22.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.355 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . 0.438 ' CE1' HG23 ' A' ' 324' ' ' ILE . 8.3 p-80 52.13 179.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.887 1.275 . . . . 0.0 114.144 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.62 -175.24 2.74 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.176 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 17.9 p -86.21 89.92 7.99 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -156.25 150.72 25.69 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.042 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 62.58 33.38 15.88 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.383 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 104.22 65.41 0.69 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.419 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 30.0 m -53.1 135.28 37.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.138 0.494 . . . . 0.0 111.924 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -96.57 -106.67 0.16 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.603 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 334' ' ' ILE . 32.7 ptt180 179.29 -54.16 0.01 OUTLIER 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.049 0.452 . . . . 0.0 110.574 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 335' ' ' GLY . 0.0 OUTLIER -179.51 145.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.489 ' N ' HD13 ' A' ' 334' ' ' ILE . . . -138.21 175.79 21.15 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 119.634 -1.27 . . . . 0.0 113.197 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -111.07 146.12 37.32 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.539 ' CG ' HD22 ' A' ' 301' ' ' LEU . 4.4 p90 -154.01 151.07 23.87 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.003 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.454 ' O ' HG12 ' A' ' 341' ' ' ILE . 70.4 Cg_endo -77.32 127.07 8.86 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.49 2.127 . . . . 0.0 112.109 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.448 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.6 Cg_endo -61.86 -13.28 29.89 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.996 2.464 . . . . 0.0 112.636 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -70.62 -18.9 76.06 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.324 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 338' ' ' PRO . 42.4 pt -103.13 4.3 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 117.4 0.6 . . . . 0.0 111.714 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 288' ' ' ALA . 35.3 m -131.2 150.86 34.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.87 0.367 . . . . 0.0 111.099 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.403 ' OE2' ' HG ' ' A' ' 289' ' ' LEU . 46.7 mt-10 -137.91 145.38 42.03 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 11.4 p -65.95 -30.47 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.786 0.327 . . . . 0.0 111.154 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.7 p -83.37 143.31 12.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 63.7 m -76.94 146.43 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.643 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.68 129.28 34.65 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 . . . . . 0 C--N 1.315 -0.919 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.382 179.302 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 312' ' ' LEU . . . . . . . . 0 N--CA 1.472 1.042 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 19.4 m -92.23 -15.78 27.05 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 285' ' ' LYS . 2.2 tm? -124.14 141.12 52.32 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.698 -0.401 . . . . 0.0 109.98 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 284' ' ' LEU . 58.9 mtpt -124.69 134.4 52.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.53 142.3 29.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 308' ' ' VAL . 58.4 mtp180 -103.8 132.9 49.61 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.894 0.378 . . . . 0.0 110.723 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -84.87 125.7 32.85 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.806 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.0 -13.76 30.49 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.052 0.453 . . . . 0.0 110.836 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 291' ' ' ASP . 14.2 tmtt? -132.55 146.47 51.94 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.464 ' N ' ' HD3' ' A' ' 290' ' ' LYS . 11.4 m-20 -73.74 120.55 19.49 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.379 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.451 ' HB3' HG12 ' A' ' 303' ' ' VAL . 3.1 t80 -103.06 113.89 27.74 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -141.53 149.64 41.11 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.511 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -139.62 147.07 40.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.602 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 37.7 tp -75.88 -44.65 39.56 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -161.37 90.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.614 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 15.3 t70 -138.46 126.68 13.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 297' ' ' ASP . 15.9 Cg_exo -68.08 -15.82 43.77 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.047 2.498 . . . . 0.0 114.234 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 20.9 p -113.81 -32.38 6.13 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.52 131.23 48.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.367 0.603 . . . . 0.0 112.53 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.402 HD11 ' HB ' ' A' ' 324' ' ' ILE . 24.0 tp -83.05 153.99 24.63 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.092 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.49 HD21 HG23 ' A' ' 331' ' ' THR . 5.5 p-10 -110.2 108.13 18.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.451 HG12 ' HB3' ' A' ' 292' ' ' PHE . 8.2 p -146.02 136.79 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 111.42 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.448 ' HG3' ' HB2' ' A' ' 307' ' ' ASP . 32.9 ptt180 -88.86 152.84 21.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.41 125.87 25.61 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.805 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 100.42 -9.17 58.99 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.023 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.448 ' HB2' ' HG3' ' A' ' 304' ' ' ARG . 1.2 t70 -84.46 164.0 19.1 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 120.684 0.278 . . . . 0.0 110.528 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.468 HG12 ' HG2' ' A' ' 287' ' ' ARG . 15.8 m -111.2 128.38 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.574 0.702 . . . . 0.0 112.301 -177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 337' ' ' PHE . 49.0 mt -97.82 130.4 46.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 7.0 m -93.63 108.08 19.85 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 18.0 m -105.46 148.31 10.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 312' ' ' LEU . 5.6 mp -64.35 -77.81 0.05 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 312' ' ' LEU . 0.1 OUTLIER 167.49 134.99 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.486 1.114 . . . . 0.0 108.321 175.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 178.79 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.771 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 16.3 m80 52.85 71.49 1.43 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.253 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.64 173.98 9.05 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.729 2.286 . . . . 0.0 111.316 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.57 125.14 45.1 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 100.69 -32.68 7.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.367 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -151.65 137.52 18.07 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.875 0.369 . . . . 0.0 111.073 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 56.1 m95 -110.52 159.03 17.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.406 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -136.48 122.23 19.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.89 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -152.86 175.02 31.55 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.472 -1.346 . . . . 0.0 113.898 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 333' ' ' ARG . 53.5 m80 -107.12 128.27 54.25 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.402 ' HB ' HD11 ' A' ' 301' ' ' LEU . 10.2 tp -111.91 155.54 13.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.563 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -50.37 148.03 3.95 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.455 0.472 . . . . 0.0 110.758 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.41 ' HA ' HG21 ' A' ' 331' ' ' THR . 0.0 OUTLIER -80.8 168.03 19.26 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 55.6 m -149.91 -170.28 3.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.452 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -68.18 -57.76 5.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.705 0.288 . . . . 0.0 111.383 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -143.12 156.18 44.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.988 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 68.85 47.14 57.05 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.869 -0.605 . . . . 0.0 113.088 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . 0.49 HG23 HD21 ' A' ' 302' ' ' ASN . 22.4 m -137.92 136.44 37.03 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -121.46 169.94 10.15 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 65.4 mtt180 -87.29 -30.49 20.83 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 120.775 0.321 . . . . 0.0 110.752 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 31.3 mm -113.26 121.35 65.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.055 0.455 . . . . 0.0 110.772 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.89 149.69 20.77 Favored Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.323 -0.941 . . . . 0.0 111.551 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 67.5 m-85 -107.64 139.15 42.62 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.461 ' CD2' HG11 ' A' ' 342' ' ' VAL . 17.0 p90 -140.93 147.19 47.02 Favored Pre-proline 0 C--N 1.31 -1.15 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.632 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 4.8 Cg_exo -75.79 130.85 12.83 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.893 2.395 . . . . 0.0 111.979 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.493 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.2 Cg_endo -59.59 -16.57 37.1 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.366 2.711 . . . . 0.0 112.921 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.78 -21.57 76.59 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.541 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 41.2 pt -107.99 1.18 9.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 117.386 0.593 . . . . 0.0 112.048 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 339' ' ' PRO . 35.4 m -124.11 150.26 28.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.985 0.421 . . . . 0.0 111.362 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -146.98 170.27 17.45 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.326 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 22.7 m -68.83 -167.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.22 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 37.2 t -67.78 -34.06 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 54.7 m -70.0 95.07 0.91 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.205 0.526 . . . . 0.0 110.907 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -100.27 136.96 39.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.694 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 . . . . . 0 C--O 1.24 0.559 0 CA-C-O 118.651 -0.69 . . . . 0.0 109.801 177.827 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.093 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 25.4 p -149.01 137.06 20.75 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.914 0.388 . . . . 0.0 110.665 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 95.9 mt -122.71 175.4 6.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.651 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -144.36 133.81 23.29 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.118 0.485 . . . . 0.0 110.509 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.81 168.42 24.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.531 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -124.34 134.48 53.15 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.05 137.04 38.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.242 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 343' ' ' GLU . 4.6 mm? -87.06 -28.8 22.36 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.517 176.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -129.16 146.76 51.02 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.929 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 304' ' ' ARG . 0.1 OUTLIER -71.87 138.06 47.93 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.851 178.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -101.92 110.5 22.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -151.32 119.62 6.37 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.083 0.468 . . . . 0.0 110.621 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -151.4 -43.57 0.11 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.325 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 14.6 mt -150.83 134.03 16.12 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.519 ' HA ' ' OD1' ' A' ' 302' ' ' ASN . 38.7 m80 -84.19 84.44 7.61 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -146.81 146.89 28.01 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.245 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.44 ' HG3' ' O ' ' A' ' 331' ' ' THR . 31.7 Cg_exo -57.88 -8.32 4.4 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.073 2.515 . . . . 0.0 113.668 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 8.1 t -87.59 -11.82 47.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.013 0.435 . . . . 0.0 110.369 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -121.76 150.56 41.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.892 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 337' ' ' PHE . 31.3 tp -88.51 104.03 16.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.576 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 296' ' ' HIS . 29.1 m-80 -84.05 94.09 8.24 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.303 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.46 146.1 24.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.699 0.285 . . . . 0.0 110.753 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 291' ' ' ASP . 77.5 mtm180 -108.73 161.29 15.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.814 0.34 . . . . 0.0 111.003 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.77 128.03 34.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.675 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 98.28 -13.3 63.2 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.827 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -80.89 161.17 24.49 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 120.688 0.28 . . . . 0.0 110.659 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 26.5 m -98.03 144.71 10.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.202 0.525 . . . . 0.0 111.678 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.407 HD13 HD21 ' A' ' 301' ' ' LEU . 42.9 mt -128.99 129.49 68.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.752 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 23.5 m -86.69 108.82 18.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 10.6 t -90.79 148.15 4.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.081 -177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 50.8 tp -65.92 -56.05 13.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.804 0.335 . . . . 0.0 110.222 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -176.68 144.63 0.5 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.431 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . 0.508 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 23.9 pt20 -92.29 79.27 5.05 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.743 0.782 . . . . 0.0 110.626 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 316' ' ' PRO . 1.4 t-80 -136.74 -53.73 0.02 OUTLIER Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.217 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 315' ' ' HIS . 2.0 Cg_endo -83.48 101.03 0.92 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.18 1.92 . . . . 0.0 110.501 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.53 146.57 48.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.824 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 126.8 -158.65 20.88 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 319' ' ' ARG . 33.2 ptt180 -80.65 98.62 7.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.227 0.537 . . . . 0.0 109.575 177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.511 ' CZ2' ' HB3' ' A' ' 339' ' ' PRO . 0.2 OUTLIER -89.4 158.91 17.57 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.908 -177.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -85.91 127.8 34.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.255 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -126.05 154.16 18.74 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.971 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -119.72 139.43 52.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 326' ' ' GLU . 37.2 mt -106.94 139.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -90.84 20.7 4.58 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.155 0.502 . . . . 0.0 110.97 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 324' ' ' ILE . 10.5 tp10 -134.63 154.53 51.47 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 22.9 t -138.67 136.34 35.76 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.017 0.437 . . . . 0.0 111.714 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -134.69 -81.09 0.44 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.11 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -131.01 132.05 44.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 106.53 67.29 0.66 Allowed Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.111 -1.042 . . . . 0.0 110.605 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . 0.44 ' O ' ' HG3' ' A' ' 298' ' ' PRO . 2.9 p -48.36 141.67 6.39 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.064 0.545 . . . . 0.0 112.152 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.404 ' H ' ' NH1' ' A' ' 333' ' ' ARG . 2.7 m-20 70.32 89.21 0.1 Allowed 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.126 -175.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 326' ' ' GLU . 0.1 OUTLIER -79.6 69.58 5.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.165 -175.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 19.5 mm -128.06 111.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.304 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -144.35 159.09 27.68 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.555 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 5.4 p90 -104.03 137.71 41.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 301' ' ' LEU . 20.2 p90 -147.81 155.08 44.58 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.278 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.405 ' O ' HG12 ' A' ' 341' ' ' ILE . 98.3 Cg_endo -84.01 134.59 6.18 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.544 2.162 . . . . 0.0 111.379 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.511 ' HB3' ' CZ2' ' A' ' 320' ' ' TRP . 11.1 Cg_endo -54.94 -19.96 21.32 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.2 2.6 . . . . 0.0 113.202 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -60.92 -20.27 57.3 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 114.258 0.463 . . . . 0.0 114.258 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.469 HG13 HG13 ' A' ' 342' ' ' VAL . 43.1 pt -100.55 4.84 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.605 0.703 . . . . 0.0 112.259 -178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 341' ' ' ILE . 31.9 m -132.77 164.19 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.096 0.474 . . . . 0.0 111.596 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.485 ' HB2' HD21 ' A' ' 289' ' ' LEU . 0.4 OUTLIER -135.06 149.57 50.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 27.4 m -77.07 -33.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.1 p -158.25 -20.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 74.0 m -80.24 14.93 1.72 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.981 -0.449 . . . . 0.0 111.981 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 348' ' ' ARG . 8.6 tmtt? -88.67 127.36 35.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.539 ' N ' ' HD3' ' A' ' 347' ' ' LYS . 40.5 ttm180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.683 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.2 m -149.62 111.94 4.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 60.0 tp -128.64 148.64 50.82 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -124.82 135.48 52.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.016 0.436 . . . . 0.0 111.266 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.465 HG11 ' CH2' ' A' ' 320' ' ' TRP . 16.0 m -125.11 146.68 30.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.898 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -103.07 139.5 38.52 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -79.86 119.67 23.06 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.076 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 11.0 mp -92.93 -26.87 17.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.413 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -127.31 146.89 50.29 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.83 122.31 25.91 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -103.49 113.02 26.2 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.417 ' HE1' HD23 ' A' ' 295' ' ' LEU . 19.8 t-105 -115.55 104.72 12.01 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.956 0.408 . . . . 0.0 111.469 -173.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -130.69 106.25 8.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.417 HD23 ' HE1' ' A' ' 293' ' ' TRP . 2.1 pp -107.24 -1.01 22.22 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.178 0.513 . . . . 0.0 110.703 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -81.42 -40.95 22.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.57 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.25 113.6 23.67 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.685 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.13 -0.48 9.17 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.621 2.214 . . . . 0.0 111.978 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 3.4 m -85.26 -16.84 38.83 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.48 0.657 . . . . 0.0 109.564 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -91.94 144.7 25.2 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.379 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 5.8 tt -82.71 110.9 18.16 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.051 0.453 . . . . 0.0 111.166 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -101.06 121.62 42.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.96 152.34 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 120.939 0.4 . . . . 0.0 111.253 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.554 ' HB2' ' OD2' ' A' ' 307' ' ' ASP . 61.2 mtm180 -101.74 146.58 27.57 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.28 125.51 23.96 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.758 0.313 . . . . 0.0 110.299 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.33 -16.06 29.79 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.699 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.554 ' OD2' ' HB2' ' A' ' 304' ' ' ARG . 33.4 m-20 -84.29 156.55 21.89 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.53 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 8.9 t -112.14 135.73 50.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.353 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 20.8 mt -114.7 134.05 58.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.952 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 39.7 m -104.19 120.09 40.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.043 0.449 . . . . 0.0 110.711 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 31.3 m -105.24 146.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.133 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 80.0 mt -83.27 -60.12 2.25 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.312 0.577 . . . . 0.0 109.795 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -114.09 114.21 25.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.065 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 141.93 43.95 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 320' ' ' TRP . 66.8 m-70 -139.95 89.47 11.3 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.22 -9.21 25.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.874 2.382 . . . . 0.0 113.318 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -123.41 117.8 26.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.3 -102.41 1.82 Allowed Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.964 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -153.62 158.0 40.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.465 ' CH2' HG11 ' A' ' 286' ' ' VAL . 0.1 OUTLIER -148.76 170.69 17.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 178.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 24.9 pttm -128.25 144.56 51.14 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.439 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.1 34.51 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.997 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 333' ' ' ARG . 3.9 p-80 -114.26 133.83 55.36 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 120.907 0.384 . . . . 0.0 110.248 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 47.2 mt -80.93 150.96 4.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.407 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -76.73 117.58 18.5 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.44 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -82.98 -90.6 0.08 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.039 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 15.5 m 51.98 24.36 2.58 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.981 0.513 . . . . 0.0 112.146 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -175.47 -69.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 329' ' ' ARG . 1.0 OUTLIER -169.65 -176.52 2.44 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.03 67.74 0.71 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 119.095 -1.526 . . . . 0.0 112.092 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 49.8 m -51.95 134.0 32.05 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.685 0.278 . . . . 0.0 111.246 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 18.9 t70 178.72 143.67 0.12 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.508 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 30.3 tpt180 -120.52 -67.74 0.96 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 14.1 mm -153.77 116.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -137.35 151.49 21.15 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 119.439 -1.363 . . . . 0.0 112.563 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -89.14 146.33 24.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.823 0.344 . . . . 0.0 110.733 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -158.38 158.48 29.7 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.896 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 341' ' ' ILE . 78.2 Cg_endo -82.39 132.97 7.15 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.334 2.023 . . . . 0.0 111.942 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.8 -14.83 19.12 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.249 2.633 . . . . 0.0 113.116 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -67.9 -19.86 71.99 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.861 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.492 HG13 HG13 ' A' ' 342' ' ' VAL . 39.5 pt -94.28 -8.15 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 117.599 0.699 . . . . 0.0 111.835 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 341' ' ' ILE . 28.8 m -123.05 170.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.974 0.416 . . . . 0.0 111.083 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.488 ' HG2' ' HB2' ' A' ' 346' ' ' SER . 6.9 tp10 -157.12 151.19 24.8 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.3 -67.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 73.7 t -104.03 -41.19 6.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.488 ' HB2' ' HG2' ' A' ' 343' ' ' GLU . 35.2 m -60.05 133.96 56.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -177.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -99.15 158.23 15.82 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.794 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.908 179.308 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 14.7 p 50.3 84.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.854 0.861 . . . . 0.0 112.53 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 97.4 mt -120.59 173.09 7.39 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.147 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 285' ' ' LYS . 0.0 OUTLIER -146.31 143.16 28.95 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.266 0.555 . . . . 0.0 112.181 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.19 164.04 34.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.242 -0.89 . . . . 0.0 108.86 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . 0.484 ' HG2' HG12 ' A' ' 308' ' ' VAL . 74.9 mtp180 -113.64 144.58 42.67 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.131 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.5 118.28 23.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.751 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.4 -5.96 48.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.29 0.567 . . . . 0.0 110.426 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -138.85 146.49 41.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -80.12 121.92 26.16 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 120.663 0.268 . . . . 0.0 110.634 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.55 ' CE1' ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.83 53.69 1.76 Allowed 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.511 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.55 ' HB2' ' CE1' ' A' ' 292' ' ' PHE . 50.4 t-20 -66.82 -61.35 2.0 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.497 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 13.9 tp -160.48 165.06 31.62 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -97.38 20.46 11.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.905 0.383 . . . . 0.0 111.936 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.47 153.54 41.36 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.017 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.86 -19.42 65.59 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.887 2.392 . . . . 0.0 112.829 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.4 m -81.25 -14.99 56.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.195 0.521 . . . . 0.0 110.698 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -109.55 137.65 47.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.963 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.476 HD11 ' CG1' ' A' ' 324' ' ' ILE . 31.4 tp -86.59 111.24 20.44 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.082 0.467 . . . . 0.0 110.978 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.14 102.68 12.08 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 14.0 p -129.17 148.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.416 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -96.05 149.25 21.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.78 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.03 126.43 27.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.743 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.42 -19.36 26.75 Favored Glycine 0 N--CA 1.435 -1.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.382 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -76.98 155.88 32.31 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 116.904 0.352 . . . . 0.0 111.146 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.484 HG12 ' HG2' ' A' ' 287' ' ' ARG . 34.4 m -101.77 134.13 43.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.344 0.592 . . . . 0.0 111.429 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.453 HG12 ' CD1' ' A' ' 324' ' ' ILE . 56.3 mt -109.24 116.85 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 22.4 m -91.2 114.84 27.47 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.2 142.09 17.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 39.1 tp -70.67 -66.73 0.57 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 313' ' ' GLU . 11.0 pt-20 -178.71 113.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.439 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -158.64 132.49 7.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.453 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -64.0 116.94 31.2 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 97.32 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.537 2.158 . . . . 0.0 113.035 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -150.57 129.2 12.28 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.503 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.24 -87.5 0.49 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -151.03 132.03 14.27 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.403 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -125.59 166.3 16.96 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.663 -175.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -89.16 140.07 29.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 111.886 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -142.96 156.23 26.33 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.371 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.628 ' CE1' ' HB3' ' A' ' 332' ' ' ASP . 6.5 t-80 -111.2 121.08 44.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.933 0.397 . . . . 0.0 110.148 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 332' ' ' ASP . 35.3 mm -85.9 121.75 37.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.438 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -109.21 92.04 3.89 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.571 ' HG2' ' H ' ' A' ' 328' ' ' GLN . 22.2 tt0 -75.28 133.4 41.32 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.241 -175.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 3.4 m -86.54 -14.03 44.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.682 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.571 ' H ' ' HG2' ' A' ' 326' ' ' GLU . 91.4 mt-30 -75.39 -78.98 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -3.3 58.88 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 120.729 0.299 . . . . 0.0 110.849 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 66.07 51.08 47.78 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.77 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.9 t -118.86 158.07 26.38 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.628 ' HB3' ' CE1' ' A' ' 323' ' ' HIS . 5.6 m-20 -126.88 130.51 50.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.156 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -136.67 132.83 35.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.543 0.211 . . . . 0.0 110.945 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 15.8 tt -101.44 140.25 20.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.847 0.356 . . . . 0.0 110.337 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.05 179.26 35.71 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -110.9 143.98 40.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.693 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 301' ' ' LEU . 9.5 p90 -149.14 156.51 40.17 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.115 -177.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.438 ' O ' HG12 ' A' ' 341' ' ' ILE . 3.5 Cg_exo -81.72 131.04 7.03 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.822 2.348 . . . . 0.0 111.363 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.408 ' HA ' HG22 ' A' ' 342' ' ' VAL . 19.0 Cg_endo -60.17 -15.79 36.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.862 2.375 . . . . 0.0 112.789 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.38 -19.55 74.48 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.397 -0.43 . . . . 0.0 113.594 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.463 HG13 HG13 ' A' ' 342' ' ' VAL . 41.1 pt -100.25 1.7 10.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.539 0.669 . . . . 0.0 111.803 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.463 HG13 HG13 ' A' ' 341' ' ' ILE . 33.5 m -128.18 164.5 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.182 0.515 . . . . 0.0 111.581 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.428 ' HG2' ' OG ' ' A' ' 346' ' ' SER . 8.6 tp10 -160.35 151.83 19.59 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.934 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.465 HG13 HG12 ' A' ' 345' ' ' VAL . 7.2 p -66.54 -40.92 87.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.774 0.321 . . . . 0.0 111.237 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.465 HG12 HG13 ' A' ' 344' ' ' VAL . 7.9 p -157.09 122.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.411 . . . . 0.0 110.752 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 343' ' ' GLU . 49.6 m -163.96 -23.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.22 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -64.56 121.09 13.62 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.653 -0.689 . . . . 0.0 109.657 179.489 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.383 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 311' ' ' VAL . 30.5 p -75.83 135.18 40.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.886 0.374 . . . . 0.0 111.109 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 311' ' ' VAL . 24.6 tp -144.39 157.48 44.23 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -115.24 133.44 56.03 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.789 0.328 . . . . 0.0 110.338 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.98 152.08 36.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -105.41 137.43 43.23 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.696 0.284 . . . . 0.0 110.518 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -82.1 110.89 17.74 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.028 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 47.0 mt -78.66 -26.31 45.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.198 0.523 . . . . 0.0 110.089 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -132.67 162.79 30.48 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.42 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.568 ' OD2' ' HD2' ' A' ' 304' ' ' ARG . 10.0 m-20 -78.44 151.97 32.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.725 0.298 . . . . 0.0 110.206 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.558 ' HB3' HG12 ' A' ' 303' ' ' VAL . 32.4 t80 -140.69 113.48 8.24 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -144.72 102.32 3.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -108.95 129.04 55.43 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 295' ' ' LEU . 1.8 pt? -111.58 7.78 20.7 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.836 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -92.2 -41.04 10.66 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.049 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 300' ' ' ALA . 29.5 m-20 -101.97 122.05 48.55 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.085 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.8 -28.55 59.3 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.318 2.012 . . . . 0.0 111.612 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 7.3 t -83.95 -3.04 57.68 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.737 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 297' ' ' ASP . . . -70.28 150.21 46.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.618 0.247 . . . . 0.0 110.501 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.563 HD22 ' CD1' ' A' ' 337' ' ' PHE . 15.7 tp -82.51 153.67 25.45 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.059 0.457 . . . . 0.0 110.77 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.434 ' N ' ' HG ' ' A' ' 301' ' ' LEU . 23.4 p-10 -128.15 119.64 25.7 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.558 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.7 p -144.4 146.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.048 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.568 ' HD2' ' OD2' ' A' ' 291' ' ' ASP . 10.3 tpt180 -96.55 142.3 28.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.1 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.37 122.11 12.46 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.733 0.301 . . . . 0.0 110.335 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.02 -10.17 40.16 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.72 -0.753 . . . . 0.0 113.028 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.2 169.56 12.95 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.151 0.475 . . . . 0.0 110.151 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.13 128.72 72.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.353 0.597 . . . . 0.0 111.583 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.529 HG12 HD13 ' A' ' 324' ' ' ILE . 68.2 mt -99.3 129.05 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.993 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.8 m -98.0 108.6 21.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 283' ' ' SER . 19.5 m -93.06 140.13 16.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 120.842 0.353 . . . . 0.0 110.603 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 312' ' ' LEU . 2.6 pt? -82.18 -12.72 57.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.574 0.702 . . . . 0.0 109.46 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -159.33 143.99 15.44 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.582 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.28 -33.09 69.44 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 123.011 0.195 . . . . 0.0 110.98 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 80.4 m80 67.77 157.38 0.14 Allowed Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.814 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.35 137.92 63.19 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.001 1.8 . . . . 0.0 110.216 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -62.24 118.77 7.86 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.768 0.794 . . . . 0.0 111.035 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 161.51 -43.9 0.39 Allowed Glycine 0 C--N 1.31 -0.908 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.608 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -157.57 123.91 4.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.023 0.439 . . . . 0.0 110.043 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 339' ' ' PRO . 45.0 m95 -94.67 174.34 7.16 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.566 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.505 ' HG2' HD11 ' A' ' 334' ' ' ILE . 86.4 tttt -156.61 114.13 3.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -145.33 176.68 24.21 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.805 -0.712 . . . . 0.0 113.453 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 332' ' ' ASP . 46.8 m80 -107.17 136.94 46.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.673 HG13 ' H ' ' A' ' 326' ' ' GLU . 11.0 tp -130.67 149.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.643 0.259 . . . . 0.0 110.629 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -95.51 10.09 37.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.864 0.364 . . . . 0.0 111.335 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.673 ' H ' HG13 ' A' ' 324' ' ' ILE . 17.9 tp10 -66.56 -30.51 70.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 43.4 m -62.81 113.64 3.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -62.41 -16.58 55.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.577 -175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -62.77 -13.92 38.85 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.522 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 101.31 -52.15 0.9 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.142 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.9 t -68.35 152.24 45.72 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.117 0.484 . . . . 0.0 111.507 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' A' ' 323' ' ' HIS . 3.0 m-20 -69.74 93.38 0.73 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.212 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 323' ' ' HIS . 57.2 ttp85 -77.35 142.58 39.29 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.901 0.381 . . . . 0.0 110.366 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.505 HD11 ' HG2' ' A' ' 321' ' ' LYS . 9.1 tp -94.82 140.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.52 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -160.41 159.1 30.54 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.602 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 321' ' ' LYS . 36.3 p90 -101.75 151.78 21.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.818 0.309 . . . . 0.0 110.314 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.563 ' CD1' HD22 ' A' ' 301' ' ' LEU . 16.7 p90 -153.71 151.08 24.38 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.469 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 341' ' ' ILE . 62.3 Cg_endo -75.29 133.43 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.714 2.276 . . . . 0.0 112.131 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 320' ' ' TRP . 20.7 Cg_endo -61.4 -17.57 54.18 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.218 2.612 . . . . 0.0 113.023 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -63.89 -19.18 62.99 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.655 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 338' ' ' PRO . 45.6 pt -107.96 6.28 9.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 339' ' ' PRO . 28.3 m -132.26 161.45 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.906 0.384 . . . . 0.0 111.78 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -160.46 161.97 33.04 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 -24.53 35.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.58 -178.59 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.095 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 22.2 m -71.54 161.01 31.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -64.24 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.011 0.434 . . . . 0.0 110.736 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.485 178.867 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.0 p -161.33 108.43 1.44 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.07 167.93 10.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.432 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -129.89 141.49 50.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.054 0.454 . . . . 0.0 110.693 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 30.2 m -123.02 144.67 31.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.636 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . 0.428 ' HG2' HG12 ' A' ' 308' ' ' VAL . 58.2 mtt85 -102.34 129.46 48.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.173 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -85.05 117.78 24.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.817 0.341 . . . . 0.0 111.159 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.97 -23.32 20.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.237 0.542 . . . . 0.0 109.563 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 341' ' ' ILE . 57.9 tptt -117.81 146.35 43.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.54 135.57 36.12 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.328 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.478 ' HD2' ' O ' ' A' ' 301' ' ' LEU . 35.6 t80 -99.25 112.62 24.75 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -77.36 167.29 21.94 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.453 -173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -74.82 133.63 41.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.255 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.42 177.6 4.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.822 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.53 45.09 0.94 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.71 138.21 6.15 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.67 -18.75 42.23 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.268 2.645 . . . . 0.0 113.85 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 2.7 m -80.45 1.14 30.47 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.169 0.509 . . . . 0.0 110.861 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -67.11 124.5 23.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.478 ' O ' ' HD2' ' A' ' 292' ' ' PHE . 21.2 tp -88.84 87.45 7.24 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.561 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -74.63 97.58 3.21 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.514 0.674 . . . . 0.0 111.116 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.45 HG21 HD11 ' A' ' 309' ' ' ILE . 13.0 p -123.55 139.83 48.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.868 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 307' ' ' ASP . 51.4 mtm180 -99.61 157.05 16.73 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -178.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -61.96 121.67 13.56 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.746 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.87 26.87 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.297 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 304' ' ' ARG . 26.7 m-20 -85.63 162.75 18.68 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 122.503 -0.41 . . . . 0.0 110.52 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.428 HG12 ' HG2' ' A' ' 287' ' ' ARG . 30.2 m -114.57 145.2 20.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.292 0.568 . . . . 0.0 112.208 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 303' ' ' VAL . 4.4 mp -118.02 130.75 72.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.84 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 85.7 m -96.99 120.55 37.55 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.061 0.458 . . . . 0.0 110.761 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.8 m -105.18 146.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.559 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.38 -78.23 0.07 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.702 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -164.62 98.91 0.79 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.438 0.637 . . . . 0.0 110.792 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -164.62 153.73 13.13 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.335 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 316' ' ' PRO . 9.3 m170 -90.63 144.19 30.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 315' ' ' HIS . 6.4 Cg_exo -75.1 49.45 2.29 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.162 2.575 . . . . 0.0 112.661 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -101.9 45.12 0.98 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.112 0.482 . . . . 0.0 110.726 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 149.43 170.01 16.5 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.437 ' H ' ' HD3' ' A' ' 319' ' ' ARG . 0.0 OUTLIER -62.8 134.79 56.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.588 0.694 . . . . 0.0 109.606 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.41 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -139.63 -179.64 6.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.062 -176.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -123.1 145.06 48.9 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -133.47 166.21 23.9 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.358 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -109.94 122.39 47.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.24 137.39 31.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.379 0.609 . . . . 0.0 112.138 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -146.69 103.54 3.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.607 -1.179 . . . . 0.0 107.981 175.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.99 -171.77 2.44 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.691 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 33.0 m -62.21 -23.83 66.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.651 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -82.96 115.93 22.02 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . 0.553 ' H ' ' HD2' ' A' ' 329' ' ' ARG . 0.0 OUTLIER -65.54 142.13 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.857 0.361 . . . . 0.0 110.658 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.34 -21.12 35.96 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.671 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 40.2 p -69.68 137.39 52.09 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -156.43 121.59 4.7 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.115 -175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 49.2 ttm-85 -157.95 139.89 14.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.018 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 13.7 tt -124.83 130.93 73.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.61 33.75 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.546 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -88.88 146.69 24.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.664 0.269 . . . . 0.0 111.279 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.69 152.66 18.18 Favored Pre-proline 0 C--O 1.242 0.679 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.489 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.584 ' O ' HG12 ' A' ' 341' ' ' ILE . 72.3 Cg_endo -79.46 133.64 10.74 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.53 2.153 . . . . 0.0 111.72 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.81 -14.92 45.92 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.821 2.347 . . . . 0.0 112.734 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -72.34 -18.8 78.44 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 116.099 -0.5 . . . . 0.0 113.574 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 338' ' ' PRO . 46.9 pt -93.51 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 117.471 0.635 . . . . 0.0 111.501 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.418 HG13 HG13 ' A' ' 341' ' ' ILE . 35.6 m -120.87 163.45 18.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -146.55 146.24 30.41 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.725 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.9 t -86.39 -35.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.426 HG11 ' NE ' ' A' ' 348' ' ' ARG . 17.5 t -72.65 158.55 6.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.046 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 30.7 m -72.75 102.77 3.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.656 0.265 . . . . 0.0 111.447 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt 45.39 37.96 3.31 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.443 1.097 . . . . 0.0 113.8 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.426 ' NE ' HG11 ' A' ' 345' ' ' VAL . 38.6 ttm180 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.375 -0.822 . . . . 0.0 109.916 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.042 0 N-CA-C 112.196 -0.362 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 51.0 m -143.05 93.11 2.46 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 54.3 tp -83.87 159.2 21.39 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -131.61 136.2 47.58 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 25.0 m -115.54 142.41 28.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -101.6 132.71 47.11 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.344 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -80.34 117.53 21.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.258 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.56 -21.91 22.64 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -126.32 147.7 49.68 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.679 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.84 153.78 28.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.111 0.482 . . . . 0.0 111.38 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.555 ' HB3' HG12 ' A' ' 303' ' ' VAL . 40.3 t80 -135.65 110.72 8.89 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -174.52 133.85 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.909 0.385 . . . . 0.0 110.881 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -124.13 161.74 25.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 295' ' ' LEU . 2.5 pt? -77.26 -8.74 58.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.64 0.734 . . . . 0.0 109.229 176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -126.71 -156.75 0.76 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.538 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 300' ' ' ALA . 6.4 m-20 66.44 91.61 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.844 0 O-C-N 123.327 0.392 . . . . 0.0 111.287 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.86 -15.74 26.4 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.445 2.097 . . . . 0.0 112.842 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.6 m -105.67 7.48 32.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 110.886 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 297' ' ' ASP . . . -72.38 139.89 48.11 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.451 ' O ' ' HD2' ' A' ' 292' ' ' PHE . 21.0 tp -84.36 91.21 7.73 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.49 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.97 106.17 1.51 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.249 0.547 . . . . 0.0 111.344 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 292' ' ' PHE . 12.8 p -134.84 135.16 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.563 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.431 ' HB3' ' OD2' ' A' ' 307' ' ' ASP . 37.6 ttp180 -97.01 147.4 24.04 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.959 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.58 125.79 25.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.086 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 111.41 -18.15 25.56 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.611 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.431 ' OD2' ' HB3' ' A' ' 304' ' ' ARG . 18.0 m-20 -86.19 165.29 16.65 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.842 0.353 . . . . 0.0 110.565 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.55 134.94 59.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 86.4 mt -101.17 128.08 53.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 18.3 m -83.22 108.75 16.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.88 0.372 . . . . 0.0 110.138 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.78 127.07 62.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-O 121.398 0.618 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 312' ' ' LEU . 2.2 pp -86.41 -9.77 55.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.506 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 117.97 6.7 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -76.97 101.4 5.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.728 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -123.01 84.4 50.8 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.45 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 -2.0 12.14 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.561 2.174 . . . . 0.0 114.236 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -108.12 106.87 17.28 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.479 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 93.79 173.12 39.46 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.779 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -68.46 128.87 38.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.041 0.448 . . . . 0.0 109.897 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.416 ' HD1' ' H ' ' A' ' 320' ' ' TRP . 0.2 OUTLIER -126.3 162.19 26.06 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.537 -176.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -98.69 136.87 38.13 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.277 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -139.8 171.85 23.63 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.154 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -109.14 128.14 54.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.954 0.407 . . . . 0.0 111.151 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 11.4 tp -124.42 154.16 31.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 54.8 t60 71.99 166.27 0.3 Allowed 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.5 0.5 . . . . 0.0 110.417 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.07 154.5 41.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.839 0.352 . . . . 0.0 110.603 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 6.2 p -101.83 108.48 19.98 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.118 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.14 179.74 7.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.685 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -73.09 117.09 14.41 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.102 0.477 . . . . 0.0 111.927 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 102.52 -53.12 0.79 Allowed Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.945 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.23 157.64 46.4 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.209 0.504 . . . . 0.0 111.516 -176.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -146.23 -170.89 3.6 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -115.1 108.83 17.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.392 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 39.8 mm -106.82 129.69 60.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.547 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -140.0 159.94 26.14 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.025 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -97.2 140.76 31.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.882 0.372 . . . . 0.0 110.243 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.458 ' HE2' HG21 ' A' ' 342' ' ' VAL . 5.9 p90 -148.78 160.56 35.37 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.259 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.484 ' O ' HG12 ' A' ' 341' ' ' ILE . 4.0 Cg_endo -87.11 132.91 3.29 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.763 2.309 . . . . 0.0 112.135 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.81 -14.07 34.34 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.133 2.555 . . . . 0.0 112.472 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.48 -18.84 68.22 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.498 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.485 HG13 HG13 ' A' ' 342' ' ' VAL . 49.2 pt -101.98 -4.49 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.485 HG13 HG13 ' A' ' 341' ' ' ILE . 27.6 m -126.83 150.92 33.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.856 0.36 . . . . 0.0 111.52 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -143.18 146.55 33.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.674 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.41 -34.82 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.727 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.42 -37.05 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.502 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.2 m -109.24 86.41 2.28 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.094 0.474 . . . . 0.0 110.204 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 347' ' ' LYS . 14.6 tmtt? -85.89 94.58 9.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.217 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.955 177.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.084 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 38.3 m -85.0 107.25 17.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.091 0.472 . . . . 0.0 110.885 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.443 ' HB2' HG23 ' A' ' 311' ' ' VAL . 73.1 mt -105.6 179.86 4.15 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.174 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 309' ' ' ILE . 25.4 pttm -153.05 145.01 23.69 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.287 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.9 m -128.88 157.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.832 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -102.42 127.99 49.22 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.906 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -81.61 128.68 34.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.89 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 82.5 mt -97.25 -9.8 26.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.581 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.473 ' HB3' ' HB ' ' A' ' 341' ' ' ILE . 54.6 tptt -133.62 147.3 51.47 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -80.25 122.41 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 302' ' ' ASN . 0.6 OUTLIER -104.94 111.38 24.13 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -162.36 -2.96 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.74 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -56.81 -44.38 81.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.147 0.498 . . . . 0.0 109.689 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 300' ' ' ALA . 26.4 tp -89.44 120.59 30.9 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -94.87 0.8 55.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.2 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 2.6 m-20 -66.24 139.34 96.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 297' ' ' ASP . 52.1 Cg_exo -56.32 -21.24 35.69 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 123.127 2.551 . . . . 0.0 113.293 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.4 t -78.03 -12.07 59.96 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.817 0.341 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.437 ' HB2' HD23 ' A' ' 295' ' ' LEU . . . -87.17 142.11 28.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.819 0.342 . . . . 0.0 110.393 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 309' ' ' ILE . 1.3 tp -82.91 89.33 6.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 292' ' ' PHE . 14.5 m120 -75.27 111.33 10.42 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 10.6 p -142.89 154.59 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.839 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -95.16 144.56 25.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.247 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -68.48 118.41 11.5 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 108.19 -2.37 33.17 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.62 150.88 20.66 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 25.6 m -97.63 124.09 50.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.418 0.628 . . . . 0.0 111.441 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.49 HD13 HD21 ' A' ' 301' ' ' LEU . 27.3 mt -88.51 132.38 33.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.479 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 323' ' ' HIS . 23.2 m -81.32 107.22 13.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 284' ' ' LEU . 17.6 m -106.59 144.66 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 120.987 0.422 . . . . 0.0 111.416 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 3.8 pp -93.78 -8.4 40.72 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.335 0.588 . . . . 0.0 110.25 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.72 171.69 13.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -139.57 13.85 2.54 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.096 0.474 . . . . 0.0 110.296 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -97.31 115.25 65.7 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.488 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.76 105.22 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.745 2.297 . . . . 0.0 112.152 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.97 8.13 45.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.653 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 81.27 107.22 0.34 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 41.05 71.4 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.833 0.825 . . . . 0.0 110.554 -174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -95.43 174.46 7.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -173.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 336' ' ' TYR . 0.4 OUTLIER -96.07 151.29 19.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.53 171.98 23.77 Favored Glycine 0 N--CA 1.436 -1.347 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.884 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.521 ' HB3' ' O ' ' A' ' 310' ' ' THR . 8.1 t60 -109.49 122.54 47.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.104 0.478 . . . . 0.0 110.692 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 40.4 mm -100.5 146.41 9.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 69.58 88.0 0.11 Allowed 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 123.509 0.505 . . . . 0.0 110.113 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.96 -26.77 38.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.985 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 5.8 t -115.36 104.02 11.38 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.577 ' C ' ' HD2' ' A' ' 329' ' ' ARG . 4.5 pp0? -97.3 167.81 10.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.879 0.371 . . . . 0.0 111.854 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . 0.577 ' HD2' ' C ' ' A' ' 328' ' ' GLN . 3.4 mpt_? -128.95 105.94 8.55 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.424 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 79.58 -52.44 4.14 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.842 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 20.8 m -139.21 146.91 41.09 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.432 ' HB2' ' CE1' ' A' ' 323' ' ' HIS . 11.5 p-10 -88.73 -172.47 3.73 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.012 0.434 . . . . 0.0 111.174 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 333' ' ' ARG . 1.5 tpp180 -135.53 107.51 7.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.846 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 34.2 mm -107.07 128.15 62.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.129 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -138.77 155.6 23.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 321' ' ' LYS . 41.1 p90 -96.33 147.74 23.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.492 0.646 . . . . 0.0 111.002 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 338' ' ' PRO . 39.8 p90 -148.61 145.13 19.37 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.855 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 341' ' ' ILE . 9.4 Cg_exo -73.22 130.01 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.384 2.056 . . . . 0.0 110.606 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.19 -16.35 33.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.726 2.284 . . . . 0.0 112.859 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -69.63 -22.76 76.8 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.238 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 338' ' ' PRO . 38.6 pt -94.84 1.95 9.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.325 0.562 . . . . 0.0 111.975 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.38 170.93 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.544 0.211 . . . . 0.0 110.584 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -158.92 168.0 27.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.02 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.1 -31.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.915 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.3 -22.94 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 111.652 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 16.5 m -106.98 22.55 15.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.206 0.527 . . . . 0.0 109.956 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -63.57 111.96 2.59 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.824 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 . . . . . 0 C--N 1.313 -0.991 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.123 -177.432 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 37.4 p -155.07 138.31 15.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.842 0.353 . . . . 0.0 110.784 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 285' ' ' LYS . 57.0 tp -136.09 166.31 23.66 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.407 ' N ' ' HG ' ' A' ' 284' ' ' LEU . 21.7 pttm -131.9 141.62 49.41 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.075 0.464 . . . . 0.0 110.95 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.74 146.4 20.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.994 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -104.47 120.36 41.07 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.666 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 342' ' ' VAL . . . -73.44 124.8 26.5 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.441 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.484 ' H ' HD23 ' A' ' 289' ' ' LEU . 1.4 pt? -89.26 -9.93 48.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.21 0.529 . . . . 0.0 109.709 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -143.53 148.08 35.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.115 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 304' ' ' ARG . 24.0 m-20 -68.74 155.7 39.63 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.984 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.428 ' HB2' HG12 ' A' ' 303' ' ' VAL . 94.2 t80 -76.66 113.81 14.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.328 178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -102.78 127.58 49.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.932 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -163.79 162.41 23.8 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 59.9 tp -54.27 122.64 10.75 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -43.37 113.55 0.51 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.787 0.679 . . . . 0.0 112.738 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -158.94 135.91 6.79 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.26 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.7 -13.28 39.04 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.126 2.551 . . . . 0.0 114.736 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 34.2 p -95.82 9.12 41.57 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.212 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -75.38 152.54 38.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.572 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 tp -79.69 102.43 8.97 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -80.58 86.32 5.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.49 0.662 . . . . 0.0 111.904 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.428 HG12 ' HB2' ' A' ' 292' ' ' PHE . 7.3 p -107.53 137.38 39.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.382 176.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.478 ' HA ' ' OD1' ' A' ' 291' ' ' ASP . 19.1 ttp180 -98.9 147.96 24.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.55 115.13 3.37 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.93 -11.25 37.84 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.042 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.2 173.16 8.57 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.81 143.98 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -175.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.403 HG12 HD13 ' A' ' 324' ' ' ILE . 81.4 mt -111.83 124.38 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.495 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 41.5 m -86.32 110.95 20.02 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.169 0.509 . . . . 0.0 110.784 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 33.9 m -107.17 148.53 11.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.996 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 4.5 tt -88.6 -52.88 4.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.12 131.02 53.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . 0.566 ' HA ' ' CZ3' ' A' ' 320' ' ' TRP . 55.9 mt-30 -79.08 130.32 35.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.199 0.524 . . . . 0.0 111.804 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -138.85 70.15 43.18 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.857 177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.07 81.92 1.63 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.825 2.35 . . . . 0.0 111.733 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -144.93 -62.27 0.36 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.966 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -130.64 -160.55 10.03 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -69.15 101.65 1.5 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 117.39 0.595 . . . . 0.0 110.362 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.566 ' CZ3' ' HA ' ' A' ' 314' ' ' GLN . 1.0 OUTLIER -102.81 169.04 8.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.348 -177.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 25.5 pttm -93.85 152.13 19.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.528 0.68 . . . . 0.0 112.795 -174.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -165.72 168.51 39.63 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.732 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -108.8 122.64 47.58 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.193 0.497 . . . . 0.0 110.402 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.403 HD13 HG12 ' A' ' 309' ' ' ILE . 10.1 tp -103.02 156.64 5.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.902 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -46.88 142.88 3.17 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.595 0.56 . . . . 0.0 110.188 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.72 108.09 19.6 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.824 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 29.1 m -58.74 143.42 47.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.371 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -74.67 -18.24 60.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.295 0.569 . . . . 0.0 110.26 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -119.46 101.21 7.79 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 84.27 65.41 1.53 Allowed Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.4 t -49.86 137.24 16.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.337 0.589 . . . . 0.0 111.673 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -98.17 171.49 8.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.324 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -148.58 -164.37 2.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.57 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.38 125.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.62 -179.8 17.64 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.62 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -104.13 147.68 27.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.892 0.377 . . . . 0.0 110.769 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -148.64 151.69 36.31 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.54 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.52 135.61 5.17 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.862 2.374 . . . . 0.0 111.642 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.485 ' HA ' HG22 ' A' ' 342' ' ' VAL . 30.5 Cg_endo -63.35 -3.5 5.26 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.964 2.443 . . . . 0.0 112.716 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -79.99 -19.6 69.66 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.852 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 37.8 pt -102.61 1.89 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.841 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 288' ' ' ALA . 27.6 m -112.41 150.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.468 0.652 . . . . 0.0 112.665 -177.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -118.5 133.34 55.95 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.905 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.55 -31.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.807 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.87 -63.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.962 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.8 m -122.52 173.44 7.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.648 0.261 . . . . 0.0 111.687 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.66 82.58 0.18 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.666 0.786 . . . . 0.0 111.223 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.512 ' H ' ' NE ' ' A' ' 348' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 54.8 m -157.83 107.93 2.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.794 0.33 . . . . 0.0 110.309 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.45 161.09 18.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.969 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -126.26 133.99 51.3 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.723 0.297 . . . . 0.0 110.376 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.48 138.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.057 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -106.06 134.62 48.9 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.425 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -78.12 131.25 37.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.9 -29.82 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.803 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -127.73 147.56 50.4 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.54 147.0 53.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.762 0.315 . . . . 0.0 110.397 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.542 ' HB2' HG12 ' A' ' 303' ' ' VAL . 69.3 t80 -64.4 133.45 52.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.084 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -77.37 102.39 6.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -66.15 103.49 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.478 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.18 4.64 51.72 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.697 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 34.1 m80 66.11 79.56 0.24 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.536 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -154.11 135.5 8.87 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.889 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.15 -23.61 66.62 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.044 2.496 . . . . 0.0 113.516 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 6.6 m -98.05 -1.85 41.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.366 0.603 . . . . 0.0 110.951 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -78.33 139.92 38.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.91 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.5 103.66 16.09 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.798 0.332 . . . . 0.0 111.154 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -78.88 123.39 27.19 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 292' ' ' PHE . 11.8 p -141.45 146.36 23.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.032 0.444 . . . . 0.0 111.064 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.497 ' HB3' ' OD2' ' A' ' 307' ' ' ASP . 17.2 ttm-85 -98.53 148.49 23.71 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.519 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.1 127.38 31.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.928 0.394 . . . . 0.0 110.127 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.14 -13.15 48.85 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.682 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 304' ' ' ARG . 81.8 m-20 -87.17 153.97 21.09 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.144 0.472 . . . . 0.0 110.422 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 6.4 t -107.07 128.57 61.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 111.094 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 303' ' ' VAL . 4.1 mp -102.1 142.37 16.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.315 179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 8.2 m -108.36 108.82 19.95 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.22 148.78 5.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.91 0.386 . . . . 0.0 111.17 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.79 -64.42 1.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.519 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -110.07 134.51 52.09 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -80.37 82.99 6.29 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.497 0.665 . . . . 0.0 110.54 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -70.53 131.78 87.89 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.052 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.79 -41.04 40.65 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.846 2.364 . . . . 0.0 113.483 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -139.66 174.9 10.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.042 0.448 . . . . 0.0 111.116 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 84.16 -155.7 31.64 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.514 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.409 ' HB3' ' HB2' ' A' ' 336' ' ' TYR . 9.5 mpt_? -110.63 110.47 21.17 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -89.78 157.75 17.8 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.856 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.93 121.89 30.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.772 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -119.09 151.54 17.59 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.129 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 332' ' ' ASP . 0.9 OUTLIER -112.37 121.39 44.73 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.193 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 332' ' ' ASP . 55.6 mt -109.35 137.23 42.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.058 0.456 . . . . 0.0 111.975 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -154.37 112.35 3.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.463 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 329' ' ' ARG . 6.3 pt-20 -91.43 179.29 5.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -177.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 15.7 m -67.71 -59.84 3.01 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -62.36 -74.32 0.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.765 0.317 . . . . 0.0 111.479 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 326' ' ' GLU . 22.8 mmm180 -131.39 -135.39 0.2 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 65.97 66.27 2.49 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 119.638 -1.268 . . . . 0.0 111.938 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 14.8 p -56.29 154.78 7.65 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.445 0.164 . . . . 0.0 111.189 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . 0.574 ' HB3' ' CE1' ' A' ' 323' ' ' HIS . 9.9 m-20 -41.81 110.14 0.16 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -116.41 138.84 51.03 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.055 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . . . . . . . . . 16.1 tt -113.56 138.68 42.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 111.676 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -166.26 174.71 41.81 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . 0.409 ' HB2' ' HB3' ' A' ' 319' ' ' ARG . 22.4 p90 -99.99 149.07 23.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.363 0.582 . . . . 0.0 111.102 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -154.49 162.63 26.56 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.781 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.401 ' O ' HG12 ' A' ' 341' ' ' ILE . 4.0 Cg_endo -87.31 122.59 1.8 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.119 2.546 . . . . 0.0 112.456 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 342' ' ' VAL . 49.2 Cg_exo -56.2 -18.61 24.33 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.417 2.745 . . . . 0.0 112.82 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -62.84 -23.98 66.1 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.115 -0.493 . . . . 0.0 113.877 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.402 HG13 HG13 ' A' ' 342' ' ' VAL . 42.8 pt -99.06 4.63 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.542 0.671 . . . . 0.0 112.228 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 288' ' ' ALA . 33.2 m -129.22 165.74 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 112.011 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 345' ' ' VAL . 10.5 tp10 -149.79 148.13 28.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.074 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.96 -35.81 61.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.465 ' H ' ' HG3' ' A' ' 343' ' ' GLU . 18.0 t -89.4 146.94 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 35.3 t -69.98 95.77 0.97 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.15 0.5 . . . . 0.0 111.645 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt 64.13 30.42 13.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 113.0 176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.491 ' C ' ' HD3' ' A' ' 348' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 112.109 -0.396 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 312' ' ' LEU . 50.7 m -148.72 158.99 44.54 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 285' ' ' LYS . 43.1 tp -146.35 166.61 25.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.778 0.323 . . . . 0.0 110.642 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . 0.425 ' N ' ' HG ' ' A' ' 284' ' ' LEU . 60.1 pttt -123.12 135.88 54.55 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.74 137.78 55.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -102.75 130.54 49.74 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.731 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -86.04 119.58 26.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.874 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.48 -21.12 24.35 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.85 0.357 . . . . 0.0 111.2 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 291' ' ' ASP . 9.7 tmtm? -123.71 146.08 48.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 290' ' ' LYS . 13.7 m-20 -72.83 122.21 21.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.05 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.453 ' HB3' ' H ' ' A' ' 303' ' ' VAL . 6.5 t80 -80.6 111.23 16.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -170.37 18.12 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.12 0.486 . . . . 0.0 109.883 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 -8.87 59.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.191 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.04 168.07 10.68 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -105.45 -24.65 12.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.521 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -100.37 131.91 23.28 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 111.737 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.3 3.36 5.84 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.04 3.16 . . . . 0.0 114.386 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 11.7 t -73.38 -12.85 60.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.241 0.543 . . . . 0.0 110.47 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -89.17 153.41 20.97 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.792 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 tt -79.78 114.66 18.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.987 0.422 . . . . 0.0 110.137 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -99.01 154.43 18.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.773 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.453 ' H ' ' HB3' ' A' ' 292' ' ' PHE . 7.5 p -156.05 146.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.432 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.416 HH21 ' CB ' ' A' ' 327' ' ' SER . 13.3 ttm180 -87.12 141.54 28.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.58 127.0 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.838 0.352 . . . . 0.0 110.761 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.7 56.79 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.373 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -89.22 164.81 14.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.4 m -120.19 132.37 70.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.399 0.619 . . . . 0.0 111.589 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.6 mt -98.49 128.98 49.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.332 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 26.2 m -85.47 110.26 19.05 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.924 0.392 . . . . 0.0 110.799 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.39 148.33 9.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 283' ' ' SER . 5.8 mp -87.37 -79.13 0.29 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.409 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -174.13 118.46 0.24 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.334 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . 0.513 HE21 ' HB2' ' A' ' 320' ' ' TRP . 13.6 pt20 178.51 178.21 0.42 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.7 177.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -83.69 119.91 74.4 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.02 98.7 1.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.247 1.965 . . . . 0.0 111.667 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -140.25 119.22 12.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.523 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' A' ' 339' ' ' PRO . . . 76.26 -95.68 1.08 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.909 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -132.74 122.92 25.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.513 ' HB2' HE21 ' A' ' 314' ' ' GLN . 0.2 OUTLIER -116.31 156.41 26.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.112 0.482 . . . . 0.0 111.936 -178.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 8.4 ttpm? -84.06 127.18 33.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.838 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -137.91 172.54 22.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.715 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.49 ' CE1' HD11 ' A' ' 312' ' ' LEU . 48.5 m170 -112.08 124.33 52.19 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.0 151.6 21.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.909 0.385 . . . . 0.0 110.82 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -92.21 114.49 27.05 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.429 ' HB3' HG22 ' A' ' 331' ' ' THR . 0.3 OUTLIER -69.06 152.38 45.28 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . 0.416 ' CB ' HH21 ' A' ' 304' ' ' ARG . 49.4 m -78.41 -37.89 42.82 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.167 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 328' ' ' GLN . 6.7 tp60 -91.9 154.45 18.85 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.25 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -59.48 150.0 28.04 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 90.46 40.09 5.8 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 326' ' ' GLU . 72.4 p -69.41 149.2 48.61 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.123 -0.539 . . . . 0.0 111.997 -176.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -114.25 173.72 6.31 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -119.47 -12.47 9.34 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.947 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.418 HG23 ' HD2' ' A' ' 321' ' ' LYS . 65.2 mt -126.38 123.89 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -152.93 171.62 31.97 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.845 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -119.96 137.17 54.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.626 0.213 . . . . 0.0 110.674 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.8 159.08 41.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.956 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.458 ' O ' HG12 ' A' ' 341' ' ' ILE . 71.6 Cg_endo -81.61 125.81 5.1 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.712 2.274 . . . . 0.0 112.1 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 318' ' ' GLY . 29.7 Cg_endo -62.97 -12.37 29.23 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.151 2.567 . . . . 0.0 113.134 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -66.13 -19.72 68.36 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.541 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.463 HG13 HG13 ' A' ' 342' ' ' VAL . 43.7 pt -96.84 -1.5 10.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 117.338 0.569 . . . . 0.0 111.761 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.463 HG13 HG13 ' A' ' 341' ' ' ILE . 31.5 m -123.96 156.58 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.076 0.465 . . . . 0.0 111.823 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -139.53 153.7 47.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.23 176.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 31.8 m -82.14 -20.17 10.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.094 0.473 . . . . 0.0 110.499 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 346' ' ' SER . 10.7 t -110.17 169.08 3.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.429 ' N ' HG12 ' A' ' 345' ' ' VAL . 43.0 m -69.47 156.63 38.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -62.24 140.56 58.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 111.425 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 . . . . . 0 C--N 1.311 -1.107 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.002 177.381 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.188 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.4 p -155.46 125.24 6.49 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.859 0.362 . . . . 0.0 110.845 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.38 -173.07 2.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.382 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -141.99 141.53 32.89 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.108 0.48 . . . . 0.0 111.306 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.25 142.23 40.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.083 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 41.8 ttm105 -102.58 128.13 49.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.901 0.382 . . . . 0.0 111.298 -177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -83.45 130.19 35.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.546 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -92.13 -11.96 34.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.876 0.37 . . . . 0.0 110.737 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 291' ' ' ASP . 2.0 tmtp? -145.69 146.58 31.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.49 ' N ' ' HD3' ' A' ' 290' ' ' LYS . 0.9 OUTLIER -62.29 122.77 16.48 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.754 0.312 . . . . 0.0 110.214 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -76.58 115.01 15.93 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.995 0.426 . . . . 0.0 110.968 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -75.06 92.29 2.62 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -60.15 149.28 33.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.889 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.77 -163.45 1.05 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.844 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' ' 297' ' ' ASP . 41.4 m170 -82.78 -173.65 4.78 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.134 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 296' ' ' HIS . 17.4 m-20 77.34 144.79 0.1 Allowed Pre-proline 0 N--CA 1.472 0.641 0 O-C-N 123.707 0.629 . . . . 0.0 110.834 -177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.55 2.5 5.72 Favored 'Trans proline' 0 C--O 1.221 -0.338 0 C-N-CA 122.907 2.405 . . . . 0.0 112.566 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 5.0 p -101.52 3.41 40.11 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.872 0.367 . . . . 0.0 111.412 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -76.85 132.48 39.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.558 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.508 HD22 ' CD1' ' A' ' 337' ' ' PHE . 0.8 OUTLIER -82.41 151.7 26.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.323 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.469 ' O ' HG12 ' A' ' 324' ' ' ILE . 33.7 m-80 -128.6 123.57 33.67 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.66 149.22 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.6 0.238 . . . . 0.0 110.558 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -109.34 165.24 11.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.078 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.85 117.12 5.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.041 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 107.48 -11.58 39.34 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.663 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -88.47 159.36 18.0 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 121.07 -0.252 . . . . 0.0 110.346 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 12.1 m -117.14 132.25 67.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.448 0.642 . . . . 0.0 112.663 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.478 HG13 HD13 ' A' ' 324' ' ' ILE . 3.8 mp -97.81 138.68 21.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.527 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 46.9 m -87.31 110.27 20.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.896 0.379 . . . . 0.0 110.53 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.452 ' HB ' HE22 ' A' ' 314' ' ' GLN . 30.4 m -105.77 141.74 20.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.301 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.59 -75.97 0.39 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.1 96.46 2.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.52 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . 0.452 HE22 ' HB ' ' A' ' 311' ' ' VAL . 0.7 OUTLIER -150.62 176.42 11.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -131.72 158.06 76.46 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.409 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.567 ' O ' ' HG3' ' A' ' 339' ' ' PRO . 25.0 Cg_exo -64.32 -20.63 66.76 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.825 2.35 . . . . 0.0 113.121 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.02 109.09 2.85 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.568 0.699 . . . . 0.0 111.183 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 106.55 -99.59 1.5 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 339' ' ' PRO . 0.0 OUTLIER -156.26 147.86 22.75 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.664 0.269 . . . . 0.0 110.305 178.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.27 153.07 22.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.545 ' HG2' HG22 ' A' ' 334' ' ' ILE . 88.8 tttt -139.25 107.5 5.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -140.09 176.88 21.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.028 -174.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -106.48 122.22 45.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.478 HD13 HG13 ' A' ' 309' ' ' ILE . 9.0 tp -110.31 152.68 12.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.681 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -77.36 103.04 7.06 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.424 ' HG2' HG23 ' A' ' 324' ' ' ILE . 6.9 mm-40 -103.02 148.7 25.37 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.813 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 45.6 m -88.83 -3.28 58.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.235 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -128.17 151.57 49.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.033 0.444 . . . . 0.0 112.043 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.65 168.49 9.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.389 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 104.77 -40.74 2.36 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 85.4 m -72.4 142.51 48.71 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.48 153.03 42.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.044 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.489 ' HG3' HG12 ' A' ' 334' ' ' ILE . 14.5 ptm180 -64.25 -25.66 68.16 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.439 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.545 HG22 ' HG2' ' A' ' 321' ' ' LYS . 5.7 mm -117.14 140.5 39.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -137.59 155.51 23.1 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.398 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -96.79 144.52 26.69 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.695 0.283 . . . . 0.0 111.437 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.508 ' CD1' HD22 ' A' ' 301' ' ' LEU . 24.5 p90 -155.19 148.38 18.32 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.922 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 337' ' ' PHE . 3.0 Cg_exo -75.86 133.74 15.66 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.02 2.48 . . . . 0.0 113.095 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . 0.567 ' HG3' ' O ' ' A' ' 316' ' ' PRO . 30.0 Cg_endo -61.7 -19.74 66.34 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.176 2.584 . . . . 0.0 112.641 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -61.2 -19.55 57.3 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.584 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . . . . . . . . . 36.8 pt -111.66 4.49 8.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 117.354 0.577 . . . . 0.0 112.355 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.5 HG22 ' HA ' ' A' ' 339' ' ' PRO . 27.5 m -129.41 153.48 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 112.003 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 345' ' ' VAL . 10.0 tp10 -148.33 150.94 34.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.16 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.57 -40.8 71.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.948 0.404 . . . . 0.0 110.62 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.43 ' H ' ' HG3' ' A' ' 343' ' ' GLU . 26.0 t -96.05 -84.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.546 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 14.7 m -154.32 -179.92 8.38 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -73.23 -26.74 61.25 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.108 0.48 . . . . 0.0 110.579 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . 0.599 ' HD3' ' O ' ' A' ' 348' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.524 -0.75 . . . . 0.0 110.335 177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.376 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 48.2 m -102.33 115.46 30.62 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.028 0.442 . . . . 0.0 110.295 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -77.59 161.74 27.61 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.699 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -122.69 136.26 54.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 308' ' ' VAL . 19.3 m -115.16 148.83 17.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 345' ' ' VAL . 13.1 mmm180 -102.42 128.48 49.01 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.318 -176.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.57 ' HA ' HG12 ' A' ' 342' ' ' VAL . . . -89.63 120.77 31.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.256 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.68 -14.74 27.65 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.981 0.42 . . . . 0.0 110.107 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -134.12 157.57 45.84 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.92 142.97 33.01 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 120.995 0.426 . . . . 0.0 111.351 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' PHE . . . . . 0.594 ' HB3' HG12 ' A' ' 303' ' ' VAL . 41.5 t80 -121.76 113.26 19.44 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -161.3 136.31 7.47 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.16 131.79 56.81 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.115 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.09 8.47 4.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.278 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -133.95 133.12 41.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.134 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 8.6 t70 69.52 120.84 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 123.56 0.744 . . . . 0.0 111.448 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.73 1.94 8.0 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.119 2.546 . . . . 0.0 114.172 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -88.26 23.07 2.26 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.393 0.616 . . . . 0.0 110.317 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -82.08 150.31 27.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.214 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.7 tp -83.04 114.36 21.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -88.32 109.8 20.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.809 0.337 . . . . 0.0 111.332 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . 0.594 HG12 ' HB3' ' A' ' 292' ' ' PHE . 11.8 p -142.64 134.39 25.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.085 0.469 . . . . 0.0 110.274 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -103.5 151.64 22.61 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.766 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.41 119.67 8.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.392 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 110.13 -11.49 31.55 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.971 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -95.06 171.32 8.82 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.641 0.257 . . . . 0.0 110.625 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 286' ' ' VAL . 15.4 m -122.03 135.77 61.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 72.7 mt -101.64 143.08 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 2.9 m -91.7 107.18 19.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.096 0.474 . . . . 0.0 110.293 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 28.9 m -108.53 149.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.574 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.627 ' HG ' ' H ' ' A' ' 313' ' ' GLU . 0.3 OUTLIER -89.44 -72.82 0.54 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.627 ' H ' ' HG ' ' A' ' 312' ' ' LEU . 13.3 pt-20 170.74 156.4 0.07 Allowed 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.095 0.958 . . . . 0.0 108.977 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' GLN . . . . . 0.505 ' OE1' ' HB3' ' A' ' 316' ' ' PRO . 35.5 tt0 -173.76 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.281 0.363 . . . . 0.0 111.265 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 48.4 m80 58.69 65.95 2.7 Favored Pre-proline 0 N--CA 1.469 0.512 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.532 ' HG3' ' CG ' ' A' ' 320' ' ' TRP . 64.9 Cg_endo -82.65 168.68 14.14 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.953 2.435 . . . . 0.0 114.088 -172.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -97.24 -7.88 31.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.943 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -164.71 -138.48 2.42 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.588 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.23 135.07 56.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.65 0.262 . . . . 0.0 111.046 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' TRP . . . . . 0.542 ' O ' ' HA ' ' A' ' 336' ' ' TYR . 0.3 OUTLIER -132.72 179.07 6.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.184 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 335' ' ' GLY . 33.5 mmtp -86.38 154.1 21.43 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.507 0.67 . . . . 0.0 112.488 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 334' ' ' ILE . . . -161.1 151.43 21.79 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.414 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -108.8 122.69 47.7 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 10.4 tp -118.97 142.89 31.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -101.05 75.88 1.7 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . 0.416 ' CD ' ' HG3' ' A' ' 333' ' ' ARG . 8.9 pt-20 -85.91 171.36 11.54 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.645 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 6.2 m -83.47 80.69 9.02 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.674 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 329' ' ' ARG . 4.4 tp60 -136.85 -170.3 2.66 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ARG . . . . . 0.419 ' H ' ' HG3' ' A' ' 328' ' ' GLN . 68.3 ttt180 -82.11 58.43 3.97 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 60.53 30.2 71.29 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 121.318 -0.468 . . . . 0.0 112.854 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' THR . . . . . . . . . . . . . 3.6 p -74.15 149.87 40.74 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.713 0.292 . . . . 0.0 111.205 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -61.06 -56.88 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.036 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.416 ' HG3' ' CD ' ' A' ' 326' ' ' GLU . 13.6 mmt180 63.01 89.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 322' ' ' GLY . 7.8 tt -133.77 117.44 26.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.095 173.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 321' ' ' LYS . . . -138.66 -169.36 11.55 Favored Glycine 0 CA--C 1.498 -1.017 0 C-N-CA 119.455 -1.355 . . . . 0.0 113.009 -176.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 320' ' ' TRP . 23.7 p90 -108.45 142.95 38.08 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.85 0.357 . . . . 0.0 110.447 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.477 ' CE2' HG21 ' A' ' 342' ' ' VAL . 21.4 p90 -151.49 146.64 19.11 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.048 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 340' ' ' GLY . 93.8 Cg_endo -84.1 128.19 4.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.498 2.132 . . . . 0.0 112.725 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.65 18.99 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.426 2.751 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 338' ' ' PRO . . . -93.96 -19.33 34.22 Favored Glycine 0 N--CA 1.436 -1.343 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' ILE . . . . . 0.494 HG13 HG13 ' A' ' 342' ' ' VAL . 44.5 pt -108.87 -8.73 11.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.159 0.504 . . . . 0.0 111.061 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 288' ' ' ALA . 25.0 m -131.81 150.02 33.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.175 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -161.54 167.7 24.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.67 100.95 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.629 0.728 . . . . 0.0 109.941 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.648 ' O ' ' HG3' ' A' ' 287' ' ' ARG . 10.3 p -156.93 152.97 7.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.429 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 15.0 m -67.06 -56.07 11.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.927 0.394 . . . . 0.0 110.031 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -157.34 154.95 29.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.897 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.318 -0.783 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.77 176.62 . . . . . . . . 0 0 . 1 stop_ save_